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X11 Summary 
Staphylococcus  aureus  is  one  of  the  most  important  pathogens  in  humans  and 
animals.  S.  aureus  is  currently  the  most  common  cause  of  infections  in 
hospitalized  patients.  The  bacterium  infects  diverse  tissues  and  causes  a  wide 
spectrum  of  diseases,  suggesting  that  it  possesses  a  repertoire  of  distinct 
molecular  mechanisms  promoting  bacterial  survival  in  disparate  in  vivo 
environments. 
A  variety  of  in  vitro  systems  have  been  developed  that  simulate  certain  aspects 
of  the  infectious  process,  enabling  the  development  of  screens  to  study  bacterial 
gene  expression  and  the  behaviour  of  mutant  strains  in  physiological  conditions 
that  reflect  the  situation  in  vivo.  In  vitro  assays  have  been  enormously  useful  and 
continue  to  provide  much  information  on  the  mechanisms  of  bacterial 
pathogenesis,  but  it  is  obvious  that  they  cannot  accurately  reproduce  all  aspects 
of  the  host-pathogen  interaction.  A  pathogen  may  encounter  several  radically 
different  environments  in  the  host,  and  it  may  therefore  have  very  different 
requirements  at  various  points  during  infection,  particularly  in  the  context  of  a 
developing  immune  response.  Consequently,  a  gene  that  seems  important  in  in 
vitro  studies  may  not  be  important  in  vivo,  and  genes  that  appear  unimportant  in 
an  in  vitro  assay  may  play  a  critical  role  during  a  natural  infection. 
For  these  reasons,  in  vivo  experimental  models  are  highly  desirable.  Recently, 
methods  have  been  developed  that  enable  the  identification  of  genes  that  are 
expressed  or  required  for  in  vivo  growth.  Most  of  these  methods  fall  into  two 
broad  classes.  In  vivo  expression  technology  (IVET)  is  a  promoter-trap  strategy 
designed  to  identify  genes  whose  expression  in  induced  in  a  specific 
environment,  typically  that  encountered  in  a  host.  Signature-tagged  mutagenesis 
(STM)  uses  comparative  hybridisation  to  isolate  mutants  unable  to  survive 
specified  environmental  conditions  and  has  been  used  to  identify  genes  critical 
for  survival  in  the  host.  Both  methods  have  been  used  to  identify  virulence  genes 
in  S.  aureus.  The  main  aim  of  this  project  was  to  find  any  probable  new  genes  of 
S.  aureus  that  are  essential  for  biofilm  formation  and  infection  mouse  model  by 
STM. 
A  library  of  tagged  insertion  mutants  of  S.  aureus  and  a  series  of  selected  tags 
in  plasmids  of  S.  aureus  strain  RN6390  were  used.  Most  of  the  experiments  with 
X111 both  the  library  and  selected  tags  had  problems  with  cross-hybridisation.  All  the 
selected  tags  were  therefore  sequenced  and  33  tags  with  less  than  50%  identity 
were  chosen  for  future  experiments.  A  library  of  825  mutants  was  made  with  the 
33  selected  tags.  The  mutants  were  arrayed  in  25  pools  of  33  mutants.  Different 
tests  were  done  to  determine  that  the  new  library  was  reliable  for  a  cross- 
hybridisation  free  screening.  The  library  was  then  used  in  an  infection  model  in 
mouse  and  biofilm  formation.  A  total  of  12  mutants  with  significantly  reduced 
signals  were  sequenced.  7  out  of  12  attenuated  mutants  showed  homology  to 
different  genes  in  S.  aureus  and  other  bacteria.  Tetrahydrodipicolinate 
succinylase  homolog,  opp-2F,  acetoin  utilization  AcuC  protein,  phosphate  ABC 
transporter,  dapD,  branched-chain-amino-acid  transporter,  pepF,  and  flaR  genes 
were  identified.  This  work  was  the  first  STM  screening  in  a  biofilm  system,  and 
the  dapD  gene  was  identified  in  a  biofilm  for  the  first  time.  2  out  of  12  genes  had 
also  been  identified  in  previous  STM  screens.  5  out  of  12  attenuated  mutants 
showed  homology  to  some  hypothetical  proteins.  A  hypothetical  protein  of  the 
same  locus  was  identified  in  two  mutants. 
xiv Part  I 
Introduction Chapter  1 
Introduction Chapter  1:  Introduction 
1.1  Microbiology  of  staphylococci 
1.1.1  Morphology 
The  name  staphylococcus  is  derived  from  the  Greek  term  staphyle,  meaning  "a 
bunch  of  grapes".  This  name  refers  to  the  fact  that  the  cells  of  these  gram-positive 
cocci  grow  in  a  pattern  resembling  a  cluster  of  grapes.  However,  staphylococci  are 
spherical  cells  about  1  µm  in  diameter  arranged  in  irregular  clusters.  Single  cocci, 
pairs,  tetrads,  and  chains  are  also  seen  in  liquid  cultures  and  clinical  material.  Young 
cocci  stain  strongly  gram-positive.  On  ageing,  many  cells  become  gram-negative. 
Staphylococci  are  non-motile  and  do  not  form  spores  (20,119). 
Staphylococcal  species  occur  worldwide  as  commensals  on  the  skin  of  animals  and 
man.  They  are  also  found  on  mucous  membranes  of  the  upper  respiratory  tract  and 
lower  urogenital  tract  and  as  transients  in  the  digestive  tract.  They  are  comparatively 
stable  in  the  environment.  Staphylococcal  strains  display  a  selective  affinity  for 
particular  animal  species.  Transfer  of  S.  aureus  strains  between  animal  species  and 
between  animals  and  man  is  limited  (138). 
1.1.2  Taxonomy 
The  genus  currently  comprises  32  species  and  15  serotypes,  many  of  which  are 
found  on  humans.  The  species  most  commonly  associated  with  human  disease  are  S. 
aureus  (the  most  virulent  and  best-known  member  of  the  genus),  S.  epidermidis,  S. 
saprophyticus,  S.  capitis,  and  S.  haemolyticus  (119).  S.  aureus  is  the  only  species 
found  in  humans  that  produces  the  enzyme  coagulase,  which  differentiates  it  from  the 
other  species  that  are  referred  to  as  coagulase-negative  staphylococci  (20,119). 
1.1.3  Biochemical  and  metabolic  characteristics 
Staphylococci  are  nonmotile,  aerobic  or  facultatively  anaerobic,  and  catalase- 
positive  and  grow  in  a  medium  containing  10%  sodium  chloride  and  at  a  temperature ranging  from  18°C  to  40°C.  Relatively  simple  biochemical  tests  can  be  used  to 
differentiate  S.  aureus  and  the  other  staphylococci.  S.  aureus  has  positive  reactions  for 
coagulase,  heat-stable  nuclease,  alkaline  phosphatase  and  mannitol  fermentation. 
Differentiation  of  the  coagulase-negative  staphylococci  is  more  complex,  however, 
and  is  not  routinely  done  in  many  clinical  laboratories  unless  the  isolates  are 
demonstrated  to  be  clinically  significant  (119). 
1.1.4  Laboratory  identification 
Staphylococci  grow  readily  on  most  bacteriological  media  under  aerobic  or 
microaerophilic  conditions.  They  grow  most  rapidly  at  37°C  but  form  pigment  best  at 
room  temperature  (20-25°C).  The  most  important  staphylococcal  species  is  S.  aureus, 
which  is  named  for  its  yellow-pigmented  colonies  (aureus  =  golden)  as  the  result  of 
the  carotenoid  pigments  that  form  during  their  growth.  Colonies  on  solid  media  are 
round,  smooth,  raised,  and  glistening.  S.  aureus  usually  forms  grey  to  deep  golden 
yellow  colonies.  S.  epidermidis  colonies  usually  are  grey  to  white  on  primary 
isolation;  many  colonies  develop  pigment  only  upon  prolonged  incubation.  No 
pigment  is  produced  anaerobically  or  in  broth.  Various  degrees  of  haemolysis  are 
produced  by  S.  aureus  and  occasionally  by  other  species.  Peptostreptococcus  species, 
which  are  anaerobic  cocci,  often  resemble  staphylococci  in  morphology  (20,119, 
160). 
1.2  Epidemiology 
Staphylococci  are  ubiquitous:  All  persons  have  coagulase-negative  staphylococci  on 
their  skin,  and  transient  colonization  of  moist  skin  folds  with  S.  aureus  is  common. 
Colonisation  of  umbilical  stump,  skin,  and  perineal  area  of  neonates  with  S.  aureus  is 
common.  S.  aureus  and  coagulase-negative  staphylococci  are  also  found  in  the 
oropharynx,  gastrointestinal  tract,  and  urogenital  tract.  Short-term  or  persistent  S. 
aureus  carriage  in  older  children  and  adults  is  more  common  in  the  anterior 
nasopharynx  than  in  the  oropharynx.  Approximately  15%  of  normal  healthy  adults  are 
persistent  nasopharyngeal  carriers  of  S.  aureus,  with  a  lighter  incidence  reported  for 
hospitalised  patients,  medical  personnel,  persons  with  eczematous  skin  diseases,  and 
those  who  regularly  use  needles  either  illicitly  or  for  medical  reasons.  Although  S. 
2 aureus  rarely  causes  problems  in  otherwise  healthy  people,  it  is  commonly  associated 
with  infections  of  prosthetic  devices  and  surgical  wounds,  bacteraemia,  endocarditis 
and  pneumonia  in  hospitalised  patients.  Many  of  these  infections  start  locally  (e.  g., 
skin  or  catheter  infections)  then  spread  to  the  bloodstream,  thus  putting  patients  at  risk 
of  developing  endocarditis  and  other  metastatic  complications  (91,99,119). 
Because  staphylococci  are  found  on  the  skin  and  in  the  nasopharynx,  shedding  of 
the  bacteria  is  common  and  is  responsible  for  many  hospital-acquired  infections. 
Some  characteristics  of  the  staphylococci  account  for  their  pathogenicity,  which  takes 
many  forms.  They  grow  comparatively  well  under  conditions  of  high  osmotic 
pressure  and  low  moisture,  which  partially  explains  why  they  can  grow  and  survive  in 
nasal  secretions  (many  people  carry  the  bacteria  in  their  noses)  and  on  the  skin.  This 
also  explains  how  S.  aureus  can  grow  in  some  foods  with  high  osmotic  pressure  (such 
as  ham  and  other  cured  meats)  or  in  low-moisture  foods  that  tend  to  inhibit  the  growth 
of  other  organisms.  The  yellow  pigment  probably  confers  some  protection  from  the 
antimicrobial  effects  of  sunlight.  Staphylococci  are  susceptible  to  high  temperatures, 
as  well  as  to  disinfectants  and  antiseptic  solutions.  The  organisms  can  survive  on  dry 
surfaces  for  long  periods.  The  organisms  can  be  transferred  to  a  susceptible  person 
either  through  direct  contact  or  through  contact  with  fomites  (e.  g.,  contaminated 
clothing,  bed  linens)(1  19,160). 
Staphylococci  are  among  the  most  common  causes  of  hospital-acquired  infections, 
including  bacteraemia,  surgical  site  infections,  pneumonia,  and  urinary  tract  infections 
(50,51,121).  In  hospitals,  the  areas  at  highest  risks  for  severe  staphylococcal 
infections  are  the  newborn  nursery,  intensive  care  units,  operating  rooms,  and  cancer 
chemotherapy  wards.  Massive  introduction  of  "epidemic"  pathogenic  S.  aureus  into 
these  areas  may  lead  to  serious  clinical  disease.  Personnel  with  active  S.  aureus 
lesions  and  carriers  may  have  to  be  excluded  from  these  areas  (20),  or  at  least, 
medical  personnel  must  use  proper  hand-washing  techniques  to  prevent  the  transfer  of 
staphylococci  from  themselves  to  patients  or  among  patients  (119). 
S.  aureus  causes  disease  through  the  production  of  toxin  or  through  the  direct 
invasion  and  destruction  of  tissue.  The  clinical  manifestations  of  some  staphylococcal 
diseases  such  as  impetigo,  staphylococcal  scalded  skin  syndrome  (SSSS), 
staphylococcal  food  poisoning  and  toxic  shock  syndrome  (TSS)  are  almost 
exclusively  the  result  of  toxin  activity,  whereas  other  diseases  result  from  the 
proliferation  of  the  organisms,  leading  to  abscess  formation  and  tissue  destruction. 
3 1.3.1.2  Beta  toxin 
P  toxin,  also  called  sphingomyelinase  C,  is  a  35  KDa  heat-labile  protein  produced 
by  most  strains  of  S.  aureus.  This  enzyme  has  a  specificity  for  sphingomyelin  and 
lysophosphatidylcholine  and  is  toxic  to  a  variety  of  cells,  including  erythrocytes, 
leukocytes,  macrophages,  and  fibroblasts.  It  catalyses  the  hydrolysis  of  membrane 
phospholipids  in  susceptible  cells,  with  lysis  proportional  to  the  concentration  of 
sphingomyelin  exposed  on  the  cell  surface.  This  is  believed  to  be  responsible  for  the 
differences  in  species  susceptibility  to  the  toxin.  Beta-toxin  displays  species- 
dependent  activity.  Sheep,  cow,  and  goat  erythrocytes  are  most  sensitive.  Human 
erythrocytes  are  intermediate  in  sensitivity,  whereas  murine  and  canine  erythrocytes 
are  resistant.  The  degree  of  erythrocytes  sensitivity  depends  on  membrane 
sphingomyelin  content.  The  role  of  ß  toxin  in  human  disease  remains  to  be  proved; 
however,  together  with  a  toxin,  it  is  believed  to  be  responsible  for  the  tissue 
destruction  and  abscess  formation  characteristic  of  staphylococcal  diseases  (51,119). 
1.3.1.3  Gamma-toxin 
Gamma-toxin  is  able  to  lyse  human,  sheep,  and  rabbit  erythrocytes  as  well  as  human 
lymphoblastic  cells.  Gamma-toxin,  leukocidin,  and  other  bicomponent  toxins  are  a 
family  of  proteins  encoded  by  hlg  and  luk  PV  loci.  All  of  the  toxins  in  this  family 
contain  two  synergistically  acting  proteins:  one  S  component  (LukS-PV,  H1gA,  or 
H1gC)  and  one  F  component  (LukF-PV  or  HIgB)  designated  on  the  basis  of  their 
mobility  (slow  or  fast)  in  ion-exchange  chromatography.  The  prototype  bicomponent 
toxins  are  the  closely  related  Panton-Valentine  leukocidin  ((PVL)  and  gamma-toxin. 
The  PVL  S  and  F  components  are  LukS-PV  and  LukF-PV.  Gamma-toxin  likewise 
contains  S  and  F  components  designated  HIgA  and  H1gB,  respectively  (51). 
Synergistic  function  involves  sequential  binding  of  the  F  and  S  components.  The 
action  of  gamma-toxin  on  erythrocytes  involves  initial  binding  of  H1gB  (F)  followed 
by  HIgA  (S)  and  subsequent  generation  of  a  pore  (38,44). 
Studies  have  shown  that  the  genes  for  gamma-toxin  are  transcribed  from  a  single 
locus,  located  on  a  4.5-kb  Scal-digested  chromosomal  fragment.  Extracts  from  a  clone 
containing  this  fragment  were  haemolytic  and  leukotoxic.  The  open  reading  frames,  in 
order,  are  named  hlgA,  hlgC,  and  hlgB,  and  they  correspond  to  previous  identified 
5 gamma-toxin  genes.  hlgC  and  hlgB  are  transcribed  on  a  single  mRNA,  while  hlgA  is 
separately  expressed  (45). 
1.3.1.4  Delta  toxin 
6  toxin  is  a3  KDa  polypeptide  produced  by  almost  all  S.  aureus  strains  and  the 
majority  of  other  staphylococci.  The  toxin  has  a  wide  spectrum  of  cytolytic  activity, 
affecting  erythrocytes,  other  eukaryotic  cells,  many  other  mammalian  cells, 
organelles,  and  spheroplasts  and  protoplasts,  as  well  as  intracellular  membrane 
structures.  This  relatively  non-specific  membrane  toxicity  is  consistent  with  the  belief 
that  the  toxin  acts  as  a  surfactant  disrupting  cellular  membranes  by  means  of  a 
detergent-like  action.  It  has  also  been  reported  to  be  dermonecrotic  and  lethal  in 
experimental  animals  when  used  in  high  concentration.  The  activity  of  delta-toxin  is 
inhibited  by  phospholipids  (36,119). 
6  toxin  is  a  26-residue  long  peptide  encoded  by  the  hlg  gene  with  peak  production  at 
the  end  of  the  exponential  growth  phase  and  can  be  purified  by  different  procedures 
(17).  The  toxin  has  different  affinity  for  different  cells  such  as  neutrophils, 
monocytes,  lymphocytes,  and  erythrocytes  (3).  The  toxin  acts  by  formation  of  pores 
in  the  membrane,  leading  to  the  lysis  of  erythrocytes  and  other  mammalian  cells.  At 
least  two  variants  of  6  toxin  exist;  toxins  expressed  by  human  and  canine  strains  of  S. 
aureus  are  only  62%  identical  and  are  immunologically  distinct  (51). 
1.3.1.5  Leukocidin 
S.  aureus  can  express  a  toxin  that  specifically  acts  on  polymorphonuclear 
leukocytes.  Phagocytosis  is  an  important  defence  against  staphylococcal  infection  so 
leukocidin  should  be  a  virulence  factor.  Its  name  arises  from  the  fact  that  it  can  kill 
leukocytes  (of  which  neutrophils  are  one  type).  Panton-Valentine  Leukocidin  (PVL) 
consists  of  two  protein  components,  S  and  F.  The  S  component  is like  the  B  part  of  an 
A-B  toxin,  in  that  it  binds  to  GM1  gangliosides.  However,  both  have  enzymatic 
activity,  involved  in  phospholipids  and  phosphatidylinositol  metabolism,  respectively. 
Phosphatidylinositol,  an  important  signalling  molecule  in  eukaryotic  cells,  controls  a 
number  of  cellular  processes.  Thus,  the  action  of  this  two-component  toxin  appears  to 
-alter  phospholipid  metabolism  and  cause  disruption  of  normal  cellular  activities  (36, 
6 141).  The  two  components  of  the  PVL  bind  sequentially  to  human  neutrophils, 
although  most  reports  indicate  that  the  S  component  binds  first  and  subsequently 
forms  pores  (31). 
1.3.1.6  Exfoliative  toxins  A  and  B 
Two  serologically  distinct  exfoliative  toxins  have  been  described,  designated 
exfoliative  toxin  A  (ETA)  and  exfoliative  toxin  B  (ETB).  These  toxins  cause  SSSS, 
usually  seen  in  new-borns  and  characterised  by  intraepidermal  separation  of  layers  of 
the  skin  at  the  desmosomes.  The  illness  begins  abruptly  with  a  generalised  erythema, 
often  near  the  mouth  and  spreading  over  the  entire  body  in  the  course  of  a  few  days. 
When  the  skin  is  lightly  rubbed,  the  epidermal  layer  wrinkles  irreversibly,  giving  rise 
to  the  characteristic  positive  Nikolsky  sign.  Later,  large  flaccid  sterile  bullae  appear 
that  lead  to  separation  through  the  stratum  granulosum  layer.  The  entire  sequence 
from  disease  onset  to  recovery  is  7  to  10  days.  There  is  no  permanent  scarring  on 
areas  of  the  skin,  and  the  causative  toxins  are  not  themselves  lethal  to  the  host  (36). 
1.3.1.7  Toxic  shock  syndrome  toxin-1 
TSS  is  characterised  by  fever,  hypotension,  and  rash  followed  by  desquamation  and 
the  involvement  of  multiple  organ  systems.  It  is  toxin  mediated.  Toxic  shock 
syndrome  toxin-1  (TSST-1),  formerly  called  pyrogenic  exotoxin  C  and  enterotoxin  F, 
is  an  exotoxin  secreted  during  the  growth  of  some  strains  of  S.  aureus  and  can 
reproduce  most  of  the  clinical  manifestations  of  TSS  in  an  experimental  rabbit  model 
(rash  and  desquamation  are  not  seen).  TSST-1  has  not  been  found  in  staphylococcal 
isolates  from  all  patients  with  TSS,  but  most  of  these  isolates  not  producing  TSST-1 
are  reported  to  produce  enterotoxin  B.  The  role  of  this  second  toxin  in  TSS  has  not 
been  adequately  defined.  Coagulase-negative  staphylococci  can  also  produce  TSS 
(118). 
1.3.1.8  Enterotoxins 
Staphylococcal  enterotoxins  (SEs)  belong  to  a  large  family  of  staphylococcal  and 
streptococcal  pyrogenic  exotoxins  (PT),  sharing  common  phylogenetic  relationships, 
7 structure,  function,  and  sequence  homology.  The  PT  family  is  composed  of  SEs, 
TTST-1,  and  streptococcal  pyrogenic  exotoxins  (SPE).  Nine  serologically  distinct 
staphylococcal  enterotoxins  (SEA  through  SEE  and  SEG  through  SEJ)  have  been 
identified  (14).  The  enterotoxins  are  resistant  to  hydrolysis  by  gastric  and  jejunal 
enzymes  and  are  stable  to  heating  at  100°C  for  30  minutes.  Thus  once  a  food  product 
has  been  contaminated  with  enterotoxin-producing  staphylococci  and  the  toxins  have 
been  produced,  reheating  the  food  will  not  be  protective.  Staphylococcal  food 
poisoning  is  the  leading  cause  of  food-borne  microbial  intoxication  worldwide  and  is 
usually  linked  to  improper  storage  of  food  (76).  The  SEs  are  stable  in  the 
gastrointestinal  tract  and  indirectly  stimulate  the  emetic  reflex  centre.  Although  the 
vagus  nerve  is  involved,  molecular  events  involved  are  unclear.  There  is  mounting 
evidence  that  mast  cell  activation  occurs  and  that  inflammatory  mediators  and 
neuropeptide  substance  P  are  released  upon  SE  activity  in  the  gastrointestinal  tract 
and  elsewhere  (2,145).  S.  aureus  and  S.  epidermidis  produce  these  toxins,  with  30% 
to  50%  of  all  S.  aureus  strains  producing  an  enterotoxin  (118). 
1.3.2  Staphylococcal  enzymes 
1.3.2.1  Coagulase 
Coagulase  production  is  the  principal  criterion  used  in  the  clinical  microbiology 
laboratory  for  the  identification  of  S.  aureus.  Although  a  few  strains  of  S.  aureus  do 
not  produce  detectable  amounts  of  coagulase,  all  strains  seem  to  possess  a  coagulase 
gene  (coa)  (163).  S.  aureus  strains  possess  two  forms  of  coagulase:  bound  (also  called 
clumping  factor)  and  free.  Coagulase  bound  to  the  staphylococcal  cell  wall  can 
directly  convert  fibrinogen  to  insoluble  fibrin  and  cause  the  staphylococci  to  clump. 
The  cell-free  coagulase  accomplishes  the  same  result  by  reacting  with  a  globulin 
plasma  factor  (coagulase-reacting  factor)  to  form  staphylothrombin,  a  thrombinlike 
factor.  This  factor  catalyses  the  conversion  of  fibrinogen  to  insoluble  fibrin. 
Coagulase  is  used  as  a  marker  for  the  virulence  of  S.  aureus.  The  role  of  coagulase  in 
the  pathogenesis  of  disease  is  speculative,  but  coagulase  may  cause  the  formation  of  a 
fibrin  layer  around  a  focal  staphylococcal  abscess,  thus  localising  the  infection  and 
protecting  the  organisms  from  phagocytosis.  However,  coagulase-negative  mutants 
were  less  virulent  than  the  parental  strain  in  a  mouse  model  of  blood-borne 
S staphylococcal  pneumonia  (144).  This  suggests  that  coagulase  may  be  more  important 
in  some  types  of  infections  than  in  others  (51,118). 
1.3.2.2  Catalase 
All  staphylococci  produce  catalase,  which  catalyses  the  conversion  of  toxic 
hydrogen  peroxide  to  water  and  oxygen.  Hydrogen  peroxide  can  accumulate  during 
bacterial  metabolism  or  after  phagocytosis  (118).  Different  toxic  forms  of  oxygen  are 
produced  as  inadvertent  by-products  during  the  reduction  of  02  to  H2O  in  respiration. 
These  reactive  oxygen  intermediates  have  many  deleterious  effects  on  living 
organisms,  ranging  from  DNA  strand  damage  to  peroxidatiori  of  membrane  lipids. 
Bacteria  have  evolved  enzymes  that  destroy  toxic  oxygen  products.  The  most 
common  enzyme  in  this  category  is  catalase,  which  attacks  hydrogen  peroxide 
(H202)(80,102). 
1.3.2.3  Hyaluronidase 
Hyaluronidase  hydrolyses  hyaluronic  acids,  the  acidic  mucopolysaccharides  that 
hold  together  certain  cells  of  the  body,  particularly  cells  in  the  connective  tissue.  This 
digesting  action  is  thought  to  be  involved  in  the  tissue  blackening  of  infected  wounds 
and  to  help  the  microorganism  spread  from  its  initial  site  of  infection.  For  therapeutic 
use,  hyaluronidase  may  be  mixed  with  a  drug  to  promote  the  spread  of  the  drug 
through  a  body  tissue.  More  than  90%  of  S.  aureus  strains  produce  this  enzyme  (118, 
160). 
1.3.2.4  Fibrinolysin 
Fibrinolysin,  also  called  staphylokinase,  is  produced  by  virtually  all  S.  aureus 
strains  and  can  dissolve  fibrin  clots.  Staphylokinase  is  distinct  from  the  fibrinolytic 
enzymes  produced  by  streptococci  (36). 
9 1.3.2.5  Lipases 
All  strains  of  S.  aureus  and  more  than  30%  of  the  strains  of  coagulase-negative 
staphylococci  produce  several  different  lipases.  As  their  names  implies,  these 
enzymes  hydrolyse  lipids,  an  essential  function  to  ensure  the  survival  of  staphylococci 
in  the  sebaceous  areas  of  the  body.  It  is  believed  that  these  enzymes  must  be  present 
for  staphylococci  to  invade  cutaneous  and  subcutaneous  tissues  and  for  superficial 
skin  infections  such  as  furuncles  (boils),  and  carbuncles  to  develop.  Lipases  break  fats 
down  into  their  fatty  acid  and  glycerol  components.  Each  component  is  then 
metabolised  separately  (118,160). 
1.3.2.6  Nuclease 
A  thermostable  nuclease  (TNase)  is  produced  by  nearly  all  strains  of  S.  aureus  and 
has  been  used  as  a  diagnostic  criterion  for  this  species.  TNase  hydrolyses  single-  and 
double-stranded  DNA  and  RNA  at  the  5'  position  of  phosphodiester  bonds  by  a 
calcium-dependent  mechanism.  The  role  of  this  enzyme  in  the  pathogenesis  of 
infection  is  unknown  (51,118). 
1.3.2.7  Penicillinase 
More  than  90%  of  staphylococcal  isolates  were  susceptible  to  penicillin  in  1941,  the 
year  the  antibiotic  was  first  used  clinically.  However,  resistance  to  penicillin  quickly 
developed,  primarily  because  the  organisms  could  produce  penicillinase  (beta- 
lactamase).  The  enzyme  cleaves  the  ß-lactam  ring  of  the  penicillin  molecule.  The 
widespread  distribution  of  this  enzyme  was  ensured  by  its  presence  on  transmissible 
plasmids  (118,160). 
1.3.3  Other  factors 
1.3.3.1  Capsule 
A  loose-fitting,  polysaccharide  layer  (slime  layer)  is  only  occasionally  found  on 
staphylococci  cultured  in  vitro,  but  it  is  believed  to  be  more  commonly  present  in 
10 vivo.  More  than  90%  of  clinical  isolates  of  S.  aureus  produce  capsular 
polysaccharides.  Eleven  capsular  serotypes  have  been  identified  in  S.  aureus,  with 
serotypes  5  and  8  associated  with  the  majority  of  infections  (136).  These  capsules  can 
also  be  divided  into  two  distinct  groups  on  the  basis  of  colony  morphology.  Mucoid- 
type  capsules  include  the  serotype  1  and  2  capsules;  strains  producing  these  capsules 
are  heavily  encapsulated  and  are  mucoid  on  solid  medium.  Microcapsules  include  the 
remaining  serotype  3  to  11  capsules;  strains  with  these  capsules  have  a  thin  capsular 
layer  and  form  non-mucoid  colonies  on  solid  medium.  Studies  showed  that  the 
mucoid-type  capsules  were  important  antiphagocytic  virulence  factors  that  masked 
C3b  deposited  on  the  bacterial  cell  wall,  preventing  its  recognition  by  receptors  on 
phagocytic  cells.  The  capsule  protects  the  bacteria  from  polymorphonuclear 
leukocytes,  as  well  as  by  inhibiting  the  proliferation  of  mononuclear  cells  after 
mitogen  exposure.  It  also  facilitates  the  adherence  of  bacteria  to  catheters  and  other 
synthetic  material  (e.  g.,  grafts,  shunts,  prosthetic  valves  and  joints).  This  property  is 
particularly  important  for  the  survival  of  relatively  avirulent  coagulase-negative 
staphylococci  (51,119).  It  has  been  shown  that  S.  aureus  strains  that  are  defective  in 
microcapsule  production  are  more  efficient  at  inducing  experimental  infective 
endocarditis  (IE)  than  their  parental  strains,  suggesting  that  the  microcapsule  may 
obscure  important  surface-expressed  cell  wall  proteins  involved  in  IE  pathogenesis 
(36). 
1.3.3.2  Protein  A 
The  surface  of  most  S.  aureus  strains  (but  not  the  coagulase-negative  staphylococci) 
is  uniformly  coated  with  protein  A.  This  protein  is  covalently  linked  to  the 
peptidoglycan  layer  and  has  a  unique  affinity  for  binding  to  the  Fc  receptor  of 
immunoglobulin  (Ig)Gi,  IgG2,  and  IgG4,  thus  effectively  preventing  the  antibody- 
mediated  immune  clearance  of  the  organism.  The  importance  of  protein  A  in 
staphylococcal  infections  is  somewhat  unclear.  It  is  possible  that,  by  binding  IgG, 
protein  A  could  interfere  with  the  phagocytosis  of  opsonized  bacteria  via  receptors  on 
the  host  cell.  Extracellular  protein  A  can  also  binds  antibodies,  thereby  forming 
immune  complexes  with  the  subsequent  consumption  of  the  complement.  Recent 
studies  has  showed  that  protein  A  can  mediate  bacterial  adherence  to  von  Willebrand 
11 Such  diseases  include  cutaneous  infections,  endocarditis,  pneumonia,  empyema, 
osteomyelitis,  and  septic  arthritis.  In  the  presence  of  a  foreign  body  like  a  splinter, 
catheter,  shunt,  prosthetic  valve  or  joint,  significantly  fewer  staphylococci  are 
necessary  to  establish  disease.  Likewise,  patients  with  congenital  diseases  associated 
with  an  impaired  chemotactic  or  phagocytic  response,  such  as  Job-Buckley  syndrome, 
Wiskott-Aldrich  syndrome,  and  chronic  granulomatous  disease,  are  more  susceptible 
to  staphylococcal  diseases  (51,119). 
1.3  Virulence  factors  of  staphylococci 
1.3.1  Staphylococcal  toxins 
1.3.1.1  Alpha  toxin 
a  toxin  (a  haemolysin)  which  is  encoded  on  the  bacterial  chromosome,  is  a  33  KDa 
polypeptide  that  is  produced  by  most  strains  of  S.  aureus.  The  toxin  disrupts  the 
smooth  muscle  in  blood  vessels  and  is  toxic  to  many  types  of  cells,  including 
erythrocytes,  leukocytes,  hepatocytes,  platelets,  and  cultivated  cells.  It  becomes 
integrated  in  the  hydrophobic  regions  of  host  cell  membrane,  leading  to  formation  of 
1-  and  2-nm  ring-shaped  pores  (51).  The  rapid  efflux  of  K+  and  influx  of  Na+,  Cat+, 
and  other  small  molecules  leads  to  osmotic  swelling  and  cell  lysis.  The  sensitivity  to 
this  varies  for  animal  species  (rabbit  erythrocytes  are  1000-fold  more  sensitive  than 
are  human  cells)  and  cell  type  (e.  g.,  fibroblasts  can  repair  membrane  damage  more 
effectively  than  can  erythrocytes).  Cells  such  as  rabbit  erythrocytes  are  suspected  to 
have  high-affinity  binding  sites,  while  other  cells  such  as  human  erythrocytes  have 
only  low-affinity  sites  (75).  a  toxin  is  believed  to  be  an  important  mediator  of  tissue 
damage  in  staphylococcal  disease  (119).  a  toxin  is  also  an  important  cause  of  damage 
to  the  air-blood  barrier  in  S.  aureus-induced  pneumonia  (109).  Most  S.  aureus  isolates 
posses  hla,  the  structural  gene  for  alpha-toxin,  but  are  variable  in  its  expression  or  in 
the  amount  of  toxin  expressed.  Work  with  mutants  in  animal  models  indicated  that 
strains  expressing  alpha-toxin  are  more  virulent  than  isogenic  derivatives  (51). 
4 factor,  an  extracellular  matrix  protein  important  in  normal  hemostasis,  suggests  that 
protein  A  may  play  additional  roles  in  the  infectious  process  (51). 
The  presence  of  protein  A  has  been  exploited  in  some  serological  tests,  in  which 
protein  A-coated  S.  aureus  is  used  as  a  non-specific  carrier  of  antibodies  directed 
against  other  antigens.  Additionally,  detection  of  protein  A  can  be  used  as  a  specific 
identification  test  for  S.  aureus  (119). 
1.4  Regulation  of  virulence  determinants 
S.  aureus  surface  proteins,  such  as  adhesins  and  protein  A,  a  major  surface  antigen, 
are  produced  early  in  growth  in  vitro  and  their  production  is  down-regulated  at  a  later 
time.  Most  secreted  proteins,  such  as  toxins,  haemolysins,  and  tissue-degrading 
enzymes,  are  produced  at  the  end  of  exponential  phase.  The  production  of  all  of  these 
factors  (the  virulence  response),  is  controlled  primarily  by  a  global  regulatory  locus 
agr  (42),  which  has  been  shown  in  several  experimental  infection  models  to  be 
required  for  virulence  (47,48,134). 
The  agr  locus  (66,70-72)  consists  of  two  divergent  transcription  units  using 
promoters  P2  and  P3  (figure  1.1)(126).  The  P2  operon  contains  four  genes,  agrA,  B, 
C,  and  D.  Genes  agrA  and  C  represent  a  classic  two-component  signal  transduction 
pathway,  of  which  agrC  encodes  the  signal  receptor  and  agrA  the  response  regulator 
(82,98,101).  The  other  two  genes,  agrB  and  D,  combine  to  produce  the  autoinducer, 
a  small  peptide  that  is  the  ligand  that  binds  to  and  activates  AgrC  (30).  AgrD  encodes 
the  autoinducer  propeptide  (30)  and  AgrB  encodes  a  protein  that  is  required  for 
processing  and  possibly  for  secretion  of  the  autoinducer  (104).  AgrC  is  a 
transmembrane  protein  that  is  phosphorylated  at  a  conserved  histidine  residue  in 
response  to  the  autoinducer  in  vitro  (112).  The  last  extracellular  loop  of  AgrC  is 
sufficient  for  binding  of  the  autoinducer  and  the  subsequent  activation  by 
phosphorylation.  The  primary  role  of  the  agrAC  signaling  pathway  is  to  up-regulate 
both  of  the  major  agr  promoters,  P2  and  P3,  which  it  does  in  conjunction  with  a 
second  transcription  factor,  SarA  (114,118).  It  may  also  up-regulate  the  coagulase 
gene  (125),  but  does  not  directly  regulate  any  of  the  other  known  agr-dependent 
genes.  The  P3  operon  specifies  a  512  nucleotide  transcript,  RNA  III,  that  is  the 
effector  molecule  of  the  agr  regulon  (70,71),  and  happens  to  encode  the  26  amino 
acid  S-hemolysin  which  is  not  involved  in  regulation.  RNA  III  up-regulates 
12 (a)  ý-  ýS 
-hem 
,  _b  (ü 
P2  P3 
ý 
Response  regulator  Receptor  -  HPK 
Required  for  response  to 
AI  P 
.. 
ý,  .  ý-- 
Required  for  synthesis  of 
,  ý.  AIP 
II% 
ADP 
I  IItý￿  ýýIt.  nitet 
gone  expression 
``  (b) 
-- 
`mntffnfftdfitgiknigniaaYSTCD  FI  Nkievevpke@gW 
T 
S.  aureus  group  I  AIP 
Figure  1.1  The  agr  system.  (a)  A  schematic  diagram,  showing  the  two  divergent  agr  promoters 
(P2  and  P3)  and  their  transcripts.  The  P2  operon  contains  four  genes,  agrA,  B,  C,  and  D.  Two  of 
these,  agrC  and  agrA,  represent  a  two-component  signal  transduction  pathway  and  the  other  two, 
agrB  and  D,  combine  to  generate  a  peptide  that  is  the  activation  ligand  for  the  signal  receptor. 
The  function  of  the  signalling  pathway  is  to  activate  the  two  agr  promoters  so  that  there  are  two- 
levels  of  positive  feedback  (open  arrow).  The  P3  transcript,  RNA  III,  regulates  transcription  of 
30  or  more  unlinked  target  genes,  including  hla  the  a-hemolysin  gene,  by  an  unknown 
mechanism.  (b)  A  blow-up  of  AgrD,  showing  the  amino  acid  sequence  of  the  autoinducing  peptide 
(AIP)  (in  bold)  that  serves  as  activating  ligand  for  the  pathway  by  binding  to  AgrC.  (c)  A  blow-up 
of  AgrC,  showing  five  transmembrane  helices,  predicted  by  sequence  analysis  and  confirmed  by 
phoA  fusions.  Deletion  analysis  suggests  that  the  last  eatracellular  loop  is  the  site  of  AIP  binding, 
which  causes  the  predicted  phosphorylation  of  a  conserved  histidine  (11) in  the  carboxy-terminal 
cytoplasmic  domain  (126). transcription  of  the  secretory  protein  genes  and  down-regulates  transcription  of  the 
surface  protein  genes  by  an  as  yet  unknown  mechanism  that  probably  involves 
proteins  encoded  by  genes  outside  of  the  agr  locus.  RNA  III  also  and  independently 
regulates  translation  of  at  least  one  product  a-hemolysin  by  complementary  pairing 
with  the  hla  mRNA  leader  region,  which,  in  the  absence  of  RNA  III,  folds  into  an 
untranslatable  configuration  (70,133). 
1.5  Staphylococcal  diseases  in  human 
It  is  important  to  keep  in  mind  that  the  staphylococci  that  cause  disease  in  humans 
and  animals  are  not  inherently  pathogenic  organisms  (unlike  the  influenza  virus,  for 
example,  which  must  cause  disease  to  propagate).  For  every  illness  caused  by 
staphylococci,  many  more  individuals  are  benignly  colonised  with  no  sign  of  disease. 
It  is  important  to  realise  that  no  single  virulence  factor  produced  by  a 
Staphylococcus  has  been  shown  to  date  to  be  either  necessary  or  sufficient  for  the 
establishment  of  an  infection,  although  the  infective  or  lethal  dose  does  vary.  No 
strain  has  yet  been  identified  that  produces  all  the  known  toxins,  or  even  members 
from  all  toxin  families. 
The  narrowest  definition  of  a  virulence  factor  would  be  a  substance  that,  when 
purified  to  homogeneity  and  introduced  into  a  test  animal,  produces  a  pathogenic 
effect.  Using  that  definition,  most  of  the  virulence  factors  especially  those  involved  in 
attachment  and  probably  most  of  the  degradative  enzymes  (e.  g.,  lipases,  proteases, 
and  hyaluronidase)  would  not  be  considered  true  virulence  factors.  In  the  broadest 
sense,  any  substance  that  is  exported  out  of  the  cytoplasm  either  to  the  cell  surface  or 
into  the  extracellular  environment  of  the  Staphylococcus  can  be  thought  of  as  a 
potential  virulence  factor.  Clearly,  those  substances  that  are  capable  of  interacting 
with  the  host  may  affect  that  host  in  some  deleterious  way.  This  second  definition  is 
probably  too  broad  and  in  many  cases  it  is  possible  that  the  production  of  at  least 
some  of  these  factors  may  actually  assist  the  host  in  combating  an  infection  (36). 
1.5.1  Bacteraemia  and  infective  endocarditis 
S.  aureus  and  coagulase-negative  staphylococci  (CoNS)  are  ideal  infective 
endocarditis  (IE)  pathogens  in  that  they  possess  a  number  of  virulence  factors,  which 
13 enable  them  to  establish  1E.  Acute  endocarditis  caused  by  S.  aureus  is  a  serious 
disease,  with  a  mortality  rate  approaching  50%.  Although  patients  with  S.  aurcus 
endocarditis  may  initially  have  non-specific  influenza-like  symptoms,  their  condition 
can  deteriorate  rapidly  and  include  disruption  of  cardiac  output  and  peripheral 
evidence  of  septic  embolization.  Unless  appropriate  medical  and  surgical  intervention 
is  instituted  immediately,  the  patient's  prognosis  is  poor.  In  addition,  S.  aureus 
continues  to  be  an  important  cause  of  both  community-acquired  (CA)  and  hospital- 
acquired  (HA)  bacteraemia.  Commonly  associated  predisposing  medical  conditions 
include  diabetes  mellitus  and  renal  insufficiency.  Most  patients  with  S.  aureus 
bacteraemia  have  an  obvious  primary  focus  of  infection,  usually  an  intravascular 
catheter.  Overall  mortality  in  patients  with  S.  aureus  bacteraemia  remains  high, 
particularly  in  the  absence  of  a  removable  primary  focus,  older  age  patients,  rapidly 
fatal  comorbid  conditions,  underlying  respiratory  or  cardiac  disease,  associated 
infective  endocarditis  (IE),  and  septic  shock.  Methicillin-resistant  S.  aureus  (MRSA) 
bacteraemia  is  a  growing  problem  globally  (36,119). 
1.5.2  Wound  infections 
Staphylococcal  infections  of  the  skin  can  be  minor  or  life  threatening,  depending  on 
the  integrity  of  the  skin  surface  and  the  invasiveness  of  the  bacterial  strain. 
Staphylococci  are  the  most  common  species  recovered  from  patients  who  develop  a 
wound  infection  after  surgery,  with  S.  aureus  and  the  CoNS  rank  first  and  third 
among  aerobic  bacteria  associated  with  wound  infections,  respectively.  In  general, 
staphylococci  that  cause  wound  infections  come  from  the  flora  of  the  patient  or  the 
personnel  performing  the  procedure.  For  S.  aureus,  studies  have  shown  that  the 
patient's  own  flora  serves  as  the  source  of  the  infecting  bacteria  in  about  one-half  of 
cases  of  surgical  infections  (36,51). 
1.5.3  Infections  of  intravascular  catheters  and  vascular  devices 
Although  intravascular  catheters  and  vascular  grafts  have  revolutionised  the  practice 
of  medicine  for  the  betterment  of  patients,  unfortunately  they  are  associated  with  a 
significant  incidence  of  infection.  Staphylococci,  both  S.  aureus  and  CoNS,  play  a 
pre-eminent  role  in  these  infections.  Because  of  their  unique  environmental  niche  on 
14 the  skin  and  mucus  membranes  of  humans  and  their  ability  to  adhere  to  biomaterials 
and  cause  infection,  they  will  undoubtedly  continue  to  cause  significant  morbidity  and 
mortality  as  the  use  of  prosthetic  medical  devices  increases.  From  20%  to  65%  of  all 
infections  of  catheters  and  shunts  are  caused  by  CoNS.  The  CoNS  are  particularly 
well  adapted  for  causing  these  infections  because  they  can  produce  a  polysaccharide 
slime  that  bonds  them  to  catheters  and  shunts  and  protects  them  from  antibiotics  and 
inflammatory  cells.  A  persistent  bacteraemia  is  generally  observed  in  patients  with 
infections  of  shunts  and  catheters  because  the  organisms  have  continual  access  to  the 
blood  stream  (36,119). 
1.5.4  Skin  and  soft  tissue  infections 
Staphylococci  are  inhabitants  of  the  skin  and  mucous  membranes  of  mammals  and 
birds,  where  they  exist  saprophytically.  However,  factors  ranging  from  tight  clothing 
or  scratching  to  immunosuppression  or  insertion  of  a  prosthesis  alter  the  host-parasite 
relationship  and  cause  disease.  Colonisation,  particularly  of  the  nares  by  S.  aureus, 
leads  to  hand  carriage,  and  from  the  hands,  the  organisms  are  frequently  spread  to 
other  areas  of  the  body.  Thus,  staphylococci  often  follow  a  nose  to  hands  to  wounds 
route  of  infection  (172).  The  variety  of  enzymes  and  toxins  produced,  especially  by  S. 
aureus,  results  in  a  spectrum  of  disease,  part  of  which  may  be  a  direct  expression  of 
the  toxin  damage,  but  also  a  result  of  a  variety  of  pathogenicity  factors  acting  in 
concert.  Purulent  skeletal  muscle  infection  (pyomyositis),  folliculitis  and  furuncles, 
recurrent  furunculosis,  impetigo,  botryomycosis  and  secondary  cutaneous  infection  in 
patients  with  eczema  are  some  staphylococcal  infections  due  to  S.  aureus  (36). 
1.5.5  Central  nervous  system 
The  staphylococci  are  important  causative  organisms  of  cerebrospinal  fluid  (CSF) 
shunt  infections,  acute  purulent  meningitis,  brain  abscess  associated  with  trauma, 
spinal  and  cranial  subdural  empyema  and  epidural  abscess.  CoNS  are  the  etiologic 
organisms  in  most  CSF  shunt  infections.  S.  aureus  is  the  second  most  common 
pathogen.  The  staphylococci  typically  enter  the  shunt  system  from  a  contaminated 
wound  or  from  the  patient's  skin  surface  at  operation. 
15 S.  aureus  is  the  causative  organism  in  most  cases  of  staphylococcal  meningitis  that 
develop  as  a  complication  of  a  neurosurgical  procedure,  from  a  parameningeal  focus 
of  infection  or  a  congenital  anomaly  or  during  the  course  of  staphylococcal 
bacteraemia  or  endocarditis.  S.  aureus  is  a  common  causative  organism  of  brain 
abscesses  that  develops  as  a  result  of  cranial  trauma,  either  penetrating  wounds  of  the 
brain  or  craniotomy.  S.  aureus  is  the  causative  organism  in  most  cases  of  spinal 
subdural  empyema  and  in  15  to  25  percent  of  cases  of  cranial  subdural  empyema. 
CoNS  are  isolated  on  rare  occasion  from  cranial  subdural  empyemas.  S.  aureus  is  the 
causative  organism  in  50  to  60  percent  of  spinal  epidural  abscess  and  in  most  cranial 
epidural  abscesses  that  occur  as  a  complication  of  craniotomy  or  compound  skull 
fracture  (36). 
1.5.6  Diseases  of  the  eye 
Staphylococcal  diseases  of  the  eye  include  both  infections  and  expression  of  cell- 
mediated  immunity  (CMI)  to  staphylococcal  antigens.  The  pathogenesis  of  diseases 
due  to  both  S.  aureus  and  CoNS  has  been  increasingly  well-characterised  in  recent 
years  (36).  A  model  of  staphylococcal  keratitis  in  guinea  pig  has  been  described  (41), 
and  a  similar  model  in  rats  was  used  to  determine  the  effects  of  antibiotics  and 
corticosteroid  treatments  on  the  progression  of  S.  aureus  infection  of  the  cornea  (10). 
Radial  incision  of  the  rabbit  conjunctiva  followed  by  inoculation  of  S.  aureus  resulted 
in  purulent  conjunctivitis  and  a  model  for  testing  antimicrobial  treatments  in  this 
disease  (16). 
1.5.7  Osteomyelitis  and  other  infections  of  bones  and  joints 
Colonization  of  the  bones  and  joints  by  S.  aureus  may  occur  as  a  result  of  either 
hematogenous  infection  or  it  can  be  a  secondary  infection  resulting  from  trauma  or 
the  extension  of  disease  from  an  adjacent  area  (51,119).  During  the  1970s,  most  cases 
of  osteomyelitis  were  caused  by  strains  of  S.  aureus.  During  the  1990s,  although  the 
incidence  of  osteomyelitis  caused  by  gram-negative  pathogens  has  increased 
dramatically,  staphylococci  are  still  the  most  commonly  isolated  pathogens  in  most 
types  of  osteomyelitis.  S.  aureus  is  the  most  frequent  single  pathogen  in  adults, 
16 accounting  for  50  to  70  percent  of  cases  of  osteomyelitis.  The  estimated  frequency  of 
S.  aureus  in  pyogenic  osteomyelitis  in  all  age  groups  may  reach  80  to  90  percent  (36).  ' 
S.  aureus  is  the  primary  cause  of  septic  arthritis  in  young  children  and  in  adults  who 
are  receiving  intra-articular  injections  or  who  have  mechanically  abnormal  joints. 
Secondary  involvement  of  multiple  joints  is  indicative  of  hematogenous  spread  from  a 
localised  focus.  Staphylococcal  arthritis  is  characterised  by  a  painful,  erythematous 
joint,  with  purulent  material  obtained  on  aspiration.  Infection  is  usually  demonstrated 
in  the  large  joints  (e.  g.,  shoulder,  knee,  hip,  and  elbow).  The  prognosis  in  children  is 
excellent,  but  in  adults,  it  depends  on  the  nature  of  the  underlying  disease  as  well  as 
the  occurrence  of  any  secondary  infectious  complications  (119). 
1.5.8  Respiratory  tract  infections 
S.  aureus,  in  distinct  contrast  to  the  CoNS,  is  a  significant  cause  of  respiratory  tract 
disease.  S.  aureus  respiratory  disease  can  develop  after  the  aspiration  of  oral 
secretions  or  from  the  hematogenous  spread  of  the  organism  from  a  distant  site. 
Aspiration  pneumonia  is  seen  primarily  in  the  very  young,  the  aged,  and  patients  with 
cystic  fibrosis,  influenza,  chronic  obstructive  pulmonary  disease,  and  bronchoiectasis. 
Hematogenous  pneumonia  is  common  for  patients  with  bacteraemia  or  endocarditis. 
While  S.  aureus  is  not  among  the  most  frequent  of  isolates  from  patients  with 
sinusitis,  bronchitis,  or  pneumonia,  it  is  isolated  from  patients  with  these  illnesses. 
Although  S.  aureus  is  an  uncommon  cause  of  severe  community-acquired  pneumonia, 
it  is  responsible  for  perhaps  20  to  30  percent  of  cases  of  nosocomial  pneumonia  (36, 
51,119). 
1.5.9  Urinary  tract  infections 
Although  staphylococci  are  not  commonly  thought  of  as  causes  of  urinary  tract 
infection  (UTI),  S.  aureus  may  cause  UTI.  The  infections  range  from  asymptomatic 
bacteriuria  to  infections  that  are  severe  and  associated  with  bacteraemia.  Given  the 
relative  frequency  with  which  the  perineal  area  is  colonised  with  S.  aureus,  it  is 
perhaps  surprising  that  this  organism  is  relatively  uncommonly  recovered  as  a  cause 
of  UTI  (36).  S.  saprophyticus  has  a  predilection  for  causing  UTI  in  young,  sexually 
17 active  women  and  is  rarely  responsible  for  infections  in  other  patients.  It  is  also 
infrequently  found  as  an  asymptomatic  colonizer  of  the  urinary  tract  (119). 
1.5.10  Toxin-mediated  syndromes 
Three  diseases  are  associated  with  specific  toxins:  (i)  toxic  shock  syndrome  (TSS), 
caused  by  toxic  shock  syndrome  toxin  type  1  (TSST-1),  (ii)  food  poisoning,  by 
staphylococcal  enterotoxins;  and  (iii)  staphylococcal  scalded  skin  syndrome  (SSSS) 
by  exfoliative  toxins.  Two  other  diseases  are  probably  related  to  staphylococcal 
toxins:  staphylococcal  enterocolitis,  caused  by  staphylococcal  enterotoxins  or  5-toxin; 
and  severe  wound  infections  associated  with  a-toxin  (36). 
Staphylococcal  toxic  shock  syndrome  (TSS)  is  an  illness  that  is  the  result  of  the 
protean  effects  of  one  or  more  toxins  of  S.  aureus  (36).  Staphylococcal  TSS  may 
manifest  in  either  of  two  general  forms,  menstrual  or  nonmenstrual.  Menstrual  TSS 
occurs  in  women  whose  vaginal/cervical  mucosa  are  colonised  by  TSST-1-producing 
S.  aureus.  Tampon  use  is  a  risk  factor  in  menstrual  TSS,  and  a  correlation  between 
tampon  absorbency  and  risk  of  developing  TSS  has  been  established.  TSS  acquired  in 
this  way  is  difficult  to  reproduce  in  animals,  although  some  success  has  been  achieved 
with  a  simulation  of  tampon  use  in  rabbits.  Attempts  have  also  been  made  to  induce 
TSS  or  a  TSS-like  syndrome  by  other  means  in  laboratory  animals  (137),  but  a 
definitive  model  for  this  disease  has  not  been  forthcoming.  Nonmenstrual  TSS  may 
result  from  S.  aureus  infection  elsewhere  in  the  body.  Either  staphylococcal 
enterotoxins  (SEs)  or  TSST-l  may  mediate  the  nonmenstrual  form  (51).  TSST-1  in 
the  bloodstream  can  trigger  a  massive  release  of  cytokines  that  cause  shock  and  death. 
In  animals,  TSST-1  makes  the  animal  hypersusceptible  to  LPS,  which  may  enter  the 
bloodstream  regularly  in  small  amounts  because  of  lysis  of  gram-negative  bacteria  in 
the  intestine.  However,  LPS  might  not  even  be  the  most  important  molecule  whose 
action  is  potentiated  by  TSST  (141). 
Staphylococcal  food  poisoning,  one  of  the  most  common  foodborne  illnesses,  is  an 
intoxication  rather  than  an  infection.  Disease  is  caused  by  bacterial  toxin  present  in 
food  rather  than  from  a  direct  effect  of  the  organisms  on  the  patient.  Certain  strains  of 
S.  aureus  can  also  cause  enterocolitis,  which  is  manifested  clinically  by  watery 
diarrhoea,  abdominal  cramps,  and  fever.  Enterocolitis  occurs  primarily  in  patients 
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flora  and  permit  the  growth  of  S.  aureus  (119). 
Staphylococcal  scalded  skin  syndrome  (SSSS)  is  characterised  by  the  abrupt  onset 
of  a  localised  perioral  erythema  (redness  and  inflammation  around  the  mouth)  and 
formation  of  the  bullae  or  skin  blisters  and  a  potential  for  widespread  peeling.  The 
lesions  cover  the  entire  body  within  2  days.  The  disease  is  predominant  in  children. 
Bullous  impetigo  is  a  localised  form  of  SSSS.  Specific  strains  of  toxin-producing  S. 
aureus  are  associated  with  the  formation  of  superficial  skin  blisters.  Unlike  patients 
with  the  disseminated  manifestations  of  SSSS,  patients  with  bullous  impetigo  have 
localised  blisters  that  are  culture-positive  (51,113,119). 
1.6  Veterinary  aspects  of  staphylococci 
The  first  systematic  study  of  pathogenic  staphylococci  was  done  by  Rosenbach  in 
1884.  The  association  of  staphylococci  with  veterinary  medicine  began  with  the 
isolation  of  the  organisms  from  mastitis  in  sheep  by  Nocard  in  1887.  In  1890 
Guillebeau  reported  that  staphylococci  were  responsible  for  mastitis  in  cattle.  Thus 
within  six  years  of  the  first  systematic  study  of  pathogenic  staphylococci  in  1884,  the 
importance  of  staphylococci  in  veterinary  medicine  was  established  (48).  S.  aureus,  S. 
intermedius,  and  the  coagulase-variable  S.  hyicus  are  important  pathogens  of  domestic 
animals.  Although  coagulase-negative  staphylococci  are  usually  of  low  virulence, 
some  occasionally  cause  disease  in  animals  (138). 
1.6.1  Bovine  mastitis 
Mastitis  is  an  inflammatory  reaction  of  the  mammary  gland.  The  most  important 
mastitis  pathogen,  worldwide,  is  S.  aureus.  Staphylococcal  mastitis  may  be 
subclinical,  or  clinical.  The  majority  of  infections  are  subclinical.  In  the  clinical  form, 
the  disease  may  be  peracute,  acute,  or  chronic.  Peracute  and  gangrenous  forms  are 
associated  with  severe  systemic  reactions  and  can  be  life  threatening.  The  peracute 
form,  which  is  rare,  is  caused  by  S.  aureus,  often  shows  a  gangrenous  udder,  and  is 
frequently  fatal.  In  gangrenous  mastitis  the  affected  quarter,  which  becomes  cold  and 
blue-black,  eventually  sloughs.  Tissue  necrosis  is  attributed  to  the  alpha-toxin  which 
causes  contraction  and  necrosis  of  smooth  muscle  in  blood  vessel  walls,  impeding 
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enzymes  from  leukocytes.  Usually,  staphylococcal  mastitis  begins  with  an  acute 
episode,  including  some  or  all  of  the  cardinal  signs  of  inflammation  in  the  udder: 
tumour,  rubor,  calor,  and  dolour  and  functio  laesa.  Systemic  signs  of  disease  are  not 
always  seen.  If  not  successfully  treated,  the  acute  form  becomes  chronic,  with  few 
clots  in  the  milk,  or  with  no  clinical  signs;  the  disease  subsequently  passes  into  a 
subclinical,  chronic  form.  An  elevated  somatic  cell  count  and  isolation  of  bacteria 
from  the  milk  can  only  detect  this  form  of  mastitis  (66,138). 
The  route  of  infection  in  staphylococcal  mastitis  is  via  the  teat,  and  the  milking 
machine  is  considered  to  be  the  most  important  predisposing  factor.  However, 
staphylococcal  mastitis  does  occur  in  hand-milked  cows,  in  suckled  cows,  and  during 
the  dry  period.  The  bacteria  pass  the  teat  duct  into  the  teat  and  udder  cisterns,  and 
subsequently  into  the  milk  ducts.  They  may  subsequently  establish  in  an  area  of 
secretory  tissue.  S.  aureus  and  other  mastitis  pathogens,  at  37°C,  are  able  to  rise  with 
the  milk  fat.  The  phenomenon  seems  to  involve  IgA  antibodies  associated  with 
membranes  of  fat  globules  in  previously  infected  animals.  This  phenomenon  may  aid 
to  invade  upper  parts  of  the  milk  ducts  and  udder. 
The  mechanism  of  penetration  via  the  teat  duct  is  not  fully  understood,  but  it  is 
suggested  that  the  organisms  gain  entrance  to  the  teat  cistern  by  propulsion  and/or  by 
bacterial  growth.  The  staphylococci  colonise  the  tip  of  the  teat,  especially  in  areas  of 
teat  lesions  or  erosions.  Colonisation  often  precedes  an  intramammary  infection  but 
does  not  always  result  in  mastitis.  Staphylococci  can  colonize  the  teat  duct  for  a 
prolonged  period  of  time.  In  the  intact  teat,  the  organisms  probably  exist  as  distinct 
microcolonies  in  the  stratum  corneum,  as  they  do  in  other  areas  of  skin.  When  contact 
is  made  between  the  staphylococci  and  milk,  then  a  medium  is  provided  in  which  the 
staphylococci  can  grow  into  the  gland.  The  nearer  the  organisms  are  to  the  milk  in  the 
teat  cistern,  the  greater  is  the  risk  for  mammary  infection  to  occur.  Once  the 
organisms  pass  the  barriers  of  the  teat  duct,  adherence  to  epithelial  cells  is  thought 
(but  still  not  proven)  to  be  the  next  critical  step  in  pathogenesis.  Adherence  is 
believed  to  involve  a  combination  of  cation-bridging,  hydrophobic  interactions,  and 
bacterial  adhesin-specific  epithelial  surface  receptors.  It  has  been  shown  that  the 
ability  of  S.  aureus  to  bind  to  epithelial  cells  of  the  ductules  and  alveoli  in  the  bovine 
mammary  gland  is  an  important  virulence  factor,  and  that  antibodies  against  whole 
cells  inhibit  the  adherence. 
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substances  that  can  be  utilised  as  nutrients  for  the  bacteria.  Although  several  potential 
virulence  determinants  have  been  purified,  or  partly  purified,  and  tested  for  toxicity  in 
different  experimental  systems,  their  relative  importance  as  virulence  determinants  is 
not  known  (66). 
The  mouse  model  of  intramammary  inoculation  has  been  used  extensively  in 
studying  this  disease  and  represents  a  reproducible  and  cheap  simulation  of  the 
disease  in  dairy  cattle  (26).  Various  attempts  have  been  made  in  the  past  to  design 
vaccines  directed  against  the  bacterial  surface  polysaccharides  and  proteins  (adhesins) 
and  against  the  toxins  of  S.  aureus  and  to  test  their  efficacy  in  bovine,  mouse,  and 
rabbit  models  (52,156).  More  recently,  a  live  attenuated  S.  aureus  strain  was  used  to 
provide  protection  in  mice  when  inoculated  locally  during  late  pregnancy  or  early 
lactation  (60). 
1.6.2  Mastitis  in  other  species 
Staphylococci  are  capable  of  causing  mastitis  in  domestic  animals  other  than  the 
cow  though  these  infections  are  far  less  well  documented  than  staphylococcal  mastitis 
in  the  cow.  In  broad  terms  the  mode  of  infection  and  the  host  defence  mechanisms  are 
similar  to  those  that  operate  in  the  cow.  However,  staphylococcal  mastitis  has  been 
seen  in  other  species  such  as  sheep,  goats,  pigs,  rabbits,  dogs,  cats  and  horses  (48).  In 
sheep  and  goats,  the  mastitis  is  predominantly  of  the  gangrenous  type  (66). 
1.6.3  Exudative  epidermitis 
Exudative  epidermitis  (greasy  pig  disease)  is  an  acute  generalised  dermatitis,  caused 
by  S.  hyicus,  which  involves  the  entire  body  surface  of  pigs  5-35  days  of  age.  It  is 
highly  contagious  and  is  characterised  by  hyperhidrosis,  excess  sebaceous  secretion, 
exfoliation  and  exudation  but  no  pruritis.  These  changes  result  in  a  loss  of  skin 
function,  extreme  dehydration  and  rapid  exhaustion,  which  may  terminate  in  death. 
Piglets  under  3  weeks  of  age  may  die  within  24  to  48  hours.  Morbidity  rates  range 
from  20%  to  100%,  and  mortality  rates  can  reach  90%  in  severely  affected  litters.  S. 
hyicus  can  be  isolated  from  the  vaginal  mucosa  and  skin  of  healthy  sows.  The 
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wounds  (48,138). 
Prevention  of  the  disease  is  by  scrubbing  the  sow  with  a  suitable  disinfectant  prior 
to  entering  the  furrowing  crate.  The  furrowing  crate  and  pen  should  be  clean  and  all 
sharp  edges  and  ridges  should  be  removed  (48). 
1.6.4  Tick  pyaemia  of  lambs 
Tick  pyaemia  is  a  prenatal  infection  of  lambs  with  S.  aureus,  characterised  by 
septicaemia  and  death  or  by  bacteraemia  and  the  localisation  of  staphylococci  in 
various  tissues.  In  the  bacteraemic  form  of  the  disease  arthritis  or  meningitis  may  first 
appear  during  the  first  2-4  weeks  of  life;  there  may  also  be  suppurative  lesions  in  the 
skin,  muscles,  tendon  sheaths  and  viscera  especially  the  heart  and  kidneys.  Tick 
pyaemia  was  originally  found  to  co-exist  with  louping  ill,  tick-borne  fever,  lamb 
dysentery  and  pulpy  kidney  disease  (48,138). 
The  association  between  the  disease  and  hill-grazing  regions  of  Britain  and  Ireland, 
where  there  are  suitable  habitats  for  the  tick  Rodes  ricinus,  is  strong  (138). 
The  first  line  in  control  of  tick  pyaemia  must  be  to  ensure  that  hygienic  conditions 
exist  for  lambing  and  carrying  out  surgical  procedures  so  that  staphylococcal 
contamination  and  infection  is  reduced  to  a  minimum  (48). 
1.6.5  Staphylococcosis  of  poultry 
As  in  other  animals  the  staphylococci  that  cause  disease  in  poultry  are  inhabitants  of 
the  skin  of  the  animals  and  do  not  differ  biochemically  from  other  skin  staphylococci. 
The  lesion  traditionally  associated  with  staphylococci  in  poultry  is  bumblefoot.  This  is 
a  localised  bulbous  lesion  of  the  ball  of  the  foot,  which  arises  from  the  penetration  of 
a  foreign  body  followed  by  secondary  invasion  by  S.  aureus.  Lameness  is  often  the 
first  symptom  of  the  condition  and  the  swelling  may  not  be  obvious  until  the  planter 
aspect  of  the  foot  is  examined.  However,  if  S.  aureus  gains  entrance  to  the  circulation 
of  birds,  then  a  septicaemia  is  produced  which  if  not  fatal,  leads  to  arthritis  and 
synovitis  (48).  S.  aureus  can  also  cause  arthritis  and  septicaemia  in  turkeys,  and 
omphalitis  in  chicks  (138). 
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Pyoderma  is  one  of  the  most  common  skin  diseases  of  dogs,  but  it  is  relatively  rare 
in  cats.  Coagulase-positive  Staphylococcus  is  the  most  commonly  isolated  organism 
from  pyoderma  in  dogs.  Prior  to  1982,  the  organism  was  called  S.  aureus,  but 
subsequently  it  has  been  identified  as  S.  intermedius.  It  is  suggested  that  changes  in 
sebum  production  provide  a  milieu  in  which  S.  intermedius  may  multiply  (66). 
1.6.7  Endometritis 
The  clinical  features  of  endometritis  vary  from  species  to  species.  Frequently  no 
more  is  observed  in  the  cow  than  a  slight  vaginal  discharge  and  repeated  return  to 
service.  On  the  other  hand  the  bitch  usually  presents  as  an  endometritis  which  has 
advanced  to  pyometritis.  The  uterus  is  palpably  enlarged,  there  is  a  vaginal  discharge, 
anorexia  and  depression.  There  are  often  signs  of  concomitant  renal  involvement  such 
as  polyuria,  nocturia  and  polydipsia  (48). 
1.7  Treatment  and  vaccines 
Staphylococci  quickly  developed  drug  resistance  after  penicillin  was  introduced  and 
today  less  than  10%  of  the  strains  are  susceptible  to  this  antibiotic.  This  resistance  is 
mediated  by  penicillinase  which  hydrolyses  the  ß-lactam  ring  of  penicillin.  The 
genetic  information  encoding  the  production  of  this  enzyme  is  carried  on 
transmissible  plasmids,  which  facilitated  the  rapid  dissemination  of  resistance  among 
staphylococci. 
Because  of  the  problems  with  penicillin-resistant  staphylococci,  semisynthetic 
penicillins  resistant  to  ß-lactamase  hydrolysis  (e.  g.,  methicillin,  nafcillin,  oxacillin, 
dicloxacillin)  were  developed.  Unfortunately,  the  staphylococci  developed  resistance 
to  these  antibiotics,  as  well.  S.  aureus  which  is  resistant  to  an  antibiotic  called 
methicillin  is  referred  to  as  methicillin-resistant  Staphylococcus  aureus  or  MRSA. 
Currently,  30%  to  50%  of  the  strains  of  S.  aureus  and  more  than  50%  of  the 
coagulase-negative  staphylococci  are  resistant  to  these  semisynthetic  penicillins. 
Resistance  occurs  as  the  result  of  acquisition  of  a  gene,  mecA,  that  codes  for  a  novel 
penicillin-binding  protein,  PBP2'.  The  penicillins  and  other  ß-lactam  antibiotics  kill 
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responsible  for  construction  of  the  cell  wall  peptidoglycan.  PBP2'  is  not  bound  by 
penicillins  but  retains  its  enzymatic  activity. 
Staphylococci  have  demonstrated  the  remarkable  ability  to  develop  resistance  to 
most  antibiotics.  Until  recently,  the  one  antibiotic  that  has  remained  uniformly  active 
against  staphylococci  has  been  vancomycin,  the  current  antibiotic  of  choice  for 
treating  staphylococci  resistant  to  oxacillin.  Unfortunately,  isolates  of  S.  aureus  have 
been  found  with  decreased  susceptibility  to  vancomycin,  and  frank  resistance  to 
vancomycin  has  been  observed  in  coagulase-negative  staphylococci.  The  mechanism 
of  this  resistance  is  unknown.  However,  there  is  evidence  that  changes  in  cell  wall 
synthesis  have  led  to  reversible  vancomycin  binding  that  effectively  prevents 
vancomycin  from  disrupting  peptidoglycan  synthesis  (119). 
Until  the  1970s  a  variety  of  whole  staphylococcal  preparations  was  used  in  clinical 
and  veterinary  trials  as  a  vaccine.  These  included  cultured,  attenuated,  fixed  or  lysed 
organisms.  None  showed  convincing  benefit  in  patients,  animal  models  or  farm 
animals.  Staphylococci  were  known  to  produce  haemolysins  and  leukocidins.  Toxoids 
prepared  from  these  were  largely  unsuccessful  as  vaccines  and  were  accompanied  by 
many  adverse  reactions.  Some  toxoids  of  veterinary  value,  such  as  the  alpha  toxoid, 
protect  ewes  against  gangrenous  mastitis,  did  not  reduce  the  overall  infection  rate. 
Polyvalent  polysaccharide  components  of  the  bacterial  wall  have  given  some 
success  in  animal  models.  However,  clinical  trials  of  staphylococcal  vaccines, 
including  those  utilising  polysaccharides,  were  beset  with  problems  with  loss  of 
potency  of  vaccine  material  and  difficulties  in  interpretation  of  trial  data  (48,116). 
Aerosol  vaccination  with  S.  aureus  endotoxins  have  shown  good  results  in  animal 
models  and  now  await  clinical  trials.  In  last  few  years,  scientists  have  tried  DNA 
vaccination  against  the  clumping  factor  A  (C1fA)  and  passive  immunisation  with 
monoclonal  antibodies  as  new  strategies  in  staphylococcal  vaccination  (116).  The 
results  suggested  that  DNA  immunization  against  adhesins  represents  a  new  and 
valuable  approach  to  combat  S.  aureus  infections  (21). 
1.8  In  vivo  methods  for  studying  bacterial  virulence  genes 
For  more  than  a  century,  microbiologists  have  tried  to  investigate  how  bacteria 
cause  disease  by  measuring  phenotypes  and  attributes  of  the  organism  in  vitro.  It  has 
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are  turned  on  only  during  infection  in  the  host.  Thus,  no  number  of  adherence  assays, 
enzyme  studies,  or  electron  microscopic  examinations  of  cultured  microorganisms 
would  reveal  a  property  that  is  only  expressed  in  vivo. 
Much  of  our  knowledge  about  the  virulence  determinants  of  pathogenic  bacteria 
comes  from  experiments  with  bacteria  grown  in  culture,  but  there  is  currently  an 
increasing  interest  in  what  happens  to  bacterial  pathogens  in  the  infected  host. 
Bacterial  pathogenicity  is  a  multifactorial  property  that  is  only  fully  manifested  in 
vivo,  where  environmental  conditions  differ  from  those  in  laboratory  cultures.  These 
conditions  are  not  only  more  complex  than  those  in  vitro  but  change  as  infection 
proceeds  in  response  to  inflammation,  tissue  breakdown  and  spread  from  one  site  to 
another.  Bacterial  behaviour  will,  therefore,  be  mediated  in  vivo  by  changes  in  the 
availability  of  nutrients  and  substrates  and  the  effect  of  these  changes  on  the 
regulation  of  gene  expression.  Bacterial  pathogens  in  vivo  will,  consequently,  differ 
from  those  grown  in  vitro,  an  effect  now  confirmed  for  many  pathogenic  species.  The 
environment  in  vivo  will  influence  bacterial  pathogenicity  by  controlling  bacterial 
growth  rate  and  population  size  and  by  affecting  the  production  of  virulence 
determinants. 
The  fact  that  environmental  conditions  in  vivo  differ  from  those  in  vitro,  and  change 
as  infection  proceeds,  has  three  implications.  First,  some  putative  virulence 
determinants  indicated  by  experiments  in  vitro  may  not  be  produced  in  vivo.  Second, 
some  of  the  virulence  determinants  that  are  formed  in  vivo  may  not  be  produced  in 
vitro.  Third,  the  complement  of  virulence  determinants  may  change  with  time  and 
anatomical  site.  Clearly,  the  production  in  vivo  of  any  putative  virulence  determinant 
has  to  be  confirmed,  and  bacteria  grown  in  vivo  must  be  examined  to  discover  novel 
virulence  determinants.  Regarding  the  third  implication,  virulence  determinants  must 
be  identified  as  infection  progresses,  together  with  the  host  factors  and  regulatory 
processes  that  induce  them  (151). 
In  the  past  few  years,  the  study  of  bacterial  pathogenesis  has  been  advanced  by  a 
number  of  techniques  that  enable  investigators  to  monitor  bacterial  gene  expression 
during  infection.  These  techniques  allow  the  investigator  to  select  and  screen  for 
genes  that  are  required  for  infection  or  that  are  expressed  in  vivo.  In  particular,  three 
methodologies  have  dramatically  impacted  our  understanding  of  bacterial 
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vivo  (151). 
1.8.1  In  vivo  Expression  Technology  (IVET) 
Defining  the  nature  and  function  of  bacterial  gene  products  expressed  during 
infection  is  critical  to  understanding  the  molecular  and  genetic  mechanisms  of 
pathogenesis.  Recent  advances  in  gene  fusion  technology  have  resulted  in  the 
development  of  a  genetic  strategy  termed  in  vivo  expression  technology  (IVET)  that 
provides  a  positive  selection  for  bacterial  genes  that  are  induced  during  host  infection 
(82,104).  The  protocol  for  IVET  is  shown  in  figure  1.2  (67). 
IVET  is  a  strategy  for  identifying  bacterial  genes  active  during  mammalian  infection 
but  relatively  inactive  at  other  times  (104).  A  subset  of  such  genes  encodes  virulence 
factors  crucial  to  the  infection  process.  The  novel  feature  of  IVET  is  its  use  of 
infected  mammalian  tissues  directly  to  induce  expression  of  candidate  virulence 
genes,  rather  than  relying  on  one's  ability  to  duplicate  the  in  vivo  milieu  in  the 
laboratory.  Accordingly,  it  is  a  powerful  advance  over  earlier  gene-finding  techniques 
(98). 
The  IVET  system  has  several  applications  in  the  area  of  vaccine  and  antimicrobial 
drug  development.  The  technique  has  been  designed  for  the  identification  of  virulence 
factors  and  thus  may  lead  to  the  discovery  of  new  antigens  useful  as  vaccine 
components.  The  IVET  system  facilitates  the  isolation  of  mutations  in  genes  involved 
in  virulence  and,  therefore,  should  aid  in  the  construction  of  live  attenuated  vaccines 
(150). 
The  original  IVET  selection  was  performed  by  creating  transcriptional  fusions  of 
random  fragments  of  the  Salmonella  typhimurium  chromosome  with  a  promoterless 
purA  gene  and  introducing  this  library  onto  the  chromosome  of  an  S.  typhimurium 
ApurA  strain  via  homologous  recombination  at  the  chromosomal  fragment.  Because 
purines  are  limiting  for  growth  of  S.  typhimurium  in  the  mouse,  only  those  strains 
expressing  purA  from  fused  promoters  would  survive  (104). 
It  should  be  noted  that  the  integration  event  resulting  from  a  single  crossover  does 
not  lead  to  disruption  of  the  wild-type  locus  on  the  chromosome,  thereby  permitting 
analysis  of  genes  essential  for  growth  in  vivo.  Bacteria  representing  the  pool  of 
chromosomal  fusions  were  then  injected  intraperitoneally  in  mice,  and  the  surviving 
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H pools  were  recovered  3  days  later  and  screened  on  laboratory  medium  for  clones  with 
low  promoter  activity.  Several  strains  carrying  promoters  meeting  the  criteria  of  in 
vivo  expression  and  in  vitro  inactivity  were,  on  subsequent  analysis,  found  to  have 
severe  virulence  defects  as  assayed  by  oral  LD50,  thereby  validating  the  ability  of 
IVET  to  isolate  virulence  genes  (29,104). 
IVET  was  applied  to  S.  aureus  using  a  promoter  trap  that  relies  on  genetic 
recombination  of  the  site-specific  resolvase  of  tnpR  from  gamma  delta  (Tn1000)  as  a 
reporter  gene  expression.  A  collection  of  45  genes  were  found  induced  during 
infection  in  a  murine  renal  abscess  model.  Of  these,  only  six  had  been  known 
previously;  11  others  have  homology  to  known  non-staphylococcal  genes.  The  known 
staphylococcal  genes  included  agrA,  a  key  locus  regulating  numerous  virulence 
products;  and  a  glycerol  ester  hydrolase  which  may  enhance  bacterial  survival  in 
abscesses.  Many  of  the  ivi  genes  identified  were  not  classical  virulence  factors  but 
rather  involved  in  adaptation  to  the  in  vivo  environment;  knowledge  of  these 
biochemical  pathways  is  clearly  the  next  phase  in  IVET  systems  (98). 
To  date,  there  are  four  variations  of  IVET,  and  each  relies  on  the  generation  of 
transcriptional  fusions  of  genomic  sequences  to  a  reporter  gene  encoding  an 
enzymatic  activity.  The  variation  in  the  four  methods  lies  in  the  particular  reporter 
gene  utilized.  These  are  (i)  auxotrophy  complementation-based  selections,  (ii) 
antibiotic  selections,  (iii)  dual  reporter  selections  or  other  types  of  genes  that  provide 
an  in  vivo  selection  and  an  in  vitro  screen  for  promoter  activity,  and  (iv) 
recombination-based  IVET  (RIVET)  (5). 
There  are  two  limitations  of  IVET  selections  as  follows:  (i)  ivi  genes  that  are 
transiently  expressed  or  expressed  at  a  low  level  in  vivo  are  difficult  or  impossible  to 
detect  because  they  either  do  not  produce  PurA  long  enough  or  do  not  produce 
enough  of  it  to  allow  survival  and  growth  of  the  strain  and  (ii)  not  all  ivi  genes  are 
essential  for  infectivity.  The  first  of  these  limitations  is  of  unknown  magnitude; 
however,  it  is  reasonable  to  predict  that  only  a  subset  of  virulence  genes  that  are 
transcriptionally  silent  in  vitro  will  be  expressed  at  levels  sufficient  for  survival 
throughout  the  course  of  an  infection.  The  second  limitation,  applicable  to  all  IVET 
selections  and  screens,  is  often  misconstrued,  particularly  since  the  advent  of 
signature-tagged  mutagenesis  (STM),  which  is  a  genetic  screen  used  to  identify  genes 
that  are  essential  for  infectivity  (5,72).  In  other  words,  IVET  is  a  selective  method 
that  positively  selects  the  bacterial  genes  that  are  required  for  virulence,  while  STM  is 
27 a  negative  selection  method  for  bacterial  mutants  that  are  present  in  the  initial 
inoculum,  but  do  not  survive  in  the  animal.  STM  is  discussed  in  session  1.8.3. 
1.8.2  Differential  Fluorescent  Induction  (DFI) 
DFI  is  a  promoter  trap  in  which  bacterial  promoters  drive  the  expression  of  the 
highly  sensitive  reporter,  green  fluorescent  protein  (GFP).  The  GFP  of  the  jellyfish 
Aequorea  victoria  is  a  unique  experimental  tool  that  permits  monitoring  of  gene 
expression  and  protein  localisation  in  living  cells.  GFP  is  stable  and,  unlike  reporter 
molecules  such  as  ZacZ  or  luciferase,  it  does  not  require  cofactors  for  its  activity. 
However,  with  the  use  of  a  fluorescence-activated  cell  sorter  (FACS),  in  vivo- 
expressed  fusions  are  identified  by  their  level  of  expression  compared  with  growth  on 
laboratory  media  (70,167). 
1.8.3  Signature-tagged  mutagenesis  (STM) 
Mutagenesis  techniques  have  been  used  extensively  for  the  identification  of  genes 
whose  functions  are  required  under  certain  conditions.  One  of  these  techniques  that 
has  been  used  in  several  pathogens  is  transposon  mutagenesis. 
Transposons  are  the  most  versatile  tools  for  the  genetic  analysis  of  bacteria.  Unlike 
the  situation  with  chemical  mutagenesis,  transposons  produce  complete  disruption  of 
the  mutated  gene,  resulting  in  nonleaky  phenotypes;  moreover,  multiple  insertions  or 
retranspositions  are  rare  events,  and  most  important,  the  resulting  phenotype  is 
genetically  linked  to  a  selectable  marker  such  as  resistance  to  an  antibiotic.  The 
spectrum  of  different  types  of  transposons,  their  mechanisms  of  transposition,  and 
their  applications  in  genetic  engineering  is  an  interesting  subject  for  molecular 
biologists  (42). 
One  approach  to  identifying  the  traits  that  contribute  to  virulence  is  to  make  random 
mutations  in  the  genome  of  a  pathogen  using  a  transposon  and  screen  the  transposon- 
generated  mutants  for  loss  of  virulence  (141). 
Transposons  are  capable  of  inactivating  genes  by  insertion,  and  the  inactivated 
genes  are  readily  identified  and  recovered.  A  typical  strategy  is  to  construct  a  plasmid 
carrying  the  transposon,  using  a  temperature-sensitive  vector,  e.  g.,  a  plasmid  that  is 
unable  to  replicate  at  an  elevated  temperature.  When  this  plasmid  is  introduced  into 
28 bacterial  cells,  and  the  cells  are  grown  at  a  temperature  permissive  for  plasmid 
replication  (e.  g.,  30°C),  all  the  cells  will  carry  the  plasmid.  If  the  culture  is 
subsequently  shifted  to  a  temperature  (e.  g.,  42°C)  at  which  the  plasmid  is  unable  to 
replicate,  the  only  cells  that  retain  the  transposon  will  be  those  in  which  the  element 
has  transposed  onto  the  chromosome.  It  is  usual  to  use  a  transposon  that  carries  an 
antibiotic  resistance  gene  (for  example  TnS,  carrying  a  gene  for  kanamycin 
resistance),  so  these  transpositions  can  be  selected  by  plating  the  culture  at  42°C  on 
agar  containing  kanamycin. 
This  generates  a  transposon  mutant  library,  with  the  transposon  inserted  at  a  variety 
of  chromosomal  positions,  and  therefore  causing  a  range  of  mutations.  Once  the 
mutants  of  interest  are  selected,  the  gene(s)  into  which  transposon  has  inserted  can  be 
identified.  This  can  be  done  as  described  above  for  deletions  and  insertions  in  general 
(i.  e.,  by  looking  for  a  change  in  size  of  specific  DNA  fragments),  but  the  presence  of 
an  antibiotic  resistance  gene  on  the  transposon  facilitates  a  more  direct  approach.  If 
the  total  DNA  is  cut  with  a  restriction  enzyme  (taking  care  to  select  one  that  does  not 
cut  the  transposon  itself),  the  collection  of  fragments  can  be  cloned  to  produce  a  gene 
library.  If  this  gene  library  is  then  plated  on  kanamycin  agar,  only  those  clones 
containing  Tn5  will  be  able  to  grow.  These  clones  will  contain  not  only  Tn5  but  also 
some  of  the  sequence  on  either  side  of  it;  this  is  the  gene  that  has  been  inactivated  by 
Tn5  insertion,  and  it  can  be  proceeded  to  characterise  (39). 
On  the  point  of  transposon  mutagenesis  in  staphylococci,  two  transposons  have 
been  used  successfully  in  S.  aureus  and  S.  epidermidis: 
(1)  The  closely  related  class  II  elements  Tn551  and  Tn917. 
(2)  The  closely  related  conjugative  transposons  Tn916  and  Tn918  (167). 
For  many  applications,  mutations  in  genes  of  interest  can  be  identified  by  screening 
a  sufficient  number  of  mutants  for  a  negative  phenotype.  Such  approaches 
traditionally  required  individual  and  labour-intensive  analysis  of  mutants  for  loss-of- 
function  phenotype.  To  circumvent  this  limitation  and  link  mutagenesis  techniques 
with  an  efficient  screening  approach  a  novel  technique  termed  "signature-tagged 
mutagenesis",  or  STM,  was  developed  (71,72).  Although  the  development  of  STM 
was  performed  for  the  identification  of  new  bacterial  virulence  genes  the  principles  of 
the  method  can  be  adapted  to  the  analysis  of  other  organisms  and  can  be  extended  to 
the  identification  of  genes  whose  functions  are  required  for  the  successful 
colonisation  of  certain  habitats  or  the  exploitation  of  specialised  metabolic  features.  A 
29 key  feature  of  STM  is  the  possibility  of  simultaneous  identification  of  mutants  by 
negative  selection.  In  contrast  to  approaches  where  the  complementation  of  mutations 
can  be  selected  as  a  positive  phenotype,  one  can  identify  a  mutation  resulting  in  a 
negative  phenotype,  such  as  attenuation  of  virulence  or  inability  to  grow  under  certain 
nutritional  conditions.  A  novelty  of  STM  is  that  such  negative  selection  is  not 
performed  by  individual  testing  of  mutants  from  a  bank  of  mutants,  but  rather  by 
collective  screening  of  pools  of  mutants  in  a  parallel  manner  (71). 
STM  is  divided  into  two  steps:  firstly,  the  construction  of  a  library  of  tagged 
mutants,  and  secondly,  in  vivo  screening  of  the  library.  In  the  original  STM,  each 
insertional  mutation  carried  a  different  DNA  tag,  which  allowed  mutants  to  be 
differentiated  from  each  other.  The  tags  were  prepared  as  a  pool  of  oligonucleotides 
containing  a  variable  central  region  flanked  by  conserved  sequences.  The  central 
region  was  designed  to  ensure  that  the  same  sequence  occurs  once  in  2x  1017 
molecules  (72).  Each  tag  comprised  a  different  central  sequence  of  40bp  flanked  by 
invariant  'arms'  of  20bp,  which  enable  the  central  portions  to  be  co-amplified  by  the 
polymerase  chain  reaction  (PCR).  Tags  were  ligated  into  the  pUT  mini-Tn5  Km2 
transposon  and  transferred  from  E.  coli  into  the  recipient  host.  Tagged  mutant  strains 
are  assembled  in  microtitre  dishes,  and  then  combined  to  form  the  'inoculum  pool'  for 
infection  studies.  At  an  appropriate  time  after  inoculation,  bacteria  are  isolated  from 
the  animal  and  pooled  to  form  the  'recovered  pool'.  The  tags  in  the  recovered  pool  and 
the  tags  in  the  inoculum  pool  are  separately  amplified,  labelled  and  then  used  to  probe 
filters  arrayed  with  the  different  tags  representing  the  mutants  in  the  inoculum. 
Mutants  with  attenuated  virulence  are  those  with  tags  that  give  hybridisation  signals 
when  probed  with  tags  from  the  inoculum  pool  but  not  when  probed  with  tags  from 
the  recovered  pool  (72).  It  became  quickly  apparent  that  the  highly  random  DNA  tags 
gave  cross-hybridisation  noise.  The  original  STM  tag  library  was  screened  to  identify 
pools  of  96  tagged  mutants  giving  a  high  and  specific  hybridisation  signal  (92).  Figure 
1.3  shows  the  design  of  STM  protocol  (130). 
When  compared  to  traditional  pathogenicity  assays,  STM  minimises  the  number  of 
animals  to  be  utilised.  The  crux  of  STM  depends  on  tagged  transposon  mutants 
defective  in  virulence  that  cannot  be  maintained  in  vivo.  Attenuated  mutants  are 
selected  and  re-tested  to  confirm  attenuation;  disrupted  genes  are  cloned  via  the 
transposon  marker  and  identified  by  DNA  sequencing  (92).  STM  is  based  on  the 
concept  of  monitoring  the  frequency  of  a  particular  mutant  in  a  population  of  other 
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Figure  1.3  A  diagrammatic  representation  of  the  STM  screening  process  (130). mutants  by  marking  each  mutant  with  a  distinct  tag.  If  a  mutant  cannot  grow  in  a 
particular  niche,  then  that  mutant's  tag  will  not  be  detected  among  the  recovered 
bacteria  (110). 
A  crucial  step  in  STM  depends  on  a  high  frequency  of  random  transposon  insertions 
into  the  chromosome.  This  is  not  always  possible,  insertion  into  an  essential  gene 
gives  a  lethal  phenotype  (defined  here  as  genes  essential  for  growth  in  vitro)  and 
transposons  are  not  easily  utilised  in  all  bacterial  species.  For  example,  STM  was 
modified  for  insertion-duplication  mutagenesis  in  Streptococcus  pneumoniae  (133) 
and  shuttle  mutagenesis  in  Neisseria  meningitidis  (30).  In  the  insertion-duplication 
mutagenesis,  tagged  plasmids  with  chromosomal  fragments,  to  facilitate  homologous 
recombination  in  the  host  strain,  were  introduced  by  transformation  (133).  STM 
shuttle  mutagenesis  is  performed  into  E.  coli  and  resulting  plasmids  are  transformed 
into  the  naturally  competent  microorganism  (30).  These  methods  allow  the  use  of 
transposon  mutagenesis  in  microorganisms  where  it  is  normally  impossible  to  use 
STM  (92). 
The  original  STM  was  also  modified  to  augment  tag  specificity  and  reduce 
hybridisation  background.  The  tag-screening  step  was  done  immediately  after  the 
initial  cloning  into  the  mini-Tn5  to  select  96  tags  (from  the  1017)  that  gave  specific 
hybridisation  signals  (112). 
In  hybridisation-based  STM,  mutants  are  pooled  in  an  in  vitro  culture  from  which 
an  aliquot  is  used  for  in  vivo  passage.  Bacterial  genomic  DNA  is  extracted  from 
bacteria  grown  in  vitro  and  from  those  recovered  after  in  vivo  selection.  Mutants  that 
gave  a  hybridisation  signal  from  the  in  vitro  pool  but  not  from  the  in  vivo  pool  are 
detected  with  respect  to  persisting  in  vivo  or  establishing  an  infection.  Chromosomal 
DNA  is  used  as  PCR  templates  for  preparation  of  radioactive  or  non-radioactive 
probes  hybridised  to  colony  or  DNA  dot  blots  from  the  arrayed  mutant  library. 
Modifications  include  PCR  that  can  be  done  directly  on  bacterial  cell  lysates  (93)  and 
chemiluminescence  (92,112). 
Another  STM  modification  is  based  on  PCR,  a  very  powerful  technique  for  DNA 
detection  and  amplification,  giving  a  PCR-based  STM  without  hybridisation  (93).  The 
initial  STM-PCR  was  built  with  12  re-usable  and  PCR-specific  tags  eliminating  the 
fastidious  tag-screening  step.  In  this  method,  mutants  from  the  same  pool  were  grown 
separately,  aliquots  were  pooled  and  a  sample  was  used  as  the  in  vitro  pool.  A  second 
sample  from  the  same  pool  is  used  for  in  vivo  passage  (the  in  vivo  pool).  The  in  vitro 
31 and  in  vivo  pools  are  used  in  comparative  PCR  where  one  of  the  tags  is  used  as  primer 
along  with  a  universal  primer  in  the  kanamycin  resistance  gene  (92). 
In  the  first  application,  STM  was  used  in  Salmonella  typhimurium  (72)  successfully 
and  resulted  in  the  identification  of  a  chromosomal  region  called  Salmonella 
pathogenicity  island  2  (SPI2).  This  encodes  a  type  III  secretion  system  critical  for 
systemic  infection  (112,147,167). 
Following  the  first  STM  screen  in  S.  typhimurium  (72,161),  the  method  has  been 
applied  for  identification  and  analysis  of  virulence  factors  in  a  vast  variety  of  gram- 
positive  and  gram-negative  bacteria  including  S.  aureus  (33,112,146),  Salmonella 
enterica  serotype  Dublin  (18),  S.  choleraesuis  (96),  Vibrio  cholerae  (28,115), 
Yersinia  enterocolitica  (40),  Y.  pseudotubereulosis  (85,111),  Proteus  mirabilis  (171), 
Pseudomonas  aeruginosa  (93,94),  Legionella  pneumophila  (49,132),  Brucella  suis 
(54),  B.  abortus  (77),  B.  melitensis  (95),  Listeria  monocytogenes  (8),  Escherichia  coli 
(11,12,61,107),  Neisseria  meningitidis  (30,58,154),  Streptococcus  pneumoniae 
(68,89,133),  S.  agalactiae  (81),  Actinobacillus  pleuropneumoniae  (57),  Haemophilus 
influenzae  (73),  Klebsiella  pneumoniae  (106,153),  Xenorhabdus  nematophila  (74), 
Burkholderia  pseudomallei  (7)  and  Pasteurella  multocida  (56),  and  acid  fast  bacilli 
like  Mycobacterium  tuberculosis  (25,34).  STM  has  also  been  used  for  identification 
of  virulence  genes  in  microorganisms  other  than  bacteria  like  Candida  glabrata  (32), 
Aspergillusfumigatus  (22),  Cryptococcus  neoformans  (122),  and  Toxoplasma  gondii 
(86). 
Virulence  in  S.  aureus  has  been  studied  by  using  STM  methodology  (33,112,146). 
In  the  study  by  Mei  et  al  (112),  Tn917  mutants  were  tested  in  a  murine  model  of 
bacteraemia.  The  majority  of  loci  from  50  mutants  that  were  identified  as  attenuated 
were  predicted  by  sequence  similarity  to  be  involved  in  cell  surface  metabolism  (e.  g. 
peptidoglycan  cross-linking  and  transport  functions),  nutrient  biosynthesis,  and 
cellular  repair  processes,  but  most  of  the  remainder  had  no  known  function.  A  slightly 
larger  signature-tagged  mutant  bank  was  constructed  by  using  the  same  transposon 
and  tested  in  models  of  bacteraemia,  abscess  and  wound  formation,  and  endocarditis 
(33).  This  enabled  the  identification  of  various  genes  affecting  growth  and  virulence 
in  specific  disease  states,  as  well  as  18  that  are  important  in  at  least  three  of  the 
infection  models.  Many  of  these  genes  appear  to  be  involved  in  the  same  kinds  of 
processes  as  those  identified  in  the  earlier  study  (112);  indeed,  seven  of  the  genes 
32 identified  by  Mei  et  al  (112)  were  also  found  by  Coulter  et  al  (33).  Tables  1.2  and  1.3 
summarise  some  details  of  the  genes  recovered  in  S.  aureus  by  STM  so  far  (33,112). 
1.9  Biofilms 
Biofilms  can  be  defined  simply  and  broadly  as  communities  of  microorganisms  that 
are  attached  to  a  surface.  It  is  clear  that  microorganisms  undergo  profound  changes 
during  their  transition  from  planktonic  (free-swimming)  organisms  to  cells  that  are 
part  of  a  complex,  surface-attached  community.  Biofilms  can  comprise  a  single 
microbial  species  or  multiple  microbial  species  and  can  form  on  a  range  of  biotic  and 
abiotic  surfaces.  Although  mixed-species  biofilms  predominate  in  most  environments, 
single-species  biofilms  exist  in  a  variety  of  infections  and  on  the  surface  of  medical 
implants  (1,6,44,127).  These  single-species  biofilms  are  the  focus  of  most  current 
research.  P.  aeruginosa  has  emerged  as  the  most  studied  single-species,  biofilm- 
forming  gram-negative  bacterium,  although,  among  the  gram-negative  bacteria,  P. 
fluorescens,  E.  coli,  and  V.  cholerae  have  also  been  studied  in  detail.  The  gram- 
positive  biofilm-forming  bacteria  that  have  been  studied  include  S.  epidermidis,  S. 
aureus,  and  the  enterococci  (127). 
A  number  of  gram-positive  infections,  including  those  caused  by  S.  epidermidis,  S. 
aureus,  and  the  enterococci,  have  proven  to  be  particularly  difficult  to  treat  with 
current  antibiotic  therapies,  partly  owing  to  their  high-level  natural  resistance  to 
antimicrobial  compounds.  Furthermore,  these  organisms  become  resistant  to  the 
highest  deliverable  levels  of  antibiotics  when  growing  in  a  biofilm  (38,79,139,164). 
The  production  of  an  exopolysaccharide  matrix,  or  glycocalyx,  is  one  of  the 
distinguishing  characteristics  of  biofilms.  It  has  been  suggested  that  this  matrix, 
among  other  functions,  prevents  the  access  of  antibiotics  to  the  bacterial  cells 
embedded  in  the  community.  Either  reaction  of  the  compound  with,  or  sorption  to,  the 
components  of  the  biofilm  can  limit  the  transport  of  antimicrobial  agents  to  the  cells 
within  the  biofilm  (103).  The  actual  structure  of  the  biofilm  matrix  will  vary  greatly 
depending  on  the  microbial  cells  present,  their  physiological  status,  the  nutrients 
available  and  prevailing  physical  conditions  (155).  It  is  estimated  that  more  than  60% 
of  nosocomial  infections  are  derived  from  biofilm-related  infections  (6,55,78). 
Biofilm  bacteria  can  be  up  to  1,000-fold  more  resistant  to  antibiotic  treatment  than  the 
same  organism  grown  planktonically,  but  the  mechanisms  by  which  the  biofilm- 
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z grown  bacteria  attain  this  resistance  are  still  a  matter  of  speculation.  Mechanisms  of 
resistance  that  are  considered  likely  include  (i)  phenotypic  changes  in  bacteria 
resulting  in  resistance  occurring  within  the  biofilm  environment,  (ii)  inactivation  of 
the  antibiotics  by  extracellular  polymers  or  modifying  enzymes,  and  (iii)  nutrient 
limitation  resulting  in  slowed  growth  rate  (59). 
1.9.1  Staphylococcal  biofilms 
Biofilm  formation  in  staphylococci  is  multifactorial,  and  the  ability  to  form  a 
biofilm  makes  the  strains  much  better  able  to  survive  in  the  normally  hostile 
environment  of  tissue  and  blood.  Numerous  studies  have  implicated  a  polysaccharide 
intercellular  adhesin  (PIA)  in  biofilm  formation  in  S.  epidermidis.  PIA  is  a 
polysaccharide  composed  of  ß-1,6-linked  N-acetylglucosamine  with  partly 
deacetylated  residues,  in  which  the  cells  are  embedded  and  protected  against  the 
host's  immune  defence  and  antibiotic  treatment  (35,63).  The  ica  genes  code  for  the 
synthesis  of  this  adhesin  (35).  Mutations  in  ica  operon  lead  to  a  pleiotropic 
phenotype;  the  cells  are  biofilm-  (35)  and  haemagglutination-negative,  less  virulent 
and  less  adhesive  on  hydrophilic  surfaces.  ica  expression  is  modulated  by  various 
environmental  conditions,  appears  to  be  controlled  by  SigB  and  can  be  turned  on  and 
off  by  insertion  sequences  (IS)  elements.  Recent  studies  have  shown  that  S.  aureus, 
like  S.  epidermidis,  has  the  ica  locus,  which  encodes  the  functions  required  for 
intracellular  adhesin.  These  data  suggest  that  the  early  stages  in  biofilm  formation 
may  be  similar  between  these  two  organisms  (35,63).  Although  it  has  been  shown 
that  ica  has  a  role  in  adhesion  for  biofilm  formation,  however,  it  was  not  identified  in 
our  biofilm  experiments. 
Bacterial  pathogens  that  are  primarily  extracellular,  such  as  S.  aureus,  can  adhere  to 
components  of  the  extracellular  matrix  (ECM)  of  the  host  to  initiate  colonization. 
Adherence  is  mediated  by  protein  adhesins  of  the  MSCRAMM  (microbial  surface 
components  recognizing  adhesive  matrix  molecules)  family,  which  in  most  cases  are 
covalently  anchored  to  the  cell  wall  peptidoglycan  (19).  Different  prototype 
MSCRAMMs  such  as  fibrinonectin-binding  protein  A  (FnBPA),  a  collagen-binding 
protein  (Cna)  and  clumping  factor  A  (C1fA)  have  been  recognized  in  S.  aureus. 
Fibrinonectin  binding  is  a  very  common  property  of  S.  aureus  isolates  (53). 
34 Proteins  have  been  identified  that  are  also  involved  in  staphylococcal  biofilm 
formation,  such  as  the  accumulation-associated  protein  (AAP),  the  clumping  factor  A 
(C1fA),  the  staphylococcal  surface  protein  (SSP1),  and  the  biofilm-associated  protein 
(Bap)(37,63).  An  S.  aureus  transposon-insertion  mutant  has  been  isolated  with  a 
significant  decrease  in  attachment  to  inert  surfaces,  intercellular  adhesion  and  biofilm 
formation.  The  transposon  is  inserted  in  the  bap  gene,  which  encodes  the  novel  cell 
wall-associated,  2276-amino-acid  protein,  Bap.  The  bap  gene  has  been  found  in  5% 
of  the  S.  aureus  bovine  mastitis  isolates,  but  it  was  absent  in  the  75  clinical  human  S. 
aureus  isolates  analysed.  All  staphylococcal  isolates  harbouring  bap  are  highly 
adherent  and  strong  biofilm  producers.  In  a  mouse  infection  model,  Bap  is  involved  in 
pathogenesis,  causing  a  persistent  infection  (37). 
Biofilm  formation  is  thought  to  be  a  two-step  process  that  requires  the  primary 
adhesion  of  bacteria  to  a  substrate  surface  followed  by  the  formation  of  multiple  cell 
layers.  In  other  words,  at  the  first  stage,  the  bacterium  approaches  the  surface  so 
closely  that  motility  is  slowed.  The  bacterium  may  then  form  a  transient  association 
with  the  surface  and/or  other  microbes  previously  attached  to  the  surface.  This 
transient  association  allows  it  to  search  for  a  place  to  settle  down.  When  the  bacterium 
forms  a  stable  association  as  a  member  of  a  microcolony,  it  becomes  a  three- 
dimensional  biofilm  structure  (43,166).  Studies  have  shown  that  teichoic  acids, 
highly  charged  cell  wall  polymers,  play  a  key  role  in  the  first  step  of  biofilm 
formation  by  S.  aureus.  The  cell  surface  of  S.  aureus,  as  in  most  bacteria,  has  a 
moderately  negative  net  charge  at  neutral  pH,  which  is  probably  due  to  the  fact  that 
the  teichoic  acids  contain  fewer  positively  charged  D-alanine  residues  than  negatively 
charged  phosphate  groups.  Nevertheless,  S.  aureus  can  adhere  to  hydrophobic  or 
slightly  negatively  charged  surfaces  such  as  polystyrene  or  glass,  respectively.  The 
direct  interaction  of  bacteria  and  surfaces  is  dependent  on  van  der  Waals  forces, 
which  are  generally  attractive,  and  interionic  forces,  which  can  be  either  attractive  or 
repulsive.  Even  if  bacteria  and  surfaces  are  charged  alike,  van  der  waals  forces  can 
overcome  repulsion  and  lead  to  adhesion  (64).  Figure  1.4  shows  the  events  associated 
with  bacterial  adherence  to  biomaterials  (4). 
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In  recent  years,  the  use  of  medical  implants  such  as  catheters,  pacemakers, 
prosthetic  heart  valves,  and  joint  replacements  has  increased  dramatically.  These 
devices  can  become  colonised  by  microorganisms  which  form  a  biofilm  consisting  of 
a  mono-  or  multilayer  of  cells  embedded  within  a  matrix  of  extracellular  polymeric 
material.  Release  of  microorganisms  from  the  biofilm  may  initiate  an  acute 
disseminated  infection.  Implant-associated  infections  are  difficult  to  resolve,  because 
biofilm  microorganisms  are  resistant  both  to  host  defence  mechanisms  and  antibiotic 
therapy.  The  majority  of  implant  infections  are  caused  by  Gram-positive  bacteria, 
notably  staphylococci. 
As  the  STM  method  has  not  been  used  for  screening  of  bacterial  virulence  genes  in 
biofilm  so  far,  the  main  aim  of  this  project  was  to  find  any  probable  new  genes  of  S. 
aureus  that  are  essential  for  biofilm  formation  by  STM.  In  addition,  it  may  be  that 
biofilm  formation  and  virulence  are  related,  so  we  attempted  to  identify  genes  related 
in  both  processes.  The  general  outline  of  the  whole  project  is  shown  in  figure  1.5. 
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11 Chapter  2 
General  methods Chapter  2:  General  methods 
General  methods  are  described  here.  For  clarity  more  specific  methods  are 
described  in  their  appropriate  chapters. 
2.1  Isolation  of  Genomic  DNA  from  S.  aureus 
Method  1 
The  bacteria  were  grown  in  5  ml  of  Brain  Heart  Infusion  (BHI)  broth  supplemented 
with  erythromycin  (20  Vg  ml').  Erythromycin  was  added  only  for  growing  the 
mutants.  One  ml  of  overnight  culture  was  removed  under  aseptic  conditions  and 
centrifuged  in  a  microcentrifuge  tube  at  15,000  rpm  for  1  minute.  The  supernatant 
was  discarded  and  the  pellet  resuspended  in  560  p1  of  TE  buffer.  5  µl  of  RNase  (10 
mg/ml)  and  5  p1  of  lysostaphin  (10  mg/ml)(Sigma)  were  added  and  mixed  vigorously 
for  30  seconds.  After  1h  incubation  at  37°C,  30  pl  of  10%  SDS,  5  p1  of  RNase  (10 
mg/ml),  and  10  µl  of  proteinase  K  (10  mg/ml)  were  added  and  the  incubation 
continued  for  an  additional  hour.  Then  100  µl  of  5M  NaCl  was  added  followed  by  80 
p1  of  prewarmed  (65°C)  10%  hexadecyltrimethyl  ammonium  bromide  in  0.7M  NaCl 
(CTAB/NaC1),  and  incubated  at  65°C  for  10  minutes.  An  equal  volume  of  chloroform 
was  added  and  the  suspension  mixed  by  vortexing.  After  centrifugation  for  5  minutes 
at  15,000  rpm,  the  viscous  upper  phase  was  removed  and  transferred  into  a  new  1.5 
ml  microcentrifuge  tube.  The  suspension  was  extracted  twice  with  an  equal  volume  of 
phenol/chloroform/isoamyl  alcohol  (25:  24:  1)  and  once  with  chloroform/isoamyl 
alcohol.  The  upper  aqueous  phase  was  transferred  into  a  new  1.5  ml  microcentrifuge 
tube  and  the  DNA  precipitated  by  adding  500  p1  isopropanol.  After  centrifugation  at 
15,000  rpm  for  10  minutes,  the  isopropanol  was  removed  and  the  pellet  washed  with  1 
ml  of  70%  ethanol.  The  DNA  pellet  was  air-dried  and  resuspended  in  30  µl  of  sterile 
water  (108). 
37 Method  2 
The  bacteria  were  grown  in  5  ml  of  BHI  broth  supplemented  with  erythromycin  (20 
µg  ml").  After  overnight  incubation  at  37°C  the  cells  were  harvested  by  centrifugation 
(10  min,  3000  g)  and  resuspended  in  5  ml  of  SET  pH  7.5,  and  then  lysozyme  to  a 
concentration  of  1  mg  ml"'  was  added.  After  0.5  h  incubation  at  37°C,  1/10  volumes 
of  10%  SDS  and  0.5  mg  ml"1  proteinase  K  were  added  and  incubation  continued  at 
55°C  with  occasional  inversion  for  2  h,  when  1/3  volumes  5M  NaCI  and  1  volume 
chloroform  were  added  and  incubation  continued  at  room  temperature  for  0.5  h  with 
frequent  inversion.  The  suspension  was  centrifuged  at  4500  g  for  15  min  and  the 
aqueous  phase  was  transferred  to  a  new  tube  using  a  blunt-ended  pipette  tip.  The 
DNA  was  precipitated  by  adding  1  volume  of  isopropanol  and  the  tube  was  inverted 
gently.  The  DNA  was  transferred  into  a  microfuge  tube,  rinsed  with  70%  ethanol,  air- 
dried  and  dissolved  in  a  suitable  volume  of  TE  buffer  (135). 
Method  3 
Chromosomal  DNA  from  S.  aureus  was  isolated  using  a  Qiagen  Genomic  DNA  Kit 
according  to  the  manufacturer's  protocol,  except  that  the  bacterial  cells  were  lysed  by 
lysostaphin  (Sigma;  200  µg  ml-)  at  37°C  for  30  minutes  before  DNA  extraction. 
2.2  Plasmid  DNA  extraction 
Plasmid  DNA  from  S.  aureus  and  transformed  E.  coli  was  isolated  using  a  Qiagen 
Plasmid  Miniprep  Kit  according  to  the  manufacturer's  protocol,  except  that  the 
staphylococcal  cells  were  lysed  by  lysostaphin  (Sigma;  200  µg  ml")  at  37°C  for  30 
minutes  before  plasmid  purification. 
2.3  Gel  extraction 
Gel  extraction  of  the  PCR-amplified  products  was  done  using  a  Qiagen  PCR 
Purification  Kit  and/or  Qiagen  QIAEX®  according  to  the  manufacturer's  protocols. 
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(which  cuts  the  signature  tags  within  the  modified  transposon) 
/  **'\4 
Half  of  the  digested  DNA  Is  subjected  to 
Southern  hybridisation  analysis  using  a 
723bp  PsU-AlwNI  fragment  of  pBR322 
containing  part  of  the  p-lactamase  gene  as 
a  probe  to  determine  the  size  of  the  DNA 
fragment  carrying  this  part  of  the 
transposon. 
Self-ligation  (the  rest  of  the  DNA) 
i 
Transform  Into  XL1-blue  cells 
ý 
Culture  on  LB  agar  with  amp 
i 
A  single  amp'  colony  Into  LB  with  amp 
i 
Plasmid  extraction 
i 
Chromosomal  DNA  sequences  flanking  the  transposon  are 
obtained  using  primer  pseq-1  corresponding  to  the  Inverted 
repeat  region  70  bp  from  the  erm-proximal  end  of  Tn917. 
i 
DNA  sequences  analysis 
Figure  2.1  Virulence  gene  identification  from  mutants  with  attenuated  virulence a1  kb  ladder  (Invitrogen)  was  used  as  a  marker.  The  gel  was  submerged  in 
denaturation  solution  for  2x  15  min  at  room  temperature.  After  rinsing  with  water,  the 
gel  was  submerged  in  neutralisation  solution  at  the  same  conditions.  The  DNA  was 
blotted  to  a  Hybond  N+  membrane  (Amersham)  by  capillary  transfer,  using  20x  SSC 
buffer  overnight.  The  membrane  was  UV-crosslinked  at  optimal  crosslink  (1200 
xl00µJ/cm2)(  Spectro  Linker,  Spectronics  Corporation)  without  prior  washing.  The 
procedure  for  hybridisation  of  the  membrane  was  the  same  as  described  in  section  2.4. 
2.5.2  Cloning  of  attenuated  genes 
The  rest  of  the  digested  DNA  in  section  2.5.1  was  resuspended  in  ligation  buffer 
(Promega)  and  self-ligated  for  12-18  h  at  16°C.  The  ligated  products  were  transformed 
into  E.  coli  XL1-blue,  plated  onto  LB  agar  containing  ampicillin  and  incubated  at 
37°C  overnight.  A  single  amp`  colony  from  each  transformation  was  grown  in  LB 
broth  containing  ampicillin.  Plasmid  DNA  was  extracted  as  described  in  section  2.2. 
DNA  flanking  the  transposon  was  sequenced  using  primer  pseq-1  made  against  the  3' 
end  of  the  transposon. 
2.6  Infection  studies 
2.6.1  Preparation  of  bacterial  inoculum 
To  prepare  a  standard  inoculum  from  S.  aureus  strain  RN6390,0.5  ml  of  overnight 
culture  was  added  into  50  ml  BHI  broth  without  antibiotics  and  incubated  in  a  37°C 
shaker.  The  OD600  was  determined  using  a  spectrophotometer  at  15  minute  intervals. 
When  the  OD  =  0.7,50%  sterile  glycerol  was  added  and  aliquoted  into  one  ml 
volumes  immediately  and  kept  at  -80°C.  The  next  day,  vials  Nos.  I  and  50  were 
thawed  and  cultured  onto  BHI  agar  plates  after  making  a  serial  dilution  of  10  fold  of 
both.  After  overnight  incubation  at  37°C,  viable  count  was  done.  As  there  was  no 
significant  difference  between  the  viable  counts  of  the  two  vials,  all  of  the  50  vials 
were  stored  as  a  standard  inoculum. 
A  cryotube  containing  Iml  of  standard  inoculum  was  removed  and  thawed  quickly 
in  37°C  water  bath.  900  pl  was  removed  and  centrifuged  at  13,000  rpm  for  3  min.  The 
supernatant  was  discarded  and  the  pellet  was  resuspended  in  900µ1  sterile  PBS. 
40 Colony  forming  units  (CFU)  were  counted  by  carrying  out  serial  10  fold  dilutions  of 
bacterial  suspension  in  PBS.  180µ1  of  PBS  was  poured  in  6  wells  of  a  "U'  bottom  96 
well  plate.  20gl  of  bacterial  suspension  was  added  into  the  first  well  and  mixed.  Then 
20µl  of  this  was  placed  into  the  next  well  containing  PBS  with  a  new  tip.  This  was 
continued  with  a  new  tip  each  time  until  this  has  been  done  for  a  total  of  6  times. 
Then  an  agar  plate  was  marked  into  6  sectors  and  3x  20µl  of  the  lowest  dilution  was 
spotted  into  one  of  the  sectors.  The  same  procedure  was  done  with  the  remaining 
dilutions.  Another  plate  was  cultured  with  the  same  dilutions  to  give  6x  20µl  spots 
per  dilution.  The  plates  were  incubated  overnight  at  37°C. 
The  colonies  in  the  sector  with  more  than  40  colonies  per  spot  were  counted  on  the 
following  day.  This  is  the  number  that  is  still  easy  to  count  (i.  e.  between  40  and  100 
colonies).  The  number  of  CFU  per  ml  is  achieved  with  multiplying  the  number  of 
colonies  by  the  dilution  factor  (83). 
2.6.2  Mouse  inoculation 
To  determine  the  number  of  bacteria  required  for  mouse  infection,  and  to  see  the 
duration  of  time  required  to  recover  the  bacteria  from  the  animals,  a  series  of 
experiments  was  done.  Different  numbers  of  CFU  of  S.  aureus  strain  RN6390  were 
injected  intraperitoneally  into  the  MF1  hairless  mice  (female,  6-8  weeks  age)  and  the 
bacteria  were  recovered  from  the  mice  24-72  hr  after  inoculation.  Bacteria  were  not 
recovered  from  the  mice  that  received  less  than  7x  106  CFU  ml'1.  The  mice  which 
received  more  than  9x  106  CFU  ml-1  died  between  12-18  hr  after  inoculation  with  no 
significant  symptoms.  We  therefore  chose  a  dose  of  8x  106  CFU  ml-1  at  incubation 
time  of  24  hr. 
A  series  of  25  pools  of  33  mutants  were  used.  Each  pool  contained  33  mutants  with 
individual  selected  tags  (see  chapter  5  for  details).  For  mouse  inoculation,  bacteria 
from  each  pool  were  washed  twice  with  Bill  broth  by  centrifugation  at  4000  rpm  for 
10  min  and  resuspended  in  BHI  broth.  The  OD620  was  determined  using  a 
spectrophotometer  [OD620  of  1.6=109  CFU  ml'']  (27).  The  bacterial  suspension  was 
diluted  to  approximately  8x  106  CFU  ml"  and  added  to  an  equal  volume  of  human 
serum  (Sigma).  This  mixture  (0.2  ml  containing  approximately  8x  105  CFU)  was 
injected  intraperitoneally  into  a  MF1  hairless  mouse  (female,  6-8  weeks  age).  The 
41 number  of  CFU  in  the  inoculum  was  verified  by  viable  count  after  plating  a  diluted 
aliquot  of  the  inoculum  onto  BHI  agar.  Bacteria  were  recovered  24  hr  after 
inoculation  from  spleens  of  animals  as  follows. 
Half  of  each  spleen  was  homogenised  in  1  ml  of  sterile  PBS  in  a  microfuge  tube. 
Cellular  debris  was  allowed  to  settle  and  1  ml  of  PBS  containing  cells  still  in 
suspension  was  removed  to  a  fresh  tube  and  centrifuged  for  2  min  at  3000  rpm.  The 
supernatant  was  discarded  and  the  pellet  resuspended  in  1  ml  of  sterile  PBS.  A 
dilution  series  was  made  in.  sterile  PBS  and  100  µl  of  each  dilution  was  plated  onto 
BHI  agar  containing  erm  (20  µg  ml'').  Bacteria  were  recovered  from  plates  containing 
between  1000  and  4000  colonies,  and  a  total  of  over  10,000  colonies  were  recovered 
from  each  spleen  were  pooled  for  DNA  extraction  (72). 
2.7  Biofilm  formation 
The  method  for  biofilm  formation  has  been  adapted  from  those  used  for  Candida 
species  with  slight  modification  (13,69).  Discs  of  catheter  material  (surface  area,  0.5 
cm2)  were  cut  from  catheters,  and  sterilized  by  UV  irradiation  for  20-30  minutes  each 
side.  Silicone  urinary  Foley  catheters  from  Vygon,  UK  were  used.  The  discs  were 
placed  in  wells  of  24-well  Nunclon  tissue  culture  plates.  Standardized  cell  suspension 
(80  µl)  was  applied  to  the  surface  of  each  disc,  and  the  discs  were  incubated  for  1h  at 
37°C.  Nonadherent  organisms  were  removed  by  gentle  washing  with  PBS.  The  discs 
were  incubated  for  24  h  at  37°C,  submerged  in  1  ml  of  BHI  with  erythromycin  (20  gg 
ml-1).  Discs  without  cells  were  incubated  in  the  same  way  as  the  control.  After  biofilm 
formation,  the  discs  were  removed  from  the  medium  and  gently  washed  with  PBS  to 
remove  nonbiofilm  cells.  Biofilm  organisms  were  washed  with  4  ml  sterile  BHI  with 
erythromycin  by  vigorous  moving  of  the  container.  The  chromosomal  DNA  was 
extracted  from  the  suspension. 
2.8  PCR 
DNA  extracted  from  single  bacterial  mutants  or  pools  of  mutants  was  used  as 
template  for  PCR  experiments.  The  PCR  was  done  in  50  µl  reactions  containing 
75mM  Tris-HC1  (pH  8.8);  20mM  (NH4)2SO4;  2mM  MgCl2;  0.01%  Tween  20;  0.2mM 
each,  dATP,  dCTP,  dGTP,  and  dTTP;  1.25  U  of  Taq  DNA  polymerase  (Promega); 
42 400  ng  each  of  primers  P12  and  P13;  and  2.5  µg  of  target  DNA.  After  initial 
denaturation  of  4  min  at  95°C,  thermal  cycling  consisted  of  35  cycles  of  45  sec  at 
50°C,  10  sec  at  72°C,  and  30  sec  at  95°C.  In  some  experiments,  a  Reddy-Load  PCR 
Mix  (Advanced  Biotechnologies,  Surrey,  UK)  was  used  at  the  same  conditions. 
2.9  Labelling 
DNA  extracted  from  single  bacterial  mutants  or  pools  of  mutants  were  used  as 
templates  for  PCR  to  generate  labelled  probes.  The  PCR  was  done  in  50  µl  reaction 
volumes  and  subjected  to  a  [digoxigenin  (DIG)-11]-dUTP-labelling  PCR  using  a  PCR 
DIG  Probe  Synthesis  Kit  as  described  by  the  manufacturer  (Boehringer  Mannheim) 
and  using  primers  P12  and  P13.  After  initial  denaturation  of  4  min  at  95°C,  thermal 
cycling  consisted  of  35  cycles  of  45  sec  at  50°C,  10  sec  at  72°C,  and  30  sec  at  95°C. 
2.10  Ethanol  precipitation 
PCR  products  of  labelled  tags  were  precipitated  with  ethanol  to  concentrate  the 
labelled  tags  and  increase  the  efficiency  of  the  digestion  process  in  making  the  probes. 
1/10  volume  of  3M  sodium  acetate  pH  5.2  and  2.5  x  volume  cold  absolute  ethanol 
were  added  and  kept  on  ice  for  10  minutes  after  vortexing.  The  solution  was 
centrifuged  at  13,500  rpm  for  15  minutes  and  the  ethanol  was  discarded.  250  µl  cold 
70%  ethanol  was  added  and  centrifuged  at  13,500  rpm  for  10  minutes.  This  was  done 
twice.  All  centrifugation  was  done  at  4°C.  The  ethanol  was  discarded  and  the  pellet 
was  air-dried  and  20  µl  sterile  water  was  added. 
2.11  Digestion  of  the  tags 
To  recover  the  tags  without  the  arms  from  the  PCR  products,  2  µl  of  the 
concentrated  labelled  PCR  products  of  single  bacterial  mutants  or  pools  of  mutants 
(section  2.10)  was  digested  with  Hind  III  enzyme  at  37°C  overnight.  1  µl  (10  U)  of 
Hind  III  enzyme  (Life  Technologies),  1µl  of  buffer,  2  µl  of  template  and  6  µl  of  water 
were  used  in  a  10  pl  reaction.  A  total  of  30-50  gl  reaction  was  used  for  each  sample  to 
make  enough  labelled  tags  as  the  probes.  After  overnight  incubation,  the  whole 
43 digestion  reaction  was  run  in  a  3%  agarose  gel  electrophoresis,  and  the  band  of  40  bp 
was  purified  using  a  QIAEX  II  Kit  according  to  the  manufacturer's  protocol. 
2.12  Gel  electrophoresis 
Different  percentages  (0.7%,  1%,  and  3%)  of  agarose  gel  were  used  to  run  the 
genomic  and  plasmid  DNAs,  digestion  products  of  genomic  DNAs  for  Southern 
blotting,  and  digestion  products  of  labelled  PCR  products  and  probes  respectively. 
44 Part  II 
Results Chapter  3 
Analysis  of  existing  library  of  mutants Chapter  3:  Analysis  of  existing  library  of  mutants 
The  identification  of  virulence  genes  and  infection  mechanisms  in  bacterial 
pathogens  can  lead  to  new  insights  for  disease-control  strategies.  Recently, 
methodologies  have  been  developed  that  enable  genetic  approaches  to  be  used  for  in 
vivo  studies  of  bacterial  pathogenesis.  One  of  these  new  methods  is  signature-tagged 
mutagenesis  (STM).  We  were  interested  to  use  STM  in  staphylococcal  mouse 
infection  and  biofilm.  A  library  of  tagged  insertion  mutants  of  S.  aureus  strain 
RN6390  with  inserted  Tn917  transposon  was  generously  provided  by  Professor 
David  W.  Holden,  Imperial  College  School  of  Medicine,  London,  UK. 
3.1  Making  the  genomic  DNAs 
Genomic  DNA  from  S.  aureus  (as  individual  and  pools  of  96  mutants)  was  isolated 
by  different  methods.  All  protocols  described  in  section  2.1.  A  typical  result  is  shown 
in  figure  3.1. 
3.2  Making  the  probes 
DNA  extracted  from  single  bacterial  mutants  or  pools  of  mutants  were  used  as 
templates  for  PCR  to  generate  labelled  probes.  The  PCR  was  done  in  50  µl  reactions 
and  subjected  to  a  [digoxigenin  (DIG)-11]-dUTP-labelling  PCR  using  a  PCR  DIG 
Probe  Synthesis  Kit  as  described  by  the  manufacturer  (Boehringer  Mannheim)  and 
using  primers  P12  and  P13.  After  an  initial  denaturation  of  4  min  at  95°C 
,  thermal 
cycling  consisted  of  35  cycles  of  45  sec  at  50°C,  10  sec  at  72°C,  and  30  sec  at  95°C 
(see  figure  3.2  for  results). 
The  PCR  products  (approximately  80  bp)  were  precipitated  with  ethanol  and  then 
digested  with  Hindlll  (which  cuts  the  signature  tags  within  the  modified  transposon) 
at  37°C  for  12-18  hr.  The  digested  products  (40  bp)  were  gel  purified  using  a  Qiagen 
PCR  Purification  Kit  and/or  Qiagen  QIAEX®  according  to  the  manufacturer's 
protocols  (figure  3.3). 
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Figure  3.3  Three  probes  from  different  genomic  DNAs 3.3  Hybridisation  experiments 
Probes  were  hybridised  to  nylon  membranes  according  to  the  method  described  in 
the  DIG  Probe  Synthesis  Kit.  For  dot  blot  hybridisations,  genomic  DNAs  (0.15-0.2 
Vg)  were  transferred  onto  a  Hybond  N+  membrane  (Amersham). 
According  to  the  literature  (29,72,112),  the  probes  should  hybridise  to  the  genomic 
DNAs  of  the  tagged  insertion  mutants.  When  we  hybridised  labelled  probes  to 
chromosomal  DNA  of  individual  mutants,  we  were  unable  to  generate  a  signal. 
Therefore,  a  series  of  experiments  was  done  to  compare  hybridisation  strategies.  PCR 
products  of  the  genomic  DNAs  and  gel  extraction  of  the  PCR  products  were 
compared.  Both  methods  had  signals.  The  PCR  products  were  chosen  for  future 
analysis. 
At  the  next  step,  artificial  input  and  output  probes  were  hybridised  to  the  different 
membranes  to  check  that  the  system  worked  properly.  All  of  the  experiments,  except 
three,  showed  cross-hybridisation  of  the  tags.  We  therefore  undertook  a  detailed 
analysis  of  the  existing  mutants  to  determine  whether  we  could  use  the  library.  The 
results  are  summarised  in  table  3.1. 
Experiment  series  1:  4  random  mutants  were  deleted  from  a  pool  of  96  mutants  to 
make  an  artificial  output  probe  of  92  mutants.  The  result  showed  signals  from  all  96 
spots  suggesting  4  signals  with  the  deleted  mutants  on  the  output  membrane.  In  a  real 
experiment  this  would  suggest  no  loss  of  mutants. 
Experiment  series  2:  The  experiment  in  series  1  was  done  in  another  way.  4 
random  mutants  (different  from  the  deleted  mutants  in  experiment  1)  were  deleted 
from  a  pool  of  94  mutants  to  make  an  artificial  output  probe  of  90  mutants.  The  result 
showed  loss  of  2  out  of  4  mutants.  In  other  words,  2  out  of  4  mutants  were  not 
detected. 
Experiment  series  3:  The  experiment  in  series  2  was  done  in  another  way.  4  probes 
were  made  from  the  4  deleted  mutants  and  then  each  probe  was  tested  with  input 
membrane  of  94  mutants  separately.  The  4  mutants  were  A6,  D4,  F9,  and  H8.  The 
mutants  D4  &  H8  showed  no  cross-hybridisation  on  the  output  membranes  that 
contained  94  mutants.  But  mutant  A6  had  a  cross-hybridisation  with  one  mutant  (A5), 
and  mutant  F9  had  cross-hybridisation  with  3  mutants  (E12,  G6,  and  G7).  In  other 
words,  the  cross-hybridisation  results  in  the  previous  experiment  were  confirmed.  The 
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ý results  in  the  experiments  series  2&3  were  also  confirmed  by  sequencing  the  tags 
(discussed  in  chapter  4). 
As  the  first  three  experiments  showed  there  was  a  problem  with  the  hybridisation,  a 
more  detailed  set  of  experiments  was  done. 
Experiment  series  4:  A  probe  from  one  mutant  was  hybridised  to  an  artificial  input 
of  10  random  mutants.  As  expected  there  was  just  one  signal  on  the  membrane 
(Figure  3.4).  According  to  the  expected  result  in  this  series,  we  decided  to  do  a  series 
of  hybridisation  experiments  on  a  pool  of  10  random  mutants. 
Experiment  series  5:  The  experiment  in  series  4  was  repeated  ten  times  with  the 
same  mutants,  and  one  mutant  was  chosen  to  prepare  the  probe  each  time.  The  results 
showed  that  two  mutants  (Nos.  5&  9)  had  cross-hybridisation  with  each  other  (Figure 
3.5).  The  details  of  this  series  are  shown  in  Table  3.2. 
Experiment  series  6:  This  experiment  was  done  on  a  pool  of  10  random  mutants. 
The  random  selected  mutants  in  this  series  were  different  from  the  10  mutants  in 
series  5.  Mutants  Nos.  3&9  were  deleted  to  make  an  artificial  output  pool  with  8 
mutants.  Probes  were  made  from  the  10  mutants  as  the  input  and  from  the  8  mutants 
as  the  output  pools.  Hybridisation  experiments  were  done  with  both  input  and  output 
probes.  As  it  is  shown  in  figure  3.6,  there  were  just  8  expected  signals  on  the  output 
membrane.  In  other  words,  there  were  no  signals  with  the  2  deleted  mutants  in  output 
probe. 
Experiment  series  7:  As  we  had  the  expected  results  in  series  6,  the  same 
experiment  was  done  on  a  different  series  of  10  random  mutants.  In  this  experiment,  9 
signals  were  seen  instead  of  8  expected  signals  on  the  output  membrane. 
Experiment  series  8:  The  probes  from  the  two  deleted  mutants  in  series  7  (with 
cross-hybridisation)  were  hybridised  with  input  membranes  of  94  mutants 
individually.  The  2  deleted  mutants  were  B5  &  D2.  The  results  showed  that  one 
mutant  (D2)  had  just  one  expected  signal,  but  the  other  (B5)  had  cross-hybridisation. 
In  other  words,  mutant  B5  had  2  signals,  but  D2  had  no  cross-hybridisation,  both  on 
the  membrane  of  94  mutants. 
Experiment  series  9:  A  pool  of  8  random  mutants  was  chosen.  Mutants  Nos.  6&8 
were  deleted  to  make  an  artificial  output  pool  with  6  mutants.  Probes  were  made  from 
the  8  mutants  as  the  input  and  from  the  6  mutants  as  the  output  pools.  Hybridisation 
experiments  were  done  with  both  input  and  output  probes.  As  expected,  there  were 
just  6  expected  signals  on  the  output  membrane  (Figure  3.7). 
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Figure  3.4  Hybridisation  of  the  membrane  of  10  mutants  with  the  probe  No.  6  that  shows 
expected  result. (a) 
(b) 
Figure  3.5  Hyhridisation  of  the  same  membrane  of  10  mutants  with  the  probes  No.  5  (a)  and  No. 
9  (b).  As  seen  there  is  also  a  strong  signal  (cross-hybridisation)  with  mutant  No.  9  in  (a)  and  with 
No.  5  in  (b).  There  is  also  some  cross-hybridisation  with  mutant  No.  4  in  both  membranes. (a) 
+ve  control  -ve  control 
(b) 
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Figure  3.6  Hybridisation  of  the  same  membrane  with  probes  of  10  mutants  as  the  input  (a)  and  8 
mutants  as  the  output  pools.  Mutants  Nos.  3&9  have  been  deleted  to  make  an  artificial  output 
probe.  The  experiment  showed  expected  results.  There  are  10  and  8  signals  on  the  input  (a)  and 
output  (h)  membranes,  respectively.  The  two  deleted  mutants  (Nos.  3&  9)  showed  no  signals  on 
the  output  membrane  (b). }k:..  ý: 
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Figure  3.7  Hybridisation  of  the  same  membrane  with  probes  of  8  mutants  as  the  input  (a)  and  6 
mutants  as  the  output  pools.  Mutants  Nos.  6&8  have  been  deleted  to  make  an  artificial  output 
probe.  The  experiment  showed  expected  results.  There  are  8  and  6  signals  on  the  input  (a)  and 
output  (b)  membranes,  respectively.  The  two  deleted  mutants  (Nos.  6&  8)  showed  no  signals  on 
the  output  membrane  (b). The  details  of  the  experiments  on  the  existing  library  are  shown  in  table  3.3. 
To  test  the  library  of  mutants  and  hybridisation  process,  a  series  of  artificial  input 
and  output  probes  were  hybridised  to  the  different  membranes  (tables  3.1,3.2,  and 
3.3).  The  results  showed  that  all  of  the  experiments,  except  three,  had  unexpected 
cross-hybridisation. 
The  experiments  on  the  existing  library  that  were  done  in  different  scales  could  be 
divided  into  2  distinct  groups.  The  first  group  includes  series  4,6,9,  and  parts  of 
series  3  and  8  that  showed  no  cross-hybridisation  and  only  expected  signals  were 
seen.  The  second  group  includes  series  1,2,5,7,  and  a  part  of  series  3  and  8  that 
showed  cross-hybridisation.  As  we  had  some  expected  results,  it  showed  that  the  STM 
method  worked  properly,  and  the  cross-hybridisation  in  some  experiments  is  probably 
because  of  a  problem  with  the  library. 
3.4  Conclusion 
The  hybridisation  experiments  on  the  existing  library  took  more  than  one  year. 
The  results  showed  that  the  library  was  not  reliable  for  cross-hybridisation  free 
experiments.  There  are  at  least  3  possible  reasons  for  this  problem,  (i)  the  problem 
with  hybridisation  itself,  (ii)  incomplete  removal  of  the  arms  of  the  tags  in  the  process 
of  digestion  and  making  the  probes,  and  (iii)  contamination  of  the  tags.  The  first  2 
possibilities  are  excluded  as  they  are  not  supported  by  some  series  of  experiments, 
and  as  results  showed  the  method  does  work  in  some  experiments.  It  is  therefore 
concluded  that  the  problem  was  more  likely  the  contamination  of  the  mutants  with 
each  other  or  original  tags  used  to  make  the  library.  This  could  have  occurred  in  the 
first  inoculation  from  the  master  plates  (which  contain  all  the  representative  tags  in 
each  plate)  to  the  cryotubes. 
As  the  existing  library  of  mutants  showed  unexpected  cross-hybridisation,  the  whole 
library  was  discarded.  We  next  tried  to  use  the  selected  tags  in  plasmids  of  S.  aureus 
strain  RN6390  for  future  experiments  that  will  be  discussed  in  details  in  chapter  4. 
48 Experiment 
series 
No.  of 
mutants  on 
the  membrane 
No.  of 
mutants 
present  in 
the  robe 
Result 
(unexpected 
signals) 
Deleted  mutants 
1a*  96  96  - 
92  4 
1b*  96  96  - 
92  4 
2  94  94  - 
90  2 
3a  94  94  - 
90  2  A6,  D4,  F9,118 
3b**  94  1  (A6)  1  AS 
1  (D4)  - 
1  3  12  GG  G 
18  - 
4  10  1  - 
1  o.  1  - 
i  o.  2  - 
1  No.  3  - 
1  o.  4  - 
5  10  1  o.  5  1 
1  o.  G  - 
1  No.  - 
1  No.  B  - 
1  No.  9  1 
1  (No.  10)  - 
6  10  10  - 
8  -  Nos.  3&9 
7a***  10  (pooled)  10  - 
8  1  BS  D2 
7b***  10  (mixed)  10  - 
8  1  BS  D2 
94  - 
8****  94  1  (B5)  1 
1  (D2)  - 
9  8  8  - 
6  - 
Table  3.3  Details  of  the  results  of  hybridisation  experiments  with  existing  library  of  mutants 
*  Two  different  series  were  tested. 
**  The  same  series  of  mutants  in  the  experiment  3a  were  tested.  Individual  probes  were  made 
from  the  mutants  which  had  cross-hybridisation  in  the  experiment  3a. 
***  The  same  series  of  10  mutants  were  tested  twice.  In  the  first  experiments,  the  probes  were 
made  from  a  pool  of  10  and  8  mutants  as  input  and  output  pools  respectively,  but  in  the  second 
one,  probes  were  made  individually  and  then  mixed  up. 
****  The  deleted  mutants  in  experiments  7a  and  7b  were  examined  with  a  membrane  with 
larger  number  of  mutants.  One  of  the  mutants  showed  cross-hybridisation  with  another  mutant 
which  was  not  present  in  the  experiments. Chapter  4 
Analysis  of  selected  tags  in  plasmids  of  strain 
RN6390 Chapter  4:  Analysis  of  selected  tags  in  plasmids  of  strain  RN6390 
Plasmid  pID408  (Figure  4.1)  has  been  constructed  for  mutagenesis  of  S.  aureus 
strain  RN6390  in  Professor  David  W.  Holden's  laboratory.  The  amp1/ori/rop  region 
from  plasmid  pBR322  allows  replication  and  selection  of  the  plasmid  in  Escherichia 
coli,  while  the  temperature-sensitive  replicon  (pE194ts)  and  the  cm`  gene  of  pTV32ts 
permit  replication  and  selection  in  S.  aureus  at  32°C.  The  DNA  signature  tags  have 
been  incorporated  in  the  EcoRl  site  of  transposon  Tn917.  A  series  of  96  plasmids 
carrying  different  tags  has  been  separately  transformed  into  S.  aureus  strain  RN6390. 
The  plate  containing  of  94  of  the  96  was  sent  to  us  by  Professor  Holden,  and 
designated  the  master  plate.  This  was  used  for  all  subsequent  mutagenesis  of  S. 
aureus. 
A  duplicate  of  the  above  master  plate  was  generously  provided  by  Professor 
David  W.  Holden,  Imperial  College  School  of  Medicine,  London,  UK. 
4.1  Preparation  of  plasmid  from  S.  aureus 
Plasmid  DNA  from  S.  aureus  strain  RN6390  which  had  the  selected  tags  (94 
strains)  was  isolated  as  described  previously  in  section  2.2.  Plasmid  DNA  was 
successfully  isolated  at  good  concentration  (Figure  4.2). 
4.2  Hybridisation  with  probes  from  S.  aureus  plasmids 
Probes  were  made  as  described  in  section  3.2.  Probes  were  hybridised  to  nylon 
membranes  according  to  the  method  described  in  the  DIG  Probe  Synthesis  Kit  (Roche 
Diagnostics  GmbH,  Germany).  For  dot  blot  hybridisations,  0.15-0.2  pg  plasmid 
DNAs  were  transferred  onto  a  Hybond  N+  membrane  (Amersham).  Artificial  input 
and  output  probes  were  hybridised  to  the  different  membranes  to  confirm  the  system 
works  properly.  Cross-hybridisation  was  seen  in  the  most  of  the  experiments,  which 
were  done  with  the  probes  from  plasmid  DNAs. 
A  series  of  experiments  was  done  to  check  whether  the  selected  tags  in  plasmids  of 
strain  RN6390  were  suitable  for  a  work  of  free  cross-hybridisation.  The  hybridisation 
experiments  on  the  selected  tags  in  plasmids  of  strain  RN6390  took  more  than  one 
year. 
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Figure  4.1  Construction  of  the  vector  pID408  (b}  courtesy  of  Prof.  hol(len) 12  kb 
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Figure  4.2  Plasmid  preparation  from  3  S.  aurcus  strain  RN6390 Experiment  series  1:  As  there  was  a  lot  of  cross-hybridisation  in  experiments  with 
genomic  DNAs  from  the  existing  library,  the  first  two  experiments  with  the  selected 
tags  in  plasmids  of  strain  RN6390  were  done  on  a  small  scale.  Four  strains  (A2,  A3, 
A4,  and  A5)  were  chosen  randomly.  Probes  were  made  from  strains  A2  and  A5  and 
hybridised  to  the  same  membranes  of  the  4  plasmids.  Results  showed  that  the  probes 
did  not  detect  just  the  expected  strain.  In  other  words,  there  were  2  signals  instead  of 
one  on  each  membrane. 
Experiment  series  2:  This  experiment  was  repeated  4  times.  4  probes  were  made, 
and  one  different  probe  was  hybridised  to  a  membrane  of  94  plasmids  each  time. 
Again,  the  results  showed  that  none  of  the  4  probes  could  detect  the  expected  strain  on 
the  membranes.  The  probes  which  were  used  in  this  series  were  the  same  4  plasmids 
in  series  1.  This  experiment  showed  that  plasmids  A2  and  A5  had  actually  more  than 
one  signal  when  hybridised  to  a  large  number  of  plasmids. 
Experiment  series  3:  The  experiment  series  1  was  repeated  4  times  with  another 
different  series  of  4  plasmids.  The  4  selected  strains  for  this  experiment  were  A6,  A7, 
A8,  and  A10.  The  results  showed  that  none  of  the  4  probes  could  detect  just  the 
expected  strain  on  the  membranes.  In  other  words,  there  was  more  than  one  signal  on 
each  membrane. 
Experiment  series  4:  In  this  series,  a  probe  was  made  from  strain  B3.  The  probe 
was  hybridised  to  8  random  plasmids  including  B3.  The  result  showed  that  the  probe 
could  not  detect  just  the  expected  strain,  and  another  signal  with  strain  B2  was  also 
seen  on  the  membrane  (Figure  4.3). 
Experiment  series  5:  In  this  series,  a  probe  was  made  from  strain  E7.  The  probe 
was  hybridised  with  8  random  plasmids  including  E7.  The  result  showed  that  the 
probe  could  detect  just  the  expected  strain  on  the  membrane.  In  other  words,  there 
was  just  one  signal  on  the  membrane. 
Experiment  series  6:  In  this  series,  the  2  strains  in  series  4  and  5  were  checked 
with  an  artificial  pool  with  a  larger  number  of  plasmids  to  check  whether  the  above 
results  could  be  confirmed.  2  probes  were  made  from  strains  B3  and  E7,  and 
hybridised  to  an  artificial  input  of  16  random  plasmids  including  the  2  strains  on  the 
same  membranes.  The  results  showed  that  one  membrane  had  just  the  expected  signal 
(E7),  but  the  probe  B3  could  not  detect  just  the  expected  strain,  and  another  signal 
with  strain  B2  was  also  seen  on  the  membrane. 
50 input 
output 
K,  ý;  --- 
c  conU"ol  iNc  control 
Figure  4.3  Hybridisation  of  8  plasmids  with  a  probe  from  No.  4.  There  was  an  additional  signal 
with  plasmid  No.  8. Experiment  series  7:  In  this  series,  the  strains  B3  and  E7  were  checked  with  all  of 
the  93  plasmids.  2  probes  of  the  strains  B3  and  E7  were  hybridised  with  a  pool  of  93 
plasmids  individually.  The  result  showed  that  the  strain  E7  had  no  cross- 
hybridisation,  and  only  one  expected  signal  was  seen  on  the  membrane.  However, 
there  were  3  signals  on  the  membrane  B3  rather  than  the  one  expected  signal;  the 
other  two  were  unexpected  cross-hybridisations  with  strains  B2  and  F7. 
The  experiments  in  series  4,6,  and  7  showed  that  strain  B3  could  not  hybridise  free 
of  cross-reactions,  whereas  the  experiments  in  series  5,6,  and  7  showed  that  the  strain 
E7  could  hybridise  clearly. 
The  results  of  the  experiments  with  the  selected  tags  in  plasmids  strains  RN6390  are 
summarised  in  table  4.1. 
4.3  Transformation  into  E.  coli 
Due  to  the  cross-hybridisation  found  in  the  experiments  with  plasmid  DNAs,  it  was 
decided  to  transform  all  of  the  plasmid  DNAs  from  S.  aureus  strain  RN6390  into 
suitable  competent  E.  coli  cells.  More  DNA  was  needed  to  test  the  tags,  and  this  was 
not  feasible  using  S.  aureus  strains.  93  out  of  94  plasmids  were  transformed  into  XL1 
blue  cells  (Stratagene).  One  sample  was  not  successfully  transformed  even  after 
several  attempts. 
4.4  Hybridisation  with  probes  from  plasmids  generated  from  E  coli 
Plasmid  DNAs  from  93  transformed  cells  was  isolated  as  described  in  section  4.1, 
except  using  lysostaphin.  Probes  were  made  as  described  in  section  3.2  and 
hybridisation  was  done  as  described  in  section  4.2.  Cross-hybridisation  was  seen  in 
some  of  the  experiments,  which  were  done  with  the  probes  from  plasmid  DNAs  from 
the  transformed  cells.  Therefore,  there  was  a  problem  with  hybridisation  of  plasmids 
as  isolated  from  E.  coll.  It  was  therefore  decided  to  check  any  possible  identity 
between  the  tags.  Plasmid  DNAs  of  a  series  of  the  strains  showing  cross-hybridisation 
were  therefore  sequenced. 
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Ln 4.5  Sequencing  and  selecting  of  non-cross  hybridising  tags 
4  plasmid  DNAs  from  experiments  series  4-7  were  subjected  to  sequence  analysis. 
The  above  experiments  showed  that  strain  B3  cross-hybridised  with  strains  B2  and 
F7,  but  strain  E7  did  not  cross-hybridise  with  any  of  the  93  plasmids.  The  results 
showed  that  the  sequences  of  3  tags  B2,  B3,  and  F7  were  exactly  the  same  (Figures 
4.4  &  4.5),  whereas  the  sequence  of  tag  E7  was  different  from  the  others.  The  result 
of  sequencing  therefore  confirmed  the  hybridisation  experiments. 
As  3  of  4  plasmids  were  found  to  contain  similar  tags,  it  was  decided  that  all  of  the 
94  plasmids  should  be  sequenced.  84  out  of  94  plasmids  were  sequenced.  The  results 
showed  that  51  strains  had  more  than  50%  similarity  between  the  tags,  and  therefore 
were  not  suitable  for  a  cross-reaction  free  hybridisation.  The  33  tags  with  no  more 
than  50%  identity  were  chosen  for  future  experiments  (Figures  4.6-4.9).  To  check 
whether  the  system  worked  properly,  a  series  of  10  random  mutants  were  chosen  and 
artificial  input  and  output  probes  were  hybridised.  The  results  showed  no  cross- 
hybridisation.  As  shown  in  figure  4.10,  there  were  good  signals  with  all  of  the  10 
mutants  in  the  input  membrane  (a).  In  membrane  (b),  two  random  mutants  (Nos.  2& 
9)  were  deleted  and  a  probe  was  made  from  the  remaining  8  mutants.  There  were  still 
good  signals  with  the  8  mutants,  but  not  with  numbers  2  and  9.  In  the  third  part  of  the 
experiment,  5  mutants  (numbers  2,4,6,8,  and  9)  were  deleted  and  a  probe  was  made 
from  the  remaining  5  mutants.  There  were  still  good  signals  with  the  5  mutants,  but 
not  the  deleted  ones. 
In  another  experiment,  all  33  selected  tags  were  checked.  All  33  gave  good  signals 
in  the  output  membrane  (Figure  4.1  1)(a).  In  membrane  (b),  4  random  tags  (Nos.  11, 
20,21,  and  29)  were  deleted  and  a  probe  was  made  from  the  remainder  29  tags.  There 
were  still  good  signals  with  the  29  tags,  but  not  the  deleted  ones. 
It  was  therefore  concluded  that  the  33  selected  tags  had  no  more  than  50%  identity 
and  were  suitable  for  cross-hybridisation-free  experiments. 
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CCAACGATßACCCCCGCCACCGCAAGCCCT'ACAACAGCA 
AGGGTGT*I1RGCIn:  GATC4  GTGC'IGGAGCGCGCGCG  TDGGAT 
G'IY'GAGGGAGZGCGATPDCGGTG'PGGGGGGGGTGGCN  G" 
GTCGAGGGAGTGCGRTTTCGGTGTGGGGGGCTGGCTAGCT 
1-GATC7lG'IGGGCWGGGATCGTi'IG7GAGCGTGGTTGGG 
AGGTAGCGCGr_,  GAGTTGGTMGCTAGTTATCGTGGGTG 
CACGAACTAACCATCCC'RAi'ACCCACCAA'iCTCCCAAACr. 
Ra4GCGCTCTAGGGAGTTAGCGGTG  GCGGTCGGGATGTGT 
AGCTAGi:  G'IGCGCGRGCCi;  TIGGGC74_  TAGCGGTTGTGTT 
i:  GAG7Gi:  'P:  GAGGTAGCTCGGGTGGGGGCTGGATATATCG 
i;  GAGTGGTGGAGGTAGCTCGGGTGGGGTCTGGATATATCi' 
RACGCACGAGAC_.  CGACCCCGCCCACTAACGCTCCATCCCT 
GAGT=  GTGGAGGTAGCT'CGGTGGCGTCTG  GATATa'r_, 
AGAGGGGGCGAGCTAGTGCGAGCGCGTIIACTGGGTGTTG 
CGAT:  GGGCTTGCGGGGGGGGGGTDGGTTTr;  GCTCTCGGG 
GGAGATATCGCTGGTGTCAGCGCGAGTGAiGAT:  GGGGGAG 
CGGGCGGTCGCTCGATTTGTCGGGGTGGTTCGCCCGATGT 
ACAACTATAACGCACCATACCCCCACAACCAACCACACCC 
AGGTCGGGCGCTACGGCGGTACTTTGGGCGCTTTAr,  GTTT 
AGCGGGTTCTGTCGCGAGGGGTGTTTGGATGGTGTGTGAG 
AGCGTGGTl'MGTTAGTICGCTrýTTGGGCGT'IIAGTGAGGT 
AGACACCCCGCCCTAACAACAGCTCCACTCTACCTACCC 
,;  GAGRGGTGGAGGTAGCTCGGGTGGGGRCTCGATATATCG. 
CGA4x1ACCCAAACCCGCCCTATAGCTC7CCCCCGCACACC 
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CTCGATAAA'1CAACAI-ATCCCACGCGCCACCGCC  CCC9HT 
i:  W,  GCTAGCGCGCGTGT.  GTGGGGATCGGGGGGGAGCGAT 
AAACATaACGAGCCCGCCCCACCGACAGCGAGCCATCGCA 
GGCGCGGGTGGGATGG77MGGCGATZ'1RGTTITIGATrjT 
GTGGGGGGAG7I1aGGGCGCGATTGGGTPGTTG'I'DG7CGGG 
AAGACGCCATATCCCCCACTACATCTCTATCACGCCAGCA 
AGAGCCCGCACACAAGCCATCCAACCAAACCGGTCGATCC 
CTCACCACCCAGCGCCAGCAACCGCCAGCCACCTAGCACT 
AAGACGCCATATCCCCCACTACATCTCTATCACGCCAGCA 
ATGGAGAGCGAGAGGGGGAGGTGTCGTGGGAGAGCGTGGT 
GGGGGGAGGTGGGGATGT7GAGTTGGTGATAT3TCGTGGG 
ACCGCAATRCCAAGCGCTACCCAT:.  GCGCTAGACCCACCT 
ACCGCAACCACACCACTCCCCGAGCGCGCCCCCCACAG 
CGATCCACCTCCCTCCATATACCACCCGATCTAACCACCT 
CGATCCACCTCCCTCCATATACCACCCGATCTRACCACCT 
ACCGCAACCACACCACTCCCCGAGCGCGCCCCCCACAG 
AGGTGGAGCGGGTTAGTGCGAGGTAGCTAGTTCGCTTPIT 
CACTCCAGCGTCCCCCCGCGACAAAGCGAGACRARCCCRT 
A'iYiCCACACCCGCGATCACGCACARRRCCCCGCCCCCTCG 
RGAACTRACCAGCACCAACCACTATCCCARCACCGCC 
ACCGCARTACCRAGCGCTACCCATCGCGCTAGACCCACCT 
TTGGCGCGGGGGG'IIiRGTTTTGCRGGCTGGGGAGGGGTCT 
AGCACAACATCACCATCCCACCAGCTCTCGCGCGCTCGCC 
CTCGAGCGGTAGATGGCGAGGGGGAGAGCTCGGTAGGTC:  T 
CAAAAGCGCACACGCCCCCGCAATA'Ix1CCCC'I'CACCCGCC 
CAAAAGCGCACACGCCCCCGCAATATACCCCTCACCCGCC 
RTCGCCACACACCRRCAAACATrlATTCGCTACATCCCACT 
ACAACACACGCCCCATACATCCAGCCCGCGCACTCACG 
ACCGCAATACCAAGCGCTACCCATCGCGCTAGACCCACCT 
ACCGCAATACCAAGCGCTACCCATCGCGCTAGACCCACCT 
RACCCAAAACACATA'ilaACACCCACTCACGCCATAACGCC 
C'IGGCACTaCCAGCACGATCCCCATACCCCCCAAACWT 
ATCAAAAGAAAGACACAAAGCCCGCTATCCCTCGCGCCCT 
GGpGAGGGTGTGTGTGTGGGGTCTCTATCTCGTTCTAGTG 
CTAGGCGTGGGRGAGAGAGCGGGTTCTAGTTTGTGAGGG 
ACCGCACACCACCAAGAACTCTCTCGCTCCCTCTCGCTCC 
ATGTGGTGGTGGAGCGCGATGGTGCGGGTGCTGTCGGTTT 
ACRTCTAACCCCCAAGCAAACACACCCGCACGACCTaTCT 
TGAGGTAGGGCGRTGTGTTTIGGGTICGTGATMTCGGT 
TGAGGTAGGGCGAGGTGTTI'IGGGTPCGTGATTTCTCGGT 
AAACCGCCACAAATCTCTCGACAGCTCTCGCCCCCTAACGI"' 
CCCGCTRGCCACCGAGACCTCCCTRAAGCGCCCACCCT;,  T 
ATCCCTRACCCCCCCCAACTAACGACCAATCTCGACCACC 
RGCCAACACAATaTCTaCCTATAACACCAGCTCCCACT'G 
CTTGGTPPGGAGCTCGGG 
Figure  4.6  (continued) <WLLS<OmWLLOO<OmýLL00LL8WS0"000ýýZWWýOZOOýLLWýWiLLypýGÜýWmmöýWýOmýgsäWýiiW°<SEÖfsI<ýE87fmI 
3338333333f$$;  $$;  333;  $33$f3$333333333n°883$33$3$33888333338388$8333YYff$888Yf83YYYYfY 
-  ------  --- 
III-TIITTI1111  TI111IITiII1ITIIIII'Y1111111111111111111.1IIIIIIITIIITII 
11 
r 
L.  J 
Týý 
0 
9 
9 
3 
Y 
9 
9 
it 
2 
r$ . ý Sequence  Name  <  Pos  =1 
-fis   +  "I  U0  -,,.  0  0  ýJFAW  _  Omm  ml 
0  Consensus  AGGG-----  GGGCGGGGGAGTGC--GGTGGGGGTGGTPDGTGCGGT-TGAAG 
33  Sequences 
A2 
A4 
A9 
A10 
34 
36 
38 
39 
310 
311 
C1 
C2 
C9 
cll 
D2 
D3 
D5 
D6 
D7 
D9 
12 
14 
F5 
110 
E11 
15 
110 
111 
112 
G12 
Ef3 
H5 
H11 
10  20  30  40  50 
CTAG----  G  GTGGGAGAGAGA--GCGGGTTCTAGTTRGTGRGG  -  GAAG 
AGTG----  GTGRGTGTGCGCGC--GCT  CGGGAGGGT  GTGGAAC-CGAAG 
CGGT-----  GGCGCGGGT6GGGT--AGGTG'IGGRT'ITTMT  GTGT  'GR  AG 
CGAG--  --  TCGG  GG'IrAA--T  GGTTTIGT'lY''P'GCGAT  TA  AG 
CTRG  -  GART  -GGAATIC  CAACCTCAAGCTI?  IGGGGG  iii' 
AGGG-----  TGTTAGGTGGATG  --GTGCTGGAGGGCGGGGGTTGG  TA  AG 
GTCG----  GGGAGTGCGATTTC--GGTGTGGG  GGGC7GGC7'RGC-1'AA  G 
CGAT----  R"IGTGGGGTAGGGR--TGGTR'IGTGAGCGTGGTTGG  -  GAAG 
AG----  TAGCGCGGGAGTIG--GTRGGCTRGTTATCGTGGGT  -  GAAG 
A  G----  GGRL""'GGGGGAGRGC--GAT  TGTG  CTGTGGTTCGGG-TGC  G 
AT  -----  GGCGC'1ý'TRGGGA--GTRIAGCGGTGGCý=i:  'I~'GGGAT  TGTAA 
AG  --  GGGTGCGCGTGCGG--TTGGGCTGTAGCGGTTG  T  TTAAG 
AGAG----  GGGCGAGCRPGTGC--GAG  CGCGTMCT  G  GGTGT-TGAAG 
GRTG-----  GGGCTRL'.  CGGGGG  --G  GGGTTGGTTIGGGCTGT-CG  GG 
GGAG----  T9'PCGCTGGTG'1GR--GCGCGRGTGRGRTPrjGGGGGA  -  GAAG 
CGGG--  --GGTCGGTCGATTPG--TC  GGGGTGGTIY'GCGCGAT  TA  AG 
AG  G--  --GGG  GCGCTRGGGC--GGTXIGTTIGGGCGCTTPRGGT-  TT 
AGCG-----  GGTIL'TGTCGCGA  --GGGGTGTTTGGRTGGTGTGTG  GA  AG 
AGCG----  GGTTTIIRGTTAGTPC--GCTGTTGG  GCGTTAGTGAGG-T  ARG 
GGAG----  GGTGGRGGTRGCTC--GG  GTGGG  GTP'TGGATqTSaT-CGAAG 
GTGG--  GCGCGCGTGTGGTG--GGGAT'GGGGGGGAGC  GAT  AG 
GGCG--  --GGGTGGGATGGTPT--GGGCGRTTTAGTTTTTGATGT-  A  AG 
GTGG--  --GGGRGTTRGGGCGC--GATPGGGTTGTTGTP3TCGGG-  A  AG 
ATGG----  GAGCGAGAGGGGGR--GGTGTCGTGGGAGAGCGTGGT  AG 
GGGG-----  GGAGGTGGGGRTGT--TGRGTPGGTGATATGTCGTGG-GR  AG 
AGGT----  GRGCGGGTTAGTGC--GAGGT1ßGCTAGTRCGCTTT  -TPAAG 
TTGG-----  CGCGGGGGGTATGT--TTTGCTGGCTG  GGGAGGGGT  TA  AG 
T  -----  AGCRCAACATCAC  TCCCACCAGCTCTCGCGCGCT  GCCAA 
CTCG----  GCGGTIRGATGGCGA--GG  ---GGGAr_,  AGCTCGGT  GGTGT 
GGAG----  GGGTGTGT  GTGT--GGGGTCTCTRTCTY'GTIICTAG-TGAAG 
AT  G--  --GG  TGGT+GGAGCGC--GATGGTGCr,  GGTGCTGTCGGT  TA  AG 
TGA  -----GGTAGGGCGATGTG--TTTIGGGTT'GTGATTTCTCG  TA  AG 
CTTG  GAGCTCGGGAAGCT  '  G4'TAGAATGGAATTCTACAAG  TCAAG 
Figure  4.8  Alignment  of  the  33  selected  tags  using  the  MegAlign  program  of  DNASTAR C1 
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Figure  4.9  Phylogenetic  tree  of  the  33  selected  tags  using  the  MegAlign  program  of  DNASTAR (a) 
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Figure  4.10  Hybridisation  of  the  membranes  of  10  random  mutants  from  the  33  selected 
tags.  The  membranes  were  hybridised  with  the  probes  from  the  input  pool  (a)  and  the  2 
different  output  pools  (b  &  c).  Hybridisation  signals  from  mutants  Nos.  2&9  in  (b),  and  2, 
4,6,8  and  9  (c)  are  present  on  the  membrane  with  the  input  pool  but  not  on  the  membranes 
with  the  output  pools. .:: 
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Figure  4.11  Hybridisation  of  the  membranes  of  the  33  selected  tags.  The  membranes  were 
hybridised  with  the  probes  from  the  input  pool  (a)  and  the  output  pool  (b).  Hybridisation  signals 
from  tags  Nos.  11,20,21,  and  29  are  present  on  the  membrane  with  the  input  pool  but  not  on  the 
membrane  with  the  output  pool. Chapter  5 
Construction  of  a  new  library Chanter  5:  Construction  of  a  new  library 
We  were  now  in  a  position  to  use  the  33  selected  tags  to  construct  a  new  library.  To 
generate  a  new  library  of  mutants,  20  µl  of  bacterial  suspension  from  each  of  the 
selected  wells  containing  33  non-cross-hybridising  tags  of  the  master  plate  of  S. 
aureus  strain  RN6390  were  cultured  into  the  wells  of  a  second  microtitre  dish 
containing  180  gl  of  BHI  and  erm  (20  µg  ml").  After  overnight  incubation  at  43°C, 
bacteria  from  each  well  were  streaked  on  BHI  agar  containing  erm  and  incubated  at 
43°C  overnight  to  obtain  single  colonies.  Approximately  30-50  different  erm1  colonies 
from  each  well  were  transferred  onto  BHI  agar  containing  cm  (20  pg  ml-1)  and 
incubated  at  32°C,  and  onto  BHI  agar  containing  erm  and  incubated  at  43°C,  to  screen 
for  cros  colonies.  The  agar  plates  were  incubated  overnight.  Ern`  cros  colonies  should 
lack  the  plasmid  and  carry  a  chromosomal  insertion  of  Tn917.  Individual  erm`  cros 
colonies  from  each  of  the  94  wells  were  transferred  into  corresponding  wells  of  a  third 
96-well  microtitre  dish  containing  Bill  broth  and  erm.  After  overnight  incubation  at 
43°C,  mutants  were  transferred  to  a  fourth  microtitre  dish  and  grown  at  37°C  before 
use  as  inoculum.  Mutant  pools  were  also  stored  at  -80°C  in  50%  glycerol.  A  series  of 
25  pools  of  33  mutants  were  used.  Each  pool  contained  33  mutants  with  individual 
selected  tags.  The  total  number  of  mutants  made  was  33  x  25  =  825. 
To  verify  that  the  constructed  mutants  lack  the  plasmid  and  carry  a  single 
chromosomal  insertion  of  Tn917,  chromosomal  DNA  samples  from  two  random 
individual  mutant  strains  that  had  been  cultured  separately  were  digested  with  Hind 
III  (which  cuts  the  signature  tags  within  the  transposon)  and  then  subjected  to 
Southern  analysis  using  a  723bp  PstI  A1wNI  fragment  of  pBR322  containing  part  of 
the  (3-lactamase  gene  as  a  probe  to  determine  the  size  of  the  DNA  fragment  carrying 
this  part  of  the  transposon.  The  fragment  of  pBR322  was  obtained  by  PCR  using 
primers  P21  and  P22.  The  digested  DNA  was  run  in  the  1%  agarose  gel,  and  a1  kb 
ladder  (Invitrogen)  was  used  as  a  marker.  The  gel  was  submerged  in  denaturation 
solution  for  2x  15  min  at  room  temperature.  After  rinsing  with  water,  the  gel  was 
submerged  in  neutralisation  solution  at  the  same  conditions.  The  DNA  was  blotted  to 
a  Hybond  N+  membrane  (Amersham)  by  capillary  transfer,  using  20x  SSC  buffer 
overnight.  The  membrane  was  UV-crosslinked  at  optimal  crosslink  (1200 
53 xlOOiJ/cm2)(  Spectro  Linker,  Spectronics  Corporation)  without  prior  washing.  The 
procedure  for  hybridisation  of  the  membrane  was  the  same  as  described  in  section  2.4. 
As  the  mutagenesis  is  random,  it  is  expected  that  the  hybridising  fragment  in  different 
mutants  has  a  different  size.  For  each  of  two  separately  analysed  mutants,  a  single 
hybridising  fragment  of  different  size  (6  and  8  kb)  was  observed  (figure  5.1).  The 
different  sizes  of  the  DNA  fragments  therefore  confirmed  that  the  mutagenesis  was 
random. 
To  verify  that  there  was  no  cross-hybridisation  between  the  mutants  of  the 
constructed  library,  a  series  of  8  random  mutants  was  chosen  and  subjected  to 
hybridisation.  As  shown  in  figure  5.2,  there  were  good  signals  with  all  of  the  8 
mutants  on  the  input  membrane.  For  output  membrane,  2  random  mutants  (Nos.  6  and 
8)  were  deleted  and  a  probe  was  made  from  the  remaining  6  mutants.  As  shown,  there 
were  still  good  signals  with  the  6  mutants,  but  not  the  deleted  ones. 
5.1  Phenotypic  analysis  of  mutants 
To  determine  that  mutagenesis  had  occurred  randomly  across  the  genomic  DNA  of 
the  mutants  of  the  constructed  library,  one  of  the  known  phenotypic  characteristics 
was  traced.  Catalase  production  was  chosen  for  this  purpose.  Different  toxic  forms  of 
oxygen  are  produced  as  inadvertent  by-products  during  the  reduction  of  02  to  H2O  in 
respiration.  These  reactive  oxygen  intermediates  have  many  deleterious  effects  on 
living  organisms,  ranging  from  DNA  strand  damage  to  peroxidation  of  membrane 
lipids.  Bacteria  have  evolved  enzymes  that  destroy  toxic  oxygen  products.  The  most 
common  enzyme  in  this  category  is  catalase,  which  attacks  hydrogen  peroxide 
(H202)(80)  102).  All  the  mutants  of  the  constructed  library  were  therefore  tested 
individually  for  catalase  production. 
5.1.1  Catalase  enzyme 
All  staphylococci  produce  catalase,  which  catalyses  the  conversion  of  toxic 
hydrogen  peroxide  to  water  and  oxygen.  Hydrogen  peroxide  can  accumulate  during 
metabolism  or  after  phagocytosis  (118).  Hydrogen  peroxide  is  produced  by  bacteria  in 
aerobes  and  facultatively  either  by  a  nonenzymatic  reaction  of  oxygen  with  reduced 
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Figure  5.1  Southern  hybridisation  analysis  of  Tn917  insertions  in  the  S.  uureus  genome  of 
constructed  library  of  mutants.  The  lanes  (a)  are  hybridising  fragments  with  different  size  from 
individual  mutants.  Lane  (b)  is  I  kb  marker. +ve  control  -ve  control 
5;  x 
+ve  control  -ve  control 
Figure  5.2  Hybridisation  of  8  random  mutants  from  the  constructed  library.  Mutants  Nos.  6 
&8  have  been  deleted  to  make  an  artificial  output  probe. flavoproteins  or  by  enzymatic  action  on  the  superoxide  radical.  Hydrogen  peroxide  is 
a  highly  reactive  molecule  that  can  damage  cell  components. 
5.1.2  Catalase  test 
When  a  drop  of  3%  hydrogen  peroxide  is  placed  on  a  culture,  bubbles  of  oxygen  gas 
will  appear  from  the  bacteria  producing  catalase.  If  no  catalase  is  present,  no  bubbles 
will  form.  The  test  may  be  performed  on  growth  transferred  to  a  slide,  or  to  an  agar 
slant.  The  culture  to  be  tested  should  be  grown  on  nutrient  agar.  If  the  culture  is 
grown  on  blood  agar,  and  the  sample  gathered  from  the  blood  plate,  there  may  be  a 
false  positive  reading  due  to  the  reaction  of  hydrogen  peroxide  with  blood. 
5.1.3  Results 
All  the  mutants  of  the  constructed  library  were  tested  individually  for  catalase.  The 
results  showed  that  1  out  of  825  mutants  (mutant  C11  from  pool  10)  of  the 
constructed  library  was  catalase  negative.  This  shows  that  integration  of  the  tags  into 
genomic  DNA  of  the  mutants  has  been  occurred  randomly,  as  some  of  the  known 
phenotypic  characteristics  such  as  catalase  production  have  been  also  affected.  To  test 
the  virulence  of  the  mutant,  a  mouse  was  injected  intraperitoneally  with  an  overnight 
culture  of  the  mutant.  The  overnight  culture  of  the  wild  type  bacteria  was  also  injected 
into  another  mouse.  The  details  of  the  procedure  are  discussed  in  section  6.1.  The 
number  of  recovered  bacteria  from  the  mice  showed  no  discernible  difference  (figure 
5.3).  It  could  be  concluded  that  catalase  did  not  affect  the  growth  of  bacteria  in  the 
mouse.  The  recovered  bacteria  from  the  mouse  which  had  been  injected  with  the 
mutant  showed  a  negative  catalase  reaction. 
5.1.4  Conclusion 
A  library  of  825  mutants  that  contained  unique  tags,  with  random  insertion  of 
transposon  Tn917  had  been  achieved.  Thus  the  STM  selection  procedure  is  now 
working  and  can  be  used  for  mutant  selection  in  the  mouse  and  in  biofilms. 
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Figure  5.3  Recovery  the  mutant  C11  and  wild  type  strains  from  mice  24  hr  post  challenge Chapter  6 
Gene  recovery  from  selected  DNA  sequences Chapter  6:  Gene  recovery  from  selected  DNA  sequences 
The  constructed  library  was  used  in  two  experimental  systems:  a  mouse  infection 
model  and  in  biofilms. 
6.1  Mouse  infection 
A  series  of  25  pools  of  33  mutants  was  used.  Each  pool  contained  33  mutants  with 
individual  selected  tags  (see  chapter  5  for  details).  The  details  of  procedure  for  mouse 
infection  and  recovery  of  the  bacteria  from  the  mice  was  discussed  in  section  2.6.2. 
6.1.1  Response  to  infection 
At  least  one  mouse  was  used  for  each  pool.  In  some  cases,  2-3  mice  were  used.  All 
mice  challenged  intraperitoneally  with  8x  105  CFU  showed  signs  of  illness  (starry 
coat,  hunched  appearance,  and  lethargic)  with  different  severity  by  18  hr  post- 
infection.  By  24  hr  post-infection,  all  the  mice  were  killed  by  cervical  dislocation.  The 
spleens  were  removed  into  2  ml  of  sterile  PBS  in  a  microfuge  tube. 
6.2  Biofilm 
Discs  of  catheter  material  (surface  area,  0.5  cm2) were  cut  from  catheters,  and 
sterilized  by  UV  irradiation  for  20-30  minutes  each  side.  The  discs  were  placed  in 
wells  of  24-well  Nunclon  tissue  culture  plates.  A  standardized  cell  suspension  (80  µl) 
was  applied  to  the  surface  of  each  disc,  and  the  discs  were  incubated  for  1h  at  37°C. 
Non-adherent  organisms  were  removed  by  gentle  washing  with  PBS.  To  determine 
the  suitable  duration  for  biofilm  formation,  a  series  of  experiments  was  done  at  24  and 
48  h.  After  24  h  incubation,  a  layer  of  bacterial  growth  was  seen  on  the  discs,  and  the 
medium  was  clear.  Although  it  seemed  that  growth  of  adherent  bacteria  was  better 
after  48  h,  the  growth  of  nonadherent  bacteria  was  also  greater.  As  a  consequence,  the 
medium  was  cloudy  in  comparison  with  the  24  h  volumes.  Therefore,  the  24  h 
incubation  time  was  chosen  for  future  experiments.  At  least  5  discs  were  used  for 
each  mutant.  The  discs  were  incubated  for  24  h  at  37°C,  submerged  in  1  ml  of  BHI 
with  erythromycin  (20  µg  m1').  Discs  without  cells  were  incubated  in  the  same  way 
as  for  the  control.  After  biofilm  formation,  the  discs  were  removed  from  the  medium 
56 and  gently  washed  with  PBS  to  remove  non-biofilm  cells.  Biofilm  organisms  were 
washed  with  4  ml  sterile  BHI  with  erythromycin  by  vigorous  moving  of  the  container. 
The  chromosomal  DNA  was  extracted  from  the  suspension. 
6.3  Membranes 
After  making  probes  from  the  extracted  genomic  DNAs  of  the  output  pools  from 
both  experiments  in  mice  and  biofilm,  at  least  one  membrane  was  used  for  each  pool, 
and  hybridisation  was  done  as  described  in  section  2.4.  The  result  of  hybridisation  of 
the  33  mutants  of  pool  8  from  mouse  experiment  is  shown  in  figure  6.1.  Hybridisation 
signals  from  mutants  A4,  A9,  B8  and  D2  are  present  on  the  membrane  with  the  input 
pool  (a)  but  not  on  the  membrane  with  the  output  pool  (b). 
6.4  Southern  blotting  and  hybridisation 
The  mutants  with  attenuated  virulence  (which  had  weak  or  no  signals  on  the  output 
membranes)  were  subjected  to  the  following  procedure  for  gene  recovery.  3-5  µg  of  S. 
aureus  Chromosomal  DNA  from  each  mutant  with  attenuated  virulence  was 
completely  digested  with  Hindlll.  Half  of  the  digested  DNA  was  then  subjected  to 
Southern  hybridisation  analysis  using  a  723bp  Pstl-AlwN1  fragment  of  pBR322 
containing  part  of  the  ß-lactamase  gene  as  a  probe  to  determine  the  size  of  the  DNA 
fragment  carrying  this  part  of  the  transposon.  The  procedure  for  Southern  blotting  was 
described  in  section  2.5.1.  The  procedure  for  hybridisation  of  the  membrane  was  the 
same  as  described  in  section  2.4. 
6.5  Cloning  of  attenuated  genes 
The  rest  of  the  digested  DNA  in  section  6.4  was  resuspended  in  ligation  buffer 
(Promega)  and  self-ligated  for  12-18  h  at  16°C.  The  ligated  products  were  transformed 
into  E.  coli  XL1-blue,  plated  onto  LB  agar  containing  amp  and  incubated  at  37°C 
overnight.  A  single  amp`  colony  from  each  transformation  was  grown  in  LB  broth 
containing  ampicillin.  Plasmid  DNA  was  extracted  as  described  in  section  2.2.  Figure 
6.2  shows  the  Southern  hybridisation  analysis  of  7  mutants  from  pool  8.  As  shown  in 
the  figure,  the  size  of  hybridising  fragments  in  different  mutants  was  different. 
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Figure  6.1  Hybridisation  of  the  33  mutants  of  pool  8  from  mouse  experiment.  The  membranes 
were  hybridised  with  the  probes  from  the  input  pool  (a)  and  the  output  pool  (b).  Ilh-bridisation 
signals  from  mutants  A4,  A9,  B8  and  D2  are  present  on  the  membrane  with  the  input  pool  but 
not  on  the  membrane  with  the  output  pool. Figure  6.2  Southern  hybridisation  analysis  of  7  mutants  from  pool  8.  The  DNAs  were  digested 
with  Hind  III  and  analysed  by  southern  hybridisation  using  a  fragment  of  the  ß-lactamase  gene 
of  pBR322  as  a  probe. 6.6  Analysis  of  the  sequences 
Chromosomal  DNA  sequences  flanking  the  transposon  in  the  self-ligated 
constructed  were  obtained  using  primer  pseq-1  corresponding  to  the  inverted  repeat 
region  70  bp  from  the  erm-proximal  end  of  Tn917.  In  total  12  samples  with 
moderately  attenuated  hybridisation  signals  were  sequenced.  The  sequencing  was 
done  by  MBSU  DNA  Sequencing  Service,  University  of  Glasgow,  UK.  DNA 
sequences  were  analysed  by  searching  the  TIGR  database  on  complete  sequences  of 
different  S.  aureus  strains  (Mu50,  N315,  COL,  and  MW2),  BLAST  and  using 
DNASTAR  software.  Mu50  is  an  MRSA  strain  with  vancomycin  resistance  isolated 
in  1997  from  the  pus  of  a  Japanese  male  baby  with  a  surgical  wound  infection  that  did 
not  respond  to  vancomycin.  N315  is  an  MRSA  strain  isolated  in  1982  from  the 
pharyngeal  smear  of  a  Japanese  patient  (88).  MW2  is  a  MRSA  strain  which  caused 
fatal  septicaemia  and  septic  arthritis  in  a  16-month-old  girl  in  North  Dakota,  USA  (9). 
The  results  are  summarised  in  tables  6.1  and  6.2. 
6.6.1  Mutants  from  mouse  experiments 
6.6.1.1  Mutant  A4  (pool  8) 
The  gene  from  this  mutant  was  identified  as  encodes  a  hypothetical  protein  with  a 
role  in  the  group  of  hypothetical  proteins.  The  gene  had  100%,  100%,  and  83.3% 
identity  with  SAV2655,  SAS090,  and  MW1322  loci  in  S.  aureus  strains  Mu50,  N315, 
and  MW2,  respectively.  In  addition,  the  gene  had  80%-92.9%  identity  with  5  different 
loci  in  each  of  the  3  strains.  Figure  6.3  shows  the  region  surrounding  SAV2655  locus 
in  S.  aureus  Mu50,  and  homology  of  the  recovered  gene  and  its  protein.  As  shown  in 
the  figure,  the  most  important  genes  surrounding  the  locus  SAV2655  are  intercellular 
adhesion  protein  B,  C,  and  D  with  unclassified  roles. 
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,  (il 6.6.1.2  Mutant  A9  (pool  8) 
The  gene  from  this  mutant  was  identified  as  a  hypothetical  protein  with  a  role  in 
DNA  metabolism.  The  gene  had  100%  identity  with  the  four  strains  of  S.  aureus.  The 
homologous  loci  for  the  gene  are  SAV1394  (strain  Mu50),  SA1241  (strain  N315), 
SA1445  (strain  COL),  and  MW1229  (strain  MW2).  The  gene  also  showed  some 
identity  with  SE0979  in  S.  epidermidis,  yojN  gene  in  Bacillus  subtilis  168,  and 
OB0843  loci  in  Oceanobacillus  iheyensis  HTE831.  All  of  the  3  are  nitric-oxide 
reductase.  Nitric-oxide  reductase  (NOR)  is  an  enzyme  involved  in  the  denitrification 
process,  in  which  nitrate  (NO3)  or  nitrite  (NO2)  is  converted  into  nitrous  oxide 
(N20)  via  nitric  oxide  (NO).  This  enzyme  catalyzes  the  reduction  of  NO  to  N20;  2N0 
+  NADH  +  H+  -º  N20  +  NAD+  +  H2O,  where  NADH  is  an  electron  donor  to  the 
enzyme.  The  turnover  number  of  this  reaction  is  over  1,000  sec"  at  10°C,  showing  an 
effective  NO  diminishing  system  in  cells  (148).  Although  there  is  no  evidence  on  the 
specific  effect  of  the  enzyme  in  S.  aureus,  it  seems  as  in  other  bacteria  (24,143,162), 
the  above  general  effect  could  decrease  the  side  effects  of  NO  on  the  cells. 
Figure  6.4  shows  the  homology  between  SAV1394  and  yojN  genes.  The  homology 
between  the  proteins  SAV1394  with  SE0979,  yojN,  and  OB0843  is  shown  in  figures 
6.5-6.7.  The  region  view  display  of  the  SAV1394,  yojN,  and  OB0843  are  shown  in 
figure  6.8.  On  one  side,  the  loci  SAV1392  and  SAV1393  are  a  branched  chain  amino 
acid  carrier  protein,  and  conserved  hypothetical  protein,  respectively.  On  the  other 
side,  there  is  SAV1395  locus  which  is  a  conserved  hypothetical  protein  and  has  a  role 
in  protein  fate. 
6.6.1.3  Mutant  A9  (pool  9) 
The  gene  from  this  mutant  was  homologous  with  SAV1364  (100%),  opp-2F 
(100%),  SA1414  (91.7%),  and  MW1267  (98.7%)  loci  in  S.  aureus  Mu50,  N315, 
COL,  and  MW2  respectively.  The  gene  had  also  some  homology  with  SAV1363 
locus  of  S.  aureus  Mu50,  and  SE1060  locus  in  S.  epidermidis.  Figure  6.9  shows  the 
protein  homology  between  the  recovered  gene  and  SE1060  in  S.  epidermidis.  The 
putative  identification  of  locus  SAV1364  is  an  oligopeptide  transporter  putative 
ATPase  domain  and  belongs  to  the  group  of  transport  and  binding  proteins.  This  gene 
has  also  been  identified  in  another  STM  screening  on  S.  aureus  (33).  The  surrounding 
59 genes  of  the  SAV1364  on  the  right  side  are  a  group  of  putative  oligopeptide 
transporter  genes  that  belongs  to  transport  and  binding  proteins  and  have  a  role  in 
protein  synthesis.  On  the  left  side,  there  are  some  hypothetical  proteins.  The  family  of 
opps  genes  encodes  the  functionally  diverse  ATP-binding  cassette  (ABC)  transporters 
proteins.  The  ATP-binding  cassette  (ABC)  transporter  proteins  were  the  largest  class 
which  were  identified  by  one  of  the  STM  screening  on  S.  aureus  (33). 
There  are  2  ABC  transporter  operons  in  S.  aureus,  referred  to  as  Opp-1  and  Opp-2. 
The  Opp-2  operon  is  near  ORFs  encoding  the  femA  and  femB  genes  that  mediate 
pentaglycine  peptidoglycan  cross-linking  of  the  S.  aureus  cell  wall  (152).  S.  aureus  is 
naturally  auxotrophic  for  several  essential  amino  acids,  and  it  is  therefore  possible 
that  Opp  mutants  are  defective  in  the  import  of  peptides  from  which  growth-essential 
amino  acids  are  salvaged.  In  Gram-negative  bacteria,  a  major  function  for  the  Opp 
system  is  the  salvage  of  cell  wall  peptides  released  from  growing  peptidoglycan  (62). 
Thus,  it  may  be  significant  that  the  Opp-2  operon  is  in  close  proximity  to  the  S. 
aureus  Fern  operon  that  encodes  genes  involved  in  cell  wall  peptidoglycan 
biosynthesis.  Oligopeptide  transporters  are  also  known  to  play  roles  in  growth 
regulation,  cell  competence,  adherence  to  host  cells  and  susceptibility  or  resistance  to 
host  defensins  and  toxic  peptides  (90,129,131). 
6.6.1.4  Mutant  B8  (pool  8) 
The  gene  from  this  mutant  was  homologous  with  SAV1722  (100%),  acuC  (100%), 
SA1785  (99.5%),  and  MW1678  (99.2%)  loci  in  S.  aureus  Mu50,  N315,  COL,  and 
MW2  respectively.  The  gene  had  also  some  identity  with  acuC  in  S.  xylosus,  B. 
subtilis  168  and  B.  halodurans  C-125  (figure  6.10).  The  gene  is  surrounded  by  a 
series  of  different  genes  which  have  some  roles  in  metabolism,  regulatory  functions, 
and  amino  acid  biosynthesis. 
This  gene  has  been  also  identified  in  other  bacteria  like  B.  subtilis  (169),  but  not  in 
any  of  the  previous  STM  works  on  the  S.  aureus.  This  gene  was  identified  in  an 
output  from  a  mouse  infection  experiment.  acuC  encodes  the  enzyme  acetoin 
dehydrogenase  and  disruption  of  this  gene  results  in  poor  growth  or  sporulation  on 
acetoin  in  B.  subtilis  (65).  The  homology  between  the  proteins  of  the  SAV1722  with 
acuC  in  S.  xylosus,  B.  subtilis,  and  B.  halodurans  are  shown  in  figures  6.11-6.13. 
60 6.6.1.5  Mutant  1311  (pool  9) 
The  gene  from  this  mutant  was  homologous  with  SAV1362  (100%),  SA1209 
(100%),  SA1412  (98.0%),  and  MW1265  (98.2%)  loci  in  S.  aureus  Mu50,  N315, 
COL,  and  MW2  respectively.  SAV1362  is  a  conserved  hypothetical  protein  with 
unknown  function.  The  surrounding  genes  of  the  SAV1362  are  the  group  of 
oligopeptide  transporter  putative  genes  with  a  role  in  protein  synthesis  on  one  side, 
and  some  hypothetical  proteins  on  the  other  side.  SAV1362  and  SA1412  encode 
putative  hydrolase  enzyme.  Homology  between  the  recovered  gene  and  SA1362  is 
shown  in  figure  6.14. 
6.6.1.6  Mutant  D2  (pool  8) 
The  gene  from  this  mutant  was  100%  homologous  with  SAV1474,  SA1316, 
SA1526,  and  MW1373  loci  in  S.  aureus  Mu50,  N315,  COL,  and  MW2,  respectively. 
The  gene  had  also  some  identity  with  SE1174  in  S.  epidermidis,  ypaA  in  B.  subtilis 
168  and  OB2329  in  0.  iheyensis  HTE831  (figures  6.15-6.17).  SAV1474  is  a 
conserved  hypothetical  protein.  All  of  the  surrounding  genes  of  SAV  1474  locus  are 
hypothetical  proteins,  except  the  SAV1473  locus  which  contains  the  ferredoxin  gene 
which  has  a  role  in  energy  metabolism.  Figure  6.18  shows  the  region  view  of 
SAV1474  in  S.  aureus  Mu50,  ypaA  in  B.  subtilis  168,  and  OB2329  in  0.  iheyensis 
HTE831,  which  both  have  an  unclassified  role.  The  homology  of  the  recovered  gene 
with  the  SAV1474  locus  in  S.  aureus  Mu50  is  shown  in  figure  6.19. 
Work  on  ypaA  gene  in  B.  subtilis  has  showed  that  after  inactivation  of  the  gene,  the 
phenotypic  pattern  obtained  showed  that  this  gene  controls  a  system  for  active  flavin 
transport  and,  possibly,  riboflavin  excretion  under  the  conditions  of  constitutive 
synthesis  (87). 
6.6.1.7  Mutant  F11  (pool  9) 
The  gene  from  this  mutant  was  homologous  with  SAV1369  (100%),  SA1216 
(100%),  SA1419  (99.8%),  and  MW1272  (99.8%)  loci  in  S.  aureus  Mu50,  N315, 
COL,  and  MW2,  respectively.  The  SAV1369  and  SA1419  encode  oligoendopeptidase 
F  (pepF),  and  the  loci  SA1216  and  MW1272  are  similar  to  oligoendopeptidase.  The 
61 surrounding  loci  of  SAV1369  belong  to  the  group  of  transport  and  binding  proteins. 
The  gene  had  also  some  identity  with  S.  epidermidis  and  0.  iheyensis.  Figure  6.20 
shows  the  homology  between  the  recovered  gene  (SAV1369  locus  in  S.  aureus  Mu50) 
and  SE  1065  locus  in  S.  epidermidis. 
PepFs  are  cytoplasmic  endopeptidases  that  hydrolyze  oligopeptides  but  cannot 
degrade  proteins  (140).  They  are  usually  named  oligopeptidases  and  constitute  a  sub- 
group  of  the  endopeptidase  family.  Several  enzymes  of  the  oligopeptidase  family  have 
been  found  in  mammals.  A  thimet  (thiol-dependent  metallo)  oligopeptidase  was 
purified  from  various  species  and  tissues.  It  hydrolyzes  peptides  which  are  6-18 
amino  acids  long.  Oligopeptidases  are  generally  characterized  by  substrate  size 
specificity.  It  was  shown  that  PepFl  did  not  cleave  peptides  containing  fewer  than  7 
or  more  than  17  amino  acids.  The  substrate  size  specificity  of  oligopeptidases  is 
probably  related  to  their  role  in  the  cells  (170).  It  seems  likely  that,  in  mammals, 
oligopeptidases  participate  in  the  later  steps  of  the  degradation  of  proteins  and  in  the 
hydrolysis  of  peptides  in  the  cytoplasm.  In  addition,  they  could  have  a  regulatory 
function  on  bioactive  peptides  like  bradykinin,  enkephalin  precursors,  luliberin, 
neurotensin,  and  angiotensin.  The  role  of  oligopeptidases  was  also  investigated  in 
bacteria.  OpdA  and  the  dipeptidyl  carboxypeptidase  of  S.  typhimurium  are  involved  in 
protein  turn-over  as  revealed  by  the  study  of  a  double  negative  mutant  for  both 
enzymes.  In  such  a  mutant,  the  release  of  trichloroacetic  acid-soluble  material  due  to 
protein  degradation  is  only  70%  of  that  obtained  in  the  wild  strain.  These  peptidases 
probably  hydrolyze  the  peptide  intermediates  formed  in  the  protein  breakdown 
pathway.  In  E.  coli,  OpdA  could  play  a  role  in  association  with  the  membrane-bound 
protease  IV.  The  two  enzymes  are  able  to  degrade  in  vitro  prolipoprotein  signal 
peptides.  In  vivo,  it  is  probable  that  OpdA  degrades  the  products  of  the  initial  cleavage 
of  the  signal  peptide  by  protease  IV  that  may  diffuse  into  the  cytoplasm  (123). 
Lactococcus  lactis  has  a  complex  proteolytic  system  which  is  essential  for  its 
growth  in  milk.  Several  oligopeptides  have  been  also  purified  in  lactococci  (158, 
170).  According  to  the  substrate  specificities  investigated,  only  two  different  enzymes 
are  apparently  present  in  L.  lactis.  PepFl  and  PepF2  are  plasmid-  and  chromosomally 
encoded  gene  products,  respectively,  of  L.  lactis  strain  NCD0763.  They  belong  to  the 
M3  family  of  peptidases  that  includes  the  mammalian  oligopeptidase  24.15  (140).  The 
gene  corresponding  to  the  lactococcal  oligopeptidase  PepFl  is  located  on  the  lactose- 
proteinase  plasmid  of  L.  lactis  subsp.  cremoris  NCD0763  (120).  The  gene  in  L.  lactis 
62 was  found  on  a  55  kb  plasmid,  which  also  carries  the  genes  coding  for  lactose 
utilization  and  for  the  cell  envelope-associated  proteinase  which  are  essential  for 
growth  in  milk.  The  gene  sequence  exhibits  similarity  around  the  catalytic  site  with 
the  thimet  oligopeptidase  and  with  the  bacterial  oligopeptidases  isolated  from  E.  coli 
and  S.  typhimurium  (124).  pepF1  and  pepF2  exhibit  80%  identity  and  encode  two 
proteins  which  are  84%  identical  (120). 
The  yjbG  gene  in  B.  subtilis  encodes  a  protein  highly  homologous  to  the  PepFl  and 
PepF2  oligopeptidases  of  L.  lactis  (84,117,120).  The  oligopeptidase  pepB  in  group  B 
streptococci  has  also  showed  high  similarity  to  PepF  in  L.  lactis  (97).  Although  the 
homology  of  the  recovered  gene  and  pepF  and  their  proteins  in  other  bacteria  is 
strong,  there  is  no  evidence  on  specific  function  of  the  gene  in  S.  aureus.  In  other 
words,  it  seems  the  enzyme  acts  in  hydrolysis  of  oligopeptides  like  other  bacteria. 
6.6.1.8  Mutant  G12  (pool  9) 
The  gene  from  this  mutant  was  homologous  with  SAV2190  (100%),  SA2005 
(100%),  and  SA2196  (99.6%)  loci  in  S.  aureus  Mu50,  N315,  and  COL  respectively. 
Figure  6.21  shows  the  region  view  of  SAV2190  locus.  SAV2190  encodes  a  conserved 
hypothetical  protein.  The  surrounding  loci  of  the  SAV2190  belong  to  different  groups 
such  as  protein  fate,  cell  envelope,  metabolism,  and  amino  acid  biosynthesis.  The 
homology  of  the  recovered  gene  from  mutant  G12  with  SAV2190  is  shown  in  figure 
6.22. 
6.6.1.9  Mutant  H3  (pool  9) 
The  gene  from  this  mutant  was  homologous  with  SAV1373  (100%),  SA1220 
(99.7%),  SA1423  (99.0%),  and  MW1276  (99.0%)  in  S.  aureus  Mu50,  N315,  COL, 
and  MW2  respectively.  These  loci  have  high  homology  to  SAV1372,  SA1219, 
SA1422,  and  MW1275  loci  in  the  same  strains  of  S.  aureus  respectively.  The  putative 
identification  for  these  loci  is  phosphate  ABC  transporter,  psiC  and  pstA  which 
belong  to  the  group  of  transport  and  binding  proteins.  The  gene  had  also  some  identity 
with  BH2993  in  B.  halodurans  C-125  and  OB3135  in  0.  iheyensis  HTE831.  The 
region  view  of  the  3  loci  is  shown  in  figure  6.23.  The  main  group  of  surrounding 
genes  is  transport  and  binding  proteins.  The  putative  identification  for  this  homology 
63 is  also  phosphate  ABC  transporter  (permease).  The  gene  had  the  same  identity  with 
different  percentage  of  homology  with  some  other  gram  positive  such  as  S. 
epidermidis  and  gram  negative  bacteria.  Figures  6.24-6.26  show  the  protein  homology 
of  recovered  gene  (SAV1373  in  S.  aureus  Mu50)  and  SE1069  in  S.  epidermidis, 
BH2993  in  B.  halodurans,  and  OB3135  in  0.  iheyensis  respectively. 
ATP  binding  cassette  (ABC)  transporters  of  pathogenic  staphylococci  are  often 
responsible  for  antibiotic  resistance  and  for  the  uptake  of  essential  solutes  and  are 
therefore  being  considered  as  targets  for  novel  antistaphylococcal  drugs.  Other  ABC 
transporters  are  involved  in  the  biosynthesis  of  a  special  class  of  peptide  antibiotics, 
the  lantibiotics,  and  in  self-protection  of  the  producer  against  them  (128). 
Bacteria  can  acquire  resistance  to  antibiotics,  among  other  possible  mechanisms,  by 
removing  the  antibiotics  from  their  place  of  action,  often  by  using  drug  exporters.  In 
staphylococci,  many  drug  exporters  are  known,  some  of  which  are  ABC  transporters. 
MsrA  and  VgaB  are  two  ABC  transporters  in  staphylococci  which  confer  resistance  to 
erythromycin  and  streptogramin  respectively  (128).  Many  of  the  proteins  involved  in 
cell  wall  metabolism  have  been  found  via  their  ability  to  confer  resistance  to 
methicillin.  Adjacent  to  the  gene  for  penicillin-binding  protein  4  (pbpD),  an  ABC 
transporter  is  encoded,  which  is  thought  to  influence  the  resistance  phenotype  by 
regulatory  means  and  not  by  serving  as  an  efflux  pump  (46). 
Several  ABC  transporters  have  been  found  in  an  approach  which  genetic  loci  with 
an  impact  on  growth  and  survival  of  S.  aureus  during  infection  were  identified  (33). 
Furthermore,  an  ABC  transporter  has  been  identified  as  the  immunodominant  protein 
during  S.  aureus  infections  (23).  Both  findings  demonstrate  that  ABC  transporters 
will  play  an  important  role  as  target  molecules  in  the  search  for  novel 
antistaphylococcal  therapies.  Oligopeptide  transporters  are  also  known  to  play  key 
roles  in  growth  regulation,  cell  competence,  adherence  to  host  cells  and  susceptibility 
or  resistance  to  host  defensins  and  toxic  peptides  (33). 
6.6.1.10  Mutant  H5  (pool  9) 
The  gene  from  this  mutant  was  homologous  with  SAV1362  (100%),  SA1209 
(100%),  SA1412  (98.0%),  and  MW1265  (98.2%)  loci  in  S.  aureus  Mu50,  N315, 
COL,  and  MW2  respectively.  The  surrounding  genes  of  the  SAV1362  are  the  group 
of  oligopeptide  transporter  putative  genes  with  a  role  in  protein  synthesis  on  one  side, 
64 and  some  hypothetical  proteins  on  the  other  side.  SAV1362  and  SA1412  locus  is  a 
putative  hydrolase.  The  gene  had  strong  identity  with  MW  1264  as  well.  The  gene  had 
also  identity  with  flaR  gene  in  L.  monocytogenes,  and  some  identity  with  S. 
epidermidis.  F1aR  is  a  histone-like  bacterial  protein  which  acts  at  specific  sites  to 
influence  DNA  topology  and,  therefore,  transcription.  flag  has  different  roles  in  DNA 
metabolism  such  as  DNA  replication,  recombination,  and  repair.  flag  is  the  first  gene 
of  this  class  that  has  been  described  in  gram  positive  pathogenic  bacteria  (142).  Figure 
6.27  shows  the  homology  between  recovered  gene  and  its  protein  (SAV1362  locus  in 
S.  aureus  Mu50)  with  LM02669locus  (f7aR)  in  L.  monocytogenes. 
6.6.2  Mutants  from  biofilm  experiments 
6.6.2.1  Mutant  F10  (pool  1) 
The  gene  from  this  mutant  had  100%  homology  with  SAV1382,  dapD,  SA1432, 
and  MW1285  loci  in  S.  aureus  Mu50,  N315,  COL,  and  MW2  respectively.  The  gene 
had  also  some  identity  with  OB1402  in  O.  iheyensis  HTE831,  EF1133  in 
Enterococcus  faecalis  V583,  BH2669  in  B.  halodurans  C-125,  and  several  other  gram 
positive  and  gram  negative  bacteria.  The  SAV1382  locus  belongs  to  the  group  of 
amino  acid  biosynthesis  which  are  also  the  next  3  genes  on  the  left  side,  and  one  on 
the  right  side.  The  other  surrounding  genes  belong  to  metabolism  and  cell  envelope 
groups.  Figure  6.28  shows  the  region  view  of  SAV1382  in  S.  aureus  Mu50,  OB1402 
in  O.  iheyensis  HTE831,  EF1133  in  E.  faecalis  V583,  and  BH2669  in  B.  halodurans 
C-125.  The  homology  of  the  recovered  gene  with  SAV1382  locus  in  S.  aureus  Mu50 
is  shown  in  figure  6.29.  Protein  homology  of  dapD  (locus  SAV1382  in  S.  aureus 
Mu50)  with  SE1077  locus  in  S.  epidermidis  is  shown  in  figure  6.30. 
The  recovered  gene  from  this  mutant  was  identified  as  tetrahydrodipicolinate 
succinylase  homolog.  This  gene  was  from  one  of  the  biofilm  experiments.  The  dap 
operon  contains  6  genes  involved  in  the  biosynthesis  of  lysine.  Tetrahydrodipicolinate 
N-succinyltransferase  (dapD)  is  essential  in  amino  acid  biosynthesis  and  catalyzes  the 
succinyl-CoA-dependent  acylation  of  L-2-amino-6-oxopimelate  to  2-N-succinyl-6- 
oxopimelate  as  part  of  the  succinylase  branch  of  the  meso-diaminopimelate/lysine 
biosynthetic  pathway  of  bacteria,  blue-green  algae,  and  plants.  This  pathway  provides 
meso-diaminopimelate  as  a  building  block  for  cell  wall  peptidoglycan  in  most 
65 bacteria,  and  is  regarded  as  a  target  pathway  for  antibacterial  agents  (15).  It  has  been 
shown  that  the  enzyme  is  a  sulfhydryl  enzyme  and  involved  in  diaminopimelate  and 
lysine  biosynthesis.  It  has  a  pH  optimum  of  8.2.  The  enzyme  has  been  identified  in 
another  STM  screening  on  S.  aureus  (33),  and  in  other  gram  positive  and  gram 
negative  bacteria  like  E.  coli  (105,149). 
A  model  system  of  growth  in  serum  has  been  shown  to  be  useful  for  the 
identification  of  genes  which  may  contribute  to  the  establishment  (surface  protein 
genes)  and  the  persistence  (biosynthetic  genes)  of  S.  aureus  in  the  bloodstream.  The 
serum  screen  is  a  simple  and  complementary  approach  to  both  STM  and  IVET  and 
may  allow  environmental  parameters  important  in  the  host  to  be  elucidated.  Several 
genes  including  dapA  have  been  identified  in  S.  aureus  by  using  the  serum  screen 
(168). 
This  work  is  the  first  that  has  used  the  STM  method  in  biofilm  systems.  This  is  also 
the  first  time  that  the  dapD  gene  has  been  recovered  from  a  gene  screening  in  biofilm, 
although  it  needs  more  work  to  confirm  the  exact  role  of  the  gene  in  biofilm 
formation.  The  enzyme  has  been  identified  in  another  STM  screening  on  S.  aureus 
(33).  This  work  also  showed  that  the  STM  method  works  well,  as  confirms  other 
findings. 
6.6.2.2  Mutant  F11  (pool  1) 
The  gene  from  this  mutant  was  homologous  with  SAV1393  (100%),  SA1240 
(100%),  SA1444  (99.7%),  and  MW1298  (99.7%)  loci  in  S.  aureus  Mu50,  N315, 
COL,  and  MW2  respectively.  The  gene  had  also  some  identity  with  branched-chain- 
amino-acid  transporter  of  S.  aureus.  The  homology  between  the  recovered  gene  and 
the  branched-chain-amino-acid  transporter  is  shown  in  figure  6.31.  The  gene  had  also 
some  identity  with  yojO  in  B.  subtilis  168  and  OB0842  in  O.  iheyensis  HTE831. 
Figure  6.32  shows  the  region  view  of  SAV1393  in  S.  aureus  Mu50,  yojO  in  B.  subtilis 
168,  and  OB0842  in  0.  iheyensis  HTE831. 
The  recovered  gene  had  some  identity  with  branched-chain-amino-acid  transporter 
of  S.  aureus.  The  branched-chain-amino-acid  transport  gene  (brnQ)  encodes  a  highly 
hydrophobic  polypeptide.  The  polypeptide  has  high  homology  to  the  Na+-dependent 
branched-chain-amino-acid  carriers  in  several  gram  negative  bacteria,  and  branched- 
chain-amino-acid  carriers  in  several  gram  positive  bacteria  (165). 
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Figure  6.8  Region  view  display  of  the  SAV1394  locus  in  S.  aureus  Mu50  (top),  yojN  in  B.  subti/is 
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Figure  6.18  Region  view  display  of  the  SAV1474  locus  in  S.  aureus  Mu50  (top),  ypaA  in  B.  subti/is 
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Figure  6.21  Region  view  display  of  the  SAV2190  locus  in  S  aureus  Mu50 OOM 
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Figure  6.28  Region  view  display  of  the  SAV1382  locus  in  S.  aureus  Mu50  (top),  OB1402  in  O. 
iheyensis  HTE831  (the  second),  EFI  133  in  Enterococcus  faecalis  V583  (the  third),  and  BH2669  in 
B.  halodurans  C-125  (bottom). 
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Figure  6.32  Region  view  display  of  the  SAV1393  locus  in  S.  aureus  Mu50  (top),  yojO  in  B.  subtilis 
168  (the  middle),  and  OB0842  in  O.  iheyensis  HTE831  (bottom). 
Note:  There  are  some  rearrangement  of  the  SAV1394  and  SAV1395  loci  in  the  sequence  of  the 
whole  genome,  as  the  two  loci  are  also  seen  with  different  sizes  in  the  opposite  direction  (see 
figure  6.28). Part  III 
Discussion Chapter  7 
General  discussion Chapter  7:  General  discussion 
S.  aureus  is  a  highly  versatile  pathogen,  well  adapted  to  survive  in  many  niches  in 
and  on  humans.  The  ability  of  S.  aureus  to  evade  the  host  immune  response  and  cause 
disease  is  due  to  an  extensive  repertoire  of  both  known  and  unknown  virulence 
factors.  Much  of  our  knowledge  about  the  virulence  determinants  of  pathogenic 
bacteria  comes  from  experiments  with  bacteria  grown  in  culture,  but  there  is  currently 
an  increasing  interest  in  what  happens  to  bacterial  pathogens  in  the  infected  host.  In 
the  past  few  years,  the  study  of  bacterial  pathogenesis  has  been  advanced  by  a  number 
of  techniques  that  enable  investigators  to  monitor  bacterial  gene  expression  during 
infection.  These  techniques  allow  the  investigator  to  select  and  screen  for  genes  that 
are  required  for  infection  or  that  are  expressed  in  vivo.  Two  main  categories  of  these 
techniques  are  in  vivo  expression  technology  (IVET)  and  signature-tagged 
mutagenesis  (STM).  Both  methods  have  been  used  to  identify  virulence  genes  in  S. 
aureus.  The  aim  of  this  project  was  to  find  any  probable  new  genes  of  S.  aureus  that 
is  essential  for  biofilm  formation  and  in  a  mouse  infection  model  by  STM. 
IVET  has  been  applied  to  S.  aureus  using  a  promoter  trap  that  relies  on  genetic 
recombination  of  the  site-specific  resolvase  of  tnpR  from  gamma  delta  (Tn1000)  as  a 
reporter  of  gene  expression.  A  collection  of  45  genes  were  found  induced  during 
infection  in  a  murine  renal  abscess  model.  Of  these,  only  six  had  been  known 
previously;  11  others  have  homology  to  known  non-staphylococcal  genes.  The  known 
staphylococcal  genes  included  agrA,  a  key  locus  regulating  numerous  virulence 
products;  and  a  glycerol  ester  hydrolase  which  may  enhance  bacterial  survival  in 
abscesses.  Many  of  the  ivi  genes  identified  were  not  classical  virulence  factors  but 
rather  involved  in  adaptation  to  the  in  vivo  environment;  knowledge  of  these 
biochemical  pathways  is  clearly  the  next  phase  in  IVET  systems  (98). 
STM  is  a  powerful  genetic  method,  developed  by  David  Holden  and  his  colleagues 
in  1995,  to  identify  genes  in  pathogens  that  are  required  for  growth  in  an  animal.  In 
essence,  STM  enables  one  to  test  a  large  number  of  potential  mutants  simultaneously 
in  one  animal,  and  to  identify  and  recover  mutants  that  fail  to  colonize  host  tissues. 
Factors  identified  by  STM  are  essential  for  colonization  in  the  niche  tested.  This 
feature  is  unique  to  STM  among  various  genomic  strategies  developed  thus  far  to 
study  pathogens  in  vivo.  Other  methods,  such  as  IVET,  DFI  and  microarray  analysis, 
67 identify  genes  whose  expression  is  induced  in  the  host;  additional  experiments  are 
required  to  determine  whether  the  gene  is  necessary  for  colonization  of  host  tissues. 
During  the  past  seven  years,  STM  has  been  successfully  applied  to  a  large  variety  of 
bacterial  pathogens  in  hosts  ranging  from  cows  to  amoeba  to  cultured  cells.  In  most 
studies,  both  predicted  and  unsuspected  virulence  factors  have  been  identified  and 
include  a  vast  variety  of  proteins  involved  in  different  functions,  as  well  as  open 
reading  frames  (ORFs)  with  unknown  function  or  with  no  homology  to  other  genes  in 
GenBank. 
Mutagenesis  techniques  have  been  used  extensively  for  the  identification  of  genes 
whose  functions  are  required  under  certain  conditions.  One  of  these  techniques  that 
has  been  used  in  several  pathogens  is  transposon  mutagenesis.  Three  limitations  of  the 
transposon  mutagenesis  approach  should  be  kept  in  mind. 
First,  transposons  carry  transcriptional  terminators.  If  a  transposon  lands  in  the  first 
gene  in  an  operon,  it  will  eliminate  expression  not  only  of  that  gene  but  also  of 
downstream  genes  as  well;  in  other  words,  transposon  insertions  are  polar.  The 
avirulent  phenotype  of  the  mutant  could  thus  be  due  to  loss  of  expression  of  either  the 
gene  interrupted  by  the  transposon  or  downstream  genes  in  the  operon. 
A  second  limitation  is  that  transposon  insertion  mutants  can  be  obtained  only  in 
genes  that  are  not  essential  for  growth  on  the  selective  medium.  A  transposon 
insertion  in  a  gene  essential  for  growth  will  not  be  isolated  because  the  bacteria  will 
not  survive  to  form  a  colony.  This  could  be  considered  an  advantage  if  one  assumes 
that  the  most  interesting  virulence  genes  are  not  the  ones  essential  for  growth  in 
laboratory  medium  but  are  genes  induced  specifically  in  an  animal  host  (141).  The 
most  important  disadvantage  of  transposon  mutagenesis  is  that  to  screen  for  loss  of 
virulence  would  require  each  mutant  to  be  tested  separately.  So,  we  need  methods  to 
label  individual  mutants,  and  then  pools  can  be  screened.  In  other  words,  a  number  of 
mutants  (e.  g.,  96  from  a  microtiter  dish)  can  be  screened  simultaneously. 
The  third  limitation  is  that  transposon  mutagenesis  is  not  fully  random  and  may 
have  favoured  mutation  of  certain  areas  of  the  chromosome  over  others  (29). 
As  STM  is  based  on  transposon  mutagenesis,  it  has  the  above  limitations.  It  should 
be  also  noted  that,  depending  on  the  sensitivity  of  the  PCR/hybridisation  protocol  for 
detecting  such  changes  in  tag  populations,  STM  might  not  identify  mutations  causing 
small  or  even  moderate  reduction  in  survival.  This  is  a  particularly  important 
consideration  because  this  category  includes  mutations  in  genes  that  are  critical  for 
68 causing  disease  but  do  not  appreciably  affect  survival  of  the  bacterium  in  the  host.  For 
example,  it  is  the  action  of  cholera  toxin  that  is  primarily  responsible  for  the  lethality 
of  cholera,  but  deletion  of  the  cholera  toxin  genes  does  not  affect  the  bacterium's 
ability  to  colonize  the  host  (159). 
In  the  first  step  of  the  project,  a  library  of  S.  aurcus  tagged  insertion  mutants  was 
given  to  us  by  Professor  Holden.  A  series  of  artificial  input  and  output  pools  was 
chosen  and  hybridisation  experiments  were  done.  Cross-hybridisation  was  seen  in 
most  of  the  experiments.  According  to  the  results  of  the  hybridisation  experiments  on 
the  existing  library,  it  was  concluded  that  the  library  was  not  reliable  for  a  cross- 
hybridisation  free  screening.  There  are  at  least  3  possible  reasons  for  this  problem,  (i) 
the  problem  with  hybridisation  itself,  (ii)  incomplete  removal  of  the  arms  of  the  tags 
in  the  process  of  digestion  and  making  the  probes,  and  (iii)  contamination  of  the  tags. 
The  first  2  possibilities  are  excluded  as  they  are  not  supported  by  some  series  of 
experiments,  and  as  results  showed  the  protocol  worked  in  some  experiments.  It  is 
therefore  concluded  that  the  problem  was  more  likely  the  contamination  of  the 
mutants  with  each  other  or  original  tags  used  to  make  the  library.  This  could  have 
occurred  in  the  first  inoculation  from  the  master  plates  (which  contain  all  the 
representative  tags  in  each  plate)  to  the  cryotubes.  As  the  existing  library  of  mutants 
showed  unexpected  cross-hybridisation,  the  whole  library  was  discarded.  The  details 
of  experiments  on  the  existing  library  are  presented  in  chapter  3.  We  next  tried  to  use 
the  selected  tags  in  plasmids  of  S.  aureus  strain  RN6390  for  future  experiments. 
In  the  second  step  of  the  project,  the  selected  tags  in  plasmids  of  S.  aureus  RN6390 
were  used.  The  plasmids  were  also  given  to  us  by  Professor  Holden.  A  series  of 
artificial  input  and  output  pools  was  chosen  and  hybridisation  experiments  were  done. 
Cross-hybridisation  was  seen  in  most  of  the  experiments.  4  plasmids  which  had  cross- 
hybridisation  were  sequenced.  The  results  showed  that  3  out  of  4  were  exactly  the 
same.  It  was  therefore  decided  that  all  94  tags  should  be  sequenced.  84  out  of  94  were 
sequenced.  The  results  showed  that  51  out  of  84  had  more  than  50%  identity,  and 
were  not  therefore  suitable  for  a  cross-hybridisation  free  screening.  33  tags  with  less 
than  50%  identity  were  chosen  for  future  experiments.  The  details  of  the  experiments 
on  the  selected  tags  in  plasmids  of  S.  aureus  are  presented  in  chapter  4. 
In  the  third  step  of  the  project,  we  tried  to  construct  a  new  library  of  mutants  from 
the  33  selected  tags.  A  library  of  825  mutants,  divided  into  25  pools  of  33  individually 
tagged  members  was  constructed  for  future  experiments.  Several  random  mutants 
69 from  the  library  were  chosen  and  tested  in  two  ways.  The  results  showed  that  (i)  the 
constructed  mutants  lacked  the  plasmid  and  carry  a  single  chromosomal  insertion  of 
Tn917,  and  (ii)  there  was  no  cross-hybridisation  between  the  mutants  of  the 
constructed  library.  In  addition,  to  determine  the  mutagenesis  had  occurred  randomly 
across  the  genomic  DNA  of  the  mutants  of  the  constructed  library,  all  the  mutants  of 
the  constructed  library  were  tested  for  catalase  enzyme  production  individually.  As 
there  was  one  catalase-negative  mutant  in  the  library,  this  showed  that  loss  of  known 
phenotypes  could  be  detected.  In  other  words,  mutagenesis  has  also  occurred  in 
known  genes  such  as  catalase  gene.  The  details  of  the  construction  of  the  library  of 
tagged  insertion  mutants  are  presented  in  chapter  5. 
In  the  fourth  and  last  step  of  the  project,  the  constructed  library  was  used  in  two 
experimental  systems:  mouse  infection  and  biofilm.  The  mouse  infection  model  has 
been  used  before  (33,112,146),  but  STM  in  biofilm  experiments  has  been  done  for 
the  first  time.  Totally  25  pools  of  33  mutants  were  screened  at  least  once  in  each 
model.  The  DNA  regions  flanking  the  pBR322  side  of  the  transposon  insertion  points 
of  12  mutants  were  cloned  as  described  before  in  section  6.5.  The  nucleotide 
sequences  of  the  flanking  regions  were  determined  and  subsequently  analysed  by 
searching  the  DNA  and  protein  databases  for  identical  or  similar  genes  (tables  6.1  & 
6.2).  The  details  of  gene  recovery  from  the  attenuated  mutants  are  presented  in 
chapter  6. 
To  determine  the  mutagenesis  had  occurred  randomly  across  the  genomic  DNA  of 
the  mutants  of  the  constructed  library,  some  of  the  known  phenotypic  characteristics 
can  be  traced.  Catalase  production  was  chosen  for  this  purpose.  The  results  showed 
that  1  out  of  825  mutants  of  the  constructed  library  was  catalase  negative.  This  shows 
that  integration  of  the  tags  into  genomic  DNA  of  the  mutants  has  been  occurred 
randomly,  as  some  of  the  known  phenotypic  characteristics  such  as  catalase 
production  have  been  also  affected.  The  catalase  negative  and  wild  type  strains  were 
injected  intraperitoneally  into  mice.  The  number  of  recovered  bacteria  from  the  mice 
showed  no  discernible  difference  (figure  5.3).  It  could  be  concluded  that  catalase  does 
not  affect  the  growth  of  bacteria  in  mouse. 
The  recovered  genes  in  this  project  can  be  viewed  in  different  aspects.  The  first  is 
the  homology  between  these  genes  and  those  from  the  published  complete  sequences 
of  four  strains  of  S.  aureus,  and  other  bacterial  genomic  sequences  in  GeneBank.  In 
this  view,  some  of  the  recovered  genes  have  strong  homology  with  the  four  strains, 
70 and  some  other  gram  positive  and  gram  negative  bacteria,  as  well.  There  are  some 
recovered  genes  that  have  homology  just  with  the  four  strains  of  S.  aurcus.  The  third 
and  last  group  which  includes  two  genes  had  homology  just  with  3  out  of  the  four 
strains.  It  seems  that  this  could  be  usual,  as  there  are  more  than  2500  ORFs  in  the 
complete  sequence  of  S.  aureus,  and  there  are  some  differences  between  different 
strains  within  a  species.  On  the  other  hand,  bacteria  have  usually  some  identical  or 
common  genes,  and  this  should  be  much  closer  within  a  definite  group  such  as  gram 
positive  and  gram  negative  bacteria.  8  out  of  12  genes  had  some  identity  with  S. 
epidermidis,  and  the  same  number  had  some  identity  with  other  bacteria  especially 
gram  positive  bacteria. 
The  second  point  of  view  could  be  the  kind  of  recovered  genes,  and  their  role  in  the 
cells.  In  addition,  the  results  could  be  compared  with  other  searches  especially  those 
that  have  done  using  STM  method.  4  out  of  12  recovered  genes  in  current  study  were 
in  the  transport  and  binding  proteins  group.  This  maybe  represents  the  frequency  and 
the  number  of  such  genes  in  comparison  to  the  total  number  of  genes  in  the  whole 
genome.  The  other  possibility,  as  discussed  before,  is  that  transposon  mutagenesis  is 
not  fully  random  and  may  have  favoured  mutation  of  certain  areas  of  the  chromosome 
over  others  (20).  As  STM  has  based  on  transposon  mutagenesis,  it  may  show  this 
limitation  in  some  cases. 
There  were  4  out  of  12  sequences  identified  as  conserved  hypothetical  protein 
and/or  hypothetical  protein  with  unknown  function  and  one  with  a  role  in  DNA 
metabolism.  All  of  these  sequences  were  from  mice  infection  experiments.  The  whole 
genome  of  S.  aureus  Mu50  and  N315  has  2697  and  2595  open  reading  frames 
respectively  including  70  putative  virulence  factors  (88).  According  to  the  high 
number  of  genes  in  the  genome  of  S.  aureus,  it  seems  that  it  is  usual  to  find  some  of 
the  genes  as  hypothetical  proteins  with  unknown  function  in  such  projects. 
One  of  the  conserved  hypothetical  proteins  with  locus  1362  has  been  identified  in  2 
strains  (B  11  and  H5)  of  output  pools  from  the  mice  experiments. 
Several  sequences  showed  different  homology  with  O.  iheyensis  HTE831  and  B. 
subtilis.  O.  iheyensis  is  an  extremely  halotolerant  and  alkaliphilic  gram  positive, 
strictly  aerobic,  rod-shaped,  motile  by  peritrichous  flagella,  and  spore  forming. 
Phylogenetic  placement  of  the  bacterium  is  comparatively  close  to  that  of  B.  subtilis 
(100).  The  genome  of  the  bacterium  also  contains  27  putative  phage-associated  genes, 
which  are  similar  to  those  of  several  bacteria  including  S.  aureus  and  B.  subtilis  (157). 
71 Media  are  made  selective  for  staphylococci  by  including  7.5%  (w/v)  NaCl. 
Staphylococci  can  tolerate  unusually  high  NaCl  concentrations,  with  S.  aurcus 
capable  of  growth  in  media  of  water  activity  (aW)  of  0.86,  which  is  equivalent  to  3.5 
M  (20%)  NaCI  (36).  That  is  not  surprising  that  there  is  some  homology  between  S. 
aureus  and  O.  iheyensis  genomes,  as  high  NaCl  tolerance  is  common  in  both  bacteria. 
In  total  12  (1.45%)  samples  showed  moderately  attenuated  hybridisation  signals  in 
this  study.  This  is  less  than  the  number  of  attenuated  mutants  in  other  works  by  Mei  et 
al  (112)  and  Coulter  et  al  (33)  which  were  50  (4.01%)  and  237  (7.11-8.36%  in 
different  infection  environments)  respectively.  In  the  last  work,  only  85  out  of  237 
mutants  were  sequenced. 
Virulence  in  S.  aureus  has  been  studied  by  using  STM  methodology  (33,112,146). 
In  the  study  by  Mei  et  al  (112),  Tn917  mutants  were  tested  in  a  murine  model  of 
bacteraemia.  The  majority  of  loci  from  50  mutants  that  were  identified  as  attenuated 
were  predicted  by  sequence  similarity  to  be  involved  in  cell  surface  metabolism  (e.  g. 
peptidoglycan  cross-linking  and  transport  functions),  nutrient  biosynthesis,  and 
cellular  repair  processes,  but  most  of  the  remainder  had  no  known  function.  A  slightly 
larger  signature-tagged  mutant  bank  was  constructed  by  using  the  same  transposon 
and  tested  in  models  of  bacteraemia,  abscess  and  wound  formation,  and  endocarditis 
(33).  This  enabled  the  identification  of  various  genes  affecting  growth  and  virulence 
in  specific  disease  states,  as  well  as  18  that  are  important  in  at  least  three  of  the 
infection  models.  Many  of  these  genes  appear  to  be  involved  in  the  same  kinds  of 
processes  as  those  identified  in  the  earlier  study  (112);  indeed,  several  genes 
identified  by  Mei  et  al  (112)  were  also  found  by  Coulter  et  al  (33).  As  in  these  earlier 
studies,  both  predicted  and  unsuspected  virulence  factors,  as  well  as  ORFs  with 
unknown  function  have  also  been  identified  in  the  present  study.  Two  genes  identified 
in  this  work  were  also  found  by  Coulter  et  al  (33).  This  similarity  shows:  first,  our 
system  with  the  new  constructed  library  worked  properly,  and  second,  this  maybe 
strengthen  the  opinion  that  transposon  mutagenesis  (including  STM)  is  not  fully 
random,  and  may  have  favoured  mutation  of  certain  areas  of  the  chromosome  over 
others. 
The  assortment  of  independent  mutations  recovered  in  peptide  and  amino  acid 
transport  mechanisms  emphasizes  the  biological  significance  of  these  loci  on  S. 
aureus  survival  in  single  or  multiple  in  vivo  environments. 
72 This  work  is  the  first  that  use  the  STM  method  in  biofilm  systems.  This  is  also  the 
first  time  that  dapD  gene  has  been  recovered  from  a  gene  screening  in  biofilm, 
although  it  needs  more  work  to  confirm  the  exact  role  of  the  gene  in  biofilm 
formation  especially  in  S.  aureus.  The  enzyme  has  been  also  identified  in  a  mouse 
infection  model  in  another  STM  screening  on  S.  aureus  (33).  In  other  words,  this 
work  also  showed  that  the  STM  method  works  well,  as  confirms  other  findings.  It 
could  also  be  concluded  that  there  is  a  link  between  biofilm  formation  and  infection  in 
vivo,  as  the  enzyme  has  been  identified  in  both  systems. 
This  work  could  be  followed  in  different  ways  in  future.  The  more  the  number  of 
tag  insertion  mutants  in  the  library  are,  the  more  efficient  the  screening  will  be.  In 
addition,  it  is  advisable  to  make  defined  single  mutations  to  determine  and  confirm 
the  role  of  the  genes  in  more  details,  e.  g.  defined  mutant  relating  to  nitric-oxide 
reductase  and  test  susceptibility  to  NO  in  vitro. 
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Materials Appendix:  Materials 
Agarose  MP  (multi  purpose  agarose): 
Roche  Diagnostics  GmbH,  #  1388991 
Ampicillin  stock  solution: 
Sigma,  #  A-9518,50  mg/ml 
Brain  heart  infusion  (BHI)  agar: 
Oxoid,  #  CM225,37  gr/litre  with  1.5%  agar,  autoclaved 
Brain  heart  infusion  (BFII)  broth: 
Oxoid,  #  CM225,37gr/litre,  autoclaved 
Blocking  Reagent  stock  solution: 
Roche  Diagnostics  GmbH,  #  1096176,  Blocking  reagent  was  dissolved  in  maleic  acid 
buffer  to  a  final  concentration  of  10%  (w/v)  with  shaking  and  heating,  and  then 
autoclaved. 
Chloramphenicol  stock  solution: 
Sigma,  #  C-0378,20mg/ml 
Chloroform: 
Fisher  Scientific,  #  C/4960/17 
CSPD®  (Disodium  3-(4-methoxyspiro{1,2-dioxetane-3,2'-(5'- 
chloro)tricycle[3.3.1.13'7]decan}-4-y1)  phenyl  phosphate: 
Roche  Diagnostics  GmbH,  #  1755633 
CTAB/NaCI  (10%  hexadecyltrimethyl  ammonium  bromide  in  0.7  M  NaCI): 
4.09  g  NaCl  was  dissolved  in  80  ml  distilled  water.  10  g  CTAB  was  added  and  mixed. 
20  ml  of  distilled  water  was  added.  The  solution  is  viscous,  and  should  be 
homogenised  by  using  stirrer  and  microwave. 
74 Denaturation  solution: 
0.5  N  NaOH,  1.5  M  NaCI 
Detection  buffer: 
100  mM  Tris-HCI,  pH  9.5  (+20°C),  100  mM  NaCI 
Epicurian  Coli®  XL1-Blue  Competent  Cells: 
Stratagene,  #  200249 
Erythromycin  stock  solution: 
Sigma,  #  E-6376,20  mg/ml 
Ethanol: 
Bamford  Laboratories,  #  200-578-6 
Glycerol: 
Sigma-Aldrich  GmbH,  #  15523 
Hind  III: 
Life  technologies,  #  15207-012 
Hybond®  N+  Nylon  membrane: 
Amersham  Pharmacia  Biotech,  #  RPN203N 
Hydrogen  peroxide: 
Sigma,  #  H-1009,30% 
Iso-amyl  alcohol: 
Fisher  Scientific,  #  A/7080/08 
Isopropanol  (Iso-propyl  alcohol): 
BDH  Company,  #  10224BQ 
1  Kb  DNA  Ladder: 
Life  Technologies,  #  15615-016 
75 25  bp  DNA  ladder: 
Invitrogen,  Life  technologies,  #  10597-011 
Luria-Bertani  (LB)  agar: 
Sigma,  #  L-3522,25  gr/litre,  with  1.5%  agar,  autoclaved 
Luria-Bertani  (LB)  broth: 
Sigma,  #  L-3522,25  gr/litre,  autoclaved 
Lysostaphin: 
Sigma,  #  L-0761;  3M  Sodium  acetate  pH  5.2,33.3  µl;  distilled  water  966.7  µl 
Lysozyme  stock  solution: 
Sigma,  #  L-6876 
Maleic  acid  buffer: 
Sigma,  #  M-0375,0.1M  Maleic  acid,  0.15  M  NaCl,  pH  7.5  (+20°C),  adjust  pH  with 
concentrated  or  solid  NaOH,  autoclaved 
NaCI: 
Sigma-Aldrich  GmbH,  #  31434 
Neutralization  solution: 
0.5  M  Tris-HCI,  pH  7.5,3  M  NaCI 
N-lauroylsarcosine: 
10%  (w/v)  in  sterile  H2O,  filtered  through  a  0.2-0.45  µm  membrane 
PCR  DIG  Labelling  Mix: 
Roche  Diagnostics  GmbH,  #  1585550 
76 Primers: 
P1  (5'---3') 
CTT  CAA  TTC  CTA  TTA  TAC 
Modification:  5'  IRD  700 
P2  (5'->3') 
CAT  ATT  TGA  ATG  TAT  TTA  G 
Modification:  5'  IRD  800 
P12  (5'--*3') 
ATT  CTA  CAA  CCT  CAA  GC 
P13  (5'->3')  ' 
ATT  CCA  TTC  TAA  CCA  AGC 
P21  (5'-3') 
TAA  GAC  ACG  ACT  TAT  CGC CA 
P22  (5'-->3') 
CGT  TGC  GCA  AAC  TAT  TAA  CT 
Pseq-1  (5'--+3') 
AGA  GAG  ATG  TCA  CCG  TCA  AGT 
P009823  (5'->3') 
CAA  CAT  GAC  GAA  TCC  CTC  C 
P009824  (5'-43') 
GGG  AAT  AAG  GGC  GAC  ACG 
Proteinase  K  stock  solution: 
Life  Technologies,  #  25530-015,20  mg/ml  distilled  water 
77 RNase: 
10  mg/ml,  Qiagen 
SDS  stock  solution: 
Fisher  scientific,  #  S/P530/53,10%  (w/v)  in  H2O,  filtered  through  a  0.2-0.45  µm 
membrane 
SET,  pH  7.5: 
20%  sucrose,  50  mM  EDTA,  50  mM  Tris  Base 
SSC  stock  solution  (20x): 
3M  NaCI,  0.3  M  sodium  citrate,  pH  7.0  (+20°C),  autoclaved 
Standard  hybridization  buffer: 
5x  SSC,  0.1%  N-lauroylsarcosine,  0.02%  SDS,  1%  Blocking  Reagent  (from  the  10% 
Blocking  Reagent  stock  solution) 
Taq  DNA  polymerase: 
Promega,  #  M1861 
T4  DNA  Ligase: 
Promega,  #  M1801 
TE  buffer: 
10  mM  Tris-HC1,1  mM  EDTA,  pH  8.0  (+20°C) 
Trizmä  Base  (Tris  [hyd  roxymethyll  amino  methane): 
Sigma,  #  T-1503 
Trizmä  Hydrochloride  (Tris[hydroxymethyl]  aminomethane  hydrochloride): 
Sigma,  #  T-3253 
Tween  20  (Polyoxyethylene-sorbitan  monolaurate): 
Sigma,  #  P-1379 
78 Washing  buffer: 
Add  0.3%  (w/v)  Tween  20  to  Maleic  acid  buffer. 
Washing  solution  2x: 
2x  SSC,  0.1%  SDS 
Washing  solution  0.5x: 
0.5x  SSC,  0.1%  SDS 
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